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List of abbreviations
α-GPDH   α-glycerophosphate dehydrogenase 
α-KGDH  α-ketoglutarate dehydrogenase
Dy   mitochondrial membrane potential
DpH   proton gradient
DV   plasma membrane potential
4HNE    4-hydroxynonenal 
AA   antimycin A
acetyl-CoA  acetyl-coenzyme A 
ANT   adenine nucleotide translocase
BA   bongkrekic acid
BIN   binary image
CI-CV   mitochondrial complex I-complex V
CAT   catalase
CM-H2DCFDA  5-(and-6)-chloromethyl-2′,7′-dichlorodihydrofluorescein 
diacetate ester
COR   background corrected image
(cp)YFP   (circularly permuted) yellow fluorescent protein
CuZnSOD  copper-zinc superoxide dismutase or SOD1
Cyt c   cytochrome c
ETC   electron transport system
ETF   electron-transferring flavoprotein
FCCP   carbonyl cyanide-p-trifluoromethoxyphenylhydrazone
F1,6bP   fructose-1,6-bisphosphate
FADH2   reduced flavin adenine dinucleotide 
G6P   glucose-6-phosphate 
GLUT   glucose transporter
GPx    glutathione peroxide
GR    glutathione reductase
GSH   glutathione
GSSG   oxidized glutathione
HEt   hydroethidium
HT   HEPES-Tris 
IMS   intermembrane space
KCN   potassium cyanide 
L•   carbon-centered lipid radicals
LCS   linear contrast stretch
LOO•   lipid peroxyl radicals 
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MALO   tert-butyl methyl malonate
MED   median filter
MEFs   mouse embryonic fibroblasts
MIM   mitochondrial inner membrane
MDA    malondialdehyde b-hydroxyacrolein 
MnSOD   manganese superoxide dismutase or SOD2
MOM   mitochondrial outer membrane
MSK   masked image
NADH   reduced nicotinamide adenine dinucleotide
NADPH   nicotinamide adenine dinucleotide phosphate 
OLI   oligomycin A
OXPHOS  oxidative phosphorylation
PA   piericidin A
PM   plasma membrane
PMF   proton-motive force 
PPP   pentose phosphate pathway
Prx    peroxiredoxin
Q/CoQ   coenzyme Q10/ubiquinone
R123   Rhodamine 123
RET   reverse electron transfer
ROI   region of interest
ROS   reactive oxygen species
ROT   rotenone
TCA   tricarboxylic acid
TMRM   tetramethyl rhodamine methyl ester
TPP+   triphenylphosphonium
TRx    thioredoxin
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1
Cellular energy metabolism
To sustain life every cell in our body has to continually perform work in the form of 
thermodynamically unfavourable reactions. Together, these reactions require substantial 
amounts of energy to achieve muscle contraction or electrical signal transduction in the 
nerve system. In biological systems the primary energy-carrying molecule is adenosine 
triphosphate (ATP) that releases its energy when hydrolysed to adenosine diposphate 
(ADP) and inorganic phosphate (Pi). In most eukaryotes ATP is synthesized by two main 
pathways: glycolysis and oxidative phosphorylation (OXPHOS). For both mechanisms 
D-glucose serves as the prime energy source and enters the cell via facilitated diffusion 
through glucose transporters (GLUTs) in the plasma membrane (PM) [1]. Following entry, 
D-glucose is phosphorylated to glucose-6-phosphate (G6P) by hexokinase. Because the 
PM generally lacks transporters for phosphorylated sugars, G6P becomes trapped inside the 
cytosol. At this stage G6P may be converted to glycogen for energy storage, oxidized in the 
pentose phosphate pathway (PPP) to yield nicotinamide adenine dinucleotide phosphate 
(NADPH) and nucleic acid precursors, or continue through glycolysis to provide ATP and 
metabolic intermediates (Fig. 1.1). Similar to D-glucose, the monosaccharides D-galactose 
and D-fructose also can serve as substrates by entering the glycolytic pathway as G6P 
and fructose-6-phosphate, respectively. Fructose-6-phosphate is then phosphorylated to 
yield fructose-1,6-bisphosphate, which is subsequently split into 2 three-carbon molecules, 
glyceraldehyde-3-phosphate and dihydroxyacetone phosphate. These are the actual “lysis” 
products that give the glycolysis pathway its name. Both phosphorylation of D-glucose and 
fructose-6-phosphate in this first phase of glycolysis actually requires an ATP molecule. 
However in the second phase of glycolysis, two molecules of glyceraldehyde-3-phosphate 
per original D-glucose molecule are ultimately converted to two pyruvate molecules, 
with the concomitant production of four ATP and two reduced nicotinamide adenine 
dinucleotide (NADH) molecules. Therefore, glycolysis yields two ATP molecules per 
molecule of glucose. 
Under anaerobic or low oxygen (hypoxic) conditions, such as can occur during endurance 
exercise, pyruvate is converted to lactate in order to regenerate the NAD+ required for 
continuation of glycolysis. However under optimally energy-efficient (i.e. aerobic) 
conditions, pyuvate is transported into the mitochondria by the mitochondrial pyruvate 
carrier (Mpc) [2] to be further oxidized and ultimately yield an additional 28-30 ATP 
molecules.
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Figure 1.1 Overview of glycolysis and the tricarboxylic acid cycle. 
For details, see text.
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Mitochondrial ATP production
Mitochondria are highly motile, granular organelles each containing an inner membrane 
(MIM) enveloped by an outer membrane (MOM; Fig. 1.2). In contrast to the MIM, the 
MOM is permeable to ions and small molecules (Mr>5,000) due to the existence of 
transmembrane channels called porins. The MIM is highly folded with protrusions into 
a matrix compartment called “cristae” that greatly increase the surface area to contain 
the components of the electron transport system (ETC), consisting of four multiprotein 
complexes (CI-CIV), and ATP synthase, together called the OXPHOS system (Fig. 1.2). In 
addition, the pyruvate dehydrogenase complex, enzymes of the tricarboxylic acid (TCA) 
cycle, the fatty acid b-oxidation pathway and the pathways for amino acid oxidation are 
located into the matrix. Therefore all fuel oxidation systems except for glycolysis, which 
takes place in the cytosol, are contained within the mitochondria. In addition, mitochondria 
participate in a number of intracellular processes such as the generation, modulation, and 
propagation of cytosolic Ca2+ signals, apoptosis, adaptive thermogenesis, ion homeostasis, 
(innate) immune responses and the production of reactive oxygen species (ROS) [3–8].
Upon entering the mitochondrial matrix, pyruvate, fatty acids and amino acids are 
oxidized to acetyl-coenzyme A (acetyl-CoA), that enters the TCA cycle (Fig. 1.1). Here, it 
will go through a series of reactions that mostly yields NADH and reduced flavin adenine 
dinucleotide (FADH2), which are rich in high-energy electrons. These electrons are abstracted 
by CI and CII of the ETC, respectively, and donated to ubiquinone (a.k.a. coenzyme Q10, or 
Q; Fig. 1.2). Although not considered a “classical” ETC enzyme, also electron-transferring 
flavoprotein (ETF) can donate electrons to Q that are derived from fatty acid b-oxidation [9]. 
From Q the electrons are transported onwards to CIII and to CIV (by cytochrome c; cyt c) to 
ultimately react with molecular oxygen (O2) yielding water (H2O). Importantly, the energy 
released by the electron transport is used at CI, CIII and CIV to extrude protons (H+) from the 
matrix to the mitochondrial intermembrane space (IMS; Fig. 1.2). This process generates an 
inward-directed proton-motive force (PMF) consisting of a trans-MIM potential difference 
(Dy) and proton gradient (DpH). As first proposed by Peter Mitchell in 1961 [10], this PMF 
is used to fuel ATP synthesis by allowing protons to flow back into mitochondrial matrix via 
the FoF1-ATPase or Complex V (CV; Fig. 1.2).
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Figure 1.2 Mitochondrial ultrastructure and the oxidative phosphorylation system. 
Schematic depiction of the mitochondrial ultrastructure (left panel) consisting of a mitochondrial 
outer membrane (MOM), intermembrane space (IMS), mitochondrial inner membrane (MIM) with 
invaginations called cristae and a matrix compartment. The oxidative phosphorylation system is 
embedded in the MIM (right panel). The dotted black arrows indicate electron transport, and the grey 
arrows and lines depict proton movement.
Abbreviations: I-V, complex I-V; Dy, mitochondrial membrane potential; DpH, difference in pH 
between matrix and IMS; Q, Co-enzyme Q; Cyt c, cytochrome c; e-, electron.
Mitochondrial ROS production
Due to the nature of the sites used by ETC complexes for electron transfer, mitochondria 
represent a consistent source of ROS production in healthy cells. The term “ROS” encompasses 
a diverse range of species, including superoxide (O2
•-), hydrogen peroxide (H2O2), nitric 
oxide (NO), peroxynitrite (ONOO-), hypochlorous acid (HOCl), singlet oxygen (1O2), and 
the hydroxyl radical (OH•). Each of these distinct chemical entities can disrupt biological 
systems by preferential reaction with and modification of cellular macromolecules such as 
DNA, lipids and proteins and thereby act as damaging molecules. In theory, there exist a 
large amount of mitochondrial enzymes with the ability to reduce oxygen to O2
•-. However, 
only a limited number of them are relevant under physiological conditions. Primarily from 
studies on isolated mitochondria, seven main mitochondrial ROS-generating sites have 
currently been identified; the Q-binding sites in CI (site IQ) and CIII (site IIIQo), glycerol 
3-phosphate dehydrogenase, the flavin in CI (site IF), ETF, and pyruvate and α-ketoglutarate 
dehydrogenases [11]. Importantly, mitochondrial ROS production in living cells critically 
depends on the PMF, NADH/NAD+ ratio, Q redox state and local O2 concentration. All 
of these parameters are not easily assessed at the cellular level in a quantitative manner. 
Because it is essential to assess these parameters at the cellular level in a quantitative 
manner to properly evaluate ROS production rates measured in living cells [7], one of the 
main objectives in this thesis is to evaluate existing experimental techniques and develop 
novel empirical strategies (see Table 1.1).
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Mitochondrial ROS in metabolic disorders
In addition to sites for ROS production, cells also contain elaborate enzymatic and 
nonenzymatic antioxidant systems to detoxify ROS. However, increased ROS generation 
and/or a reduced antioxidant activity creates an imbalance ultimately leading to (local) 
increased ROS levels. These elevated cellular ROS levels have been linked to multiple 
human pathologies such as diabetes, cancer, premature ageing, neurodegenerative 
disease and inborn errors of metabolism [12–15]. The latter includes mutations arising in 
mitochondrial proteins encoded by either nuclear genes or the mitochondrial genome. 
Mutations of the OXPHOS system are most frequently encountered, with an estimated 
incidence of 1 in 10,000 live births [16–18]. The resulting complex multisystem syndromes 
generally manifest themselves within 2 years after birth, and in the majority of cases (40%), 
OXPHOS dysfunction is associated with either a combined or isolated deficiency of CI 
[19]. Previous studies on cultured human skin fibroblasts of patients with nuclear-inherited 
isolated CI deficiency revealed that virtually all patients displayed increased ROS levels 
as detected by hydroethidine (HEt) oxidation and CM-H2-DCFDA oxidation (Fig. 1.3). 
However, these increased ROS levels were not associated with increased peroxidation 
of cellular lipids or changes in thiol redox status [20], implying the absence of oxidative 
damage. In contract to CI deficiency, CIII deficiency is one of the least commonly observed 
respiratory chain disorders [21] and patient fibroblasts usually do not display increased 
HEt oxidation levels (unpublished data; Fig. 1.3). Surprisingly, while patient fibroblasts 
are viable in culture, both CI and CIII deficiency in patients leads to multisystem diseases 
and an untimely death [15,16,18]. This suggests that fibroblasts can adapt to the increased 
ROS levels but possibly other cells in the human body cannot. Therefore the main aim of 
this thesis was to fundamentally understand the damaging but also the signalling roles of 
mitochondrial ROS in order to find treatment strategies that can be tested in more advanced 
animal models and hopefully one day, patients. 
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Figure 1.3 ROS levels and redox status in patients with CI and CIII deficiency.
In CI-deficient patient fibroblasts the mean CI activity is ~50% decreased compared to control C5120. 
Consequently, NAD(P)H autofluorescence, HEt oxidation (ROS) and CM-H2-DCFDA fluorescence 
(ROS) are increased. However, C11-BODIPY ratio (general lipid peroxidation) and mitochondrial and 
cytosolic redox state (mito- and cyto-roGFP1, GSH and GSSG) are not detectably altered [20]. Even 
though CIII activity is decreased in CIII patient fibroblasts, HEt oxidation remains unaltered. Numerals 
in bars indicate the number of controls or CI or CIII patients that were analysed.
The involvement of mitochondrial ROS in cellular signalling
The signalling capacities of mitochondrial ROS are regulated by several factors. First, the 
location where the ROS are produced determines which effectors can be reached. Whereas 
most mitochondrial ROS is produced on the matrix side of the MIM, only site IIIQo and 
glycerol-3-phosphate dehydrogenase release O2
•- in the IMS. In theory, these latter ROS can 
reach the cytosol across the MOM possibly through the voltage-dependent anion channel, 
while matrix-produced ROS are not likely to cross the MIM [22,23]. O2
•- has a short half-life 
(mainly due to its rapid conversion to H2O2 by highly active superoxide dismutases in the 
mitochondrial matrix and the cytosol) and therefore a short free aqueous diffusion distance 
[19]. As a consequence, O2
•- range of action is small and its role in signalling is therefore 
thought to be local [24]. In this sense, O2
•- is able to react with biologically relevant targets 
close to its site of production, such as quinones, nitric oxide and iron-sulfur centres within 
proteins [25–27]. The TCA cycle enzyme aconitase is particularly sensitive to inactivation 
by O2
•- because its active site contains an iron-sulfur cluster that is exposed to the solvent 
and therefore reacts rapidly with O2
•- [25]. This specific inactivation of aconitase could be 
a regulatory mechanism to control TCA cycle activity [28].
In contrast to O2
•-, H2O2 can freely diffuse through membranes. In addition, H2O2 can 
be transported through aquaporins and related channels, providing a mechanism to 
regulate local H2O2 levels [29,30]. The second factor that determines signalling capacity 
is the chemistry of the ROS molecule. H2O2 mostly initiates oxidative damage to lipids, 
protein and DNA when it reacts with reduced iron (Fe2+) or copper (Cu+) to generate OH•, 
which will indiscriminately oxidize the first molecule it encounters. However, the oxidant 
18  |  CHAPTER 1
chemistry of H2O2 itself is largely limited to proteins with susceptible cysteine thiols [31], 
consequently altering the activity of enzymes, kinases, phosphatases and transcription 
factors in mitochondria, the cytosol or the nucleus. The reactivity of a cysteine residue 
with H2O2 is dependent on its protonation state, which is determined by the pH of the 
milieu and the pKa of the cysteine. Because the latter is also determined by the neighboring 
residues, the reactivity of H2O2 is not random but rather selective [32]. Due to the alkaline 
pH of the mitochondrial matrix and the close proximity of mitochondrial protein thiols to 
the origin of ROS production, mitochondrial thiols are more likely modified by ROS than 
cytosolic thiols [33,34]. Moreover, H2O2 is mostly produced in very specific locations close 
to signalling targets, and the H2O2 levels are further regulated by the relative localization 
and activity of antioxidants and other signalling molecules [31]. Therefore, ROS production 
by mitochondria might function as a redox signal integrating mitochondrial function with 
that of the rest of the cell. Retrograde signalling of for instance the PMF or the redox state 
of the NADH pool will allow individual mitochondria to auto-regulate their metabolism via 
transcription, translation, import or degradation of mitochondrial components or via post-
translational modification of the ETC [7].
Aim and outline of this thesis
This thesis aims to investigate the potential signalling roles of mitochondrial ROS during 
mitochondrial dysfunction and physiological (healthy) conditions. To do so, this thesis 
focuses on the first key determinants for signalling; (i) the amount, type and location of 
ROS and (ii) changes in mitochondrial function that might influence ROS production. An 
overview of broadly used fluorescent reporter molecules that are currently available for ROS 
quantification in living cells is presented in Chapter 2. Some reporters for ROS and other 
key mitochondrial parameters are explained in more detail in Chapter 3. In a collaborative 
effort with the group of Dr. Mike Murphy (MRC-MBU Cambridge), a method was developed 
allowing measurement of mitochondria-specific lipid peroxidation (Chapter 4). Since 
CI and CIII are believed to be primary sources of mitochondrial ROS, the bioenergetic 
effects as a result of their inhibition was studied with special attention to the influence on 
Dy (Chapter 5). Next, these findings were linked to different types of both cytosolic and 
mitochondrial ROS levels (Chapter 6). The study in Chapter 7 describes the role of ROS in 
the more physiological context of the Crabtree effect, which entails the acute and reversible 
decrease of mitochondrial oxygen consumption by increased glucose levels. Finally, the 
obtained results are integratively discussed and future perspectives are presented in the 
General discussion (Chapter 8).
CHAPTER 2
Detection and manipulation of mitochondrial 
reactive oxygen species in mammalian cells
Adapted from:
Marleen Forkink, Jan A.M. Smeitink, Roland Brock, 
Peter H.G.M. Willems & Werner J.H. Koopman 
Biochimica et biophysica acta. (2010) 1797, 1034–44.
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Abstract
Reactive oxygen species (ROS) are formed upon incomplete reduction of molecular 
oxygen (O2) as an inevitable consequence of mitochondrial metabolism. Because ROS 
can damage biomolecules, cells contain elaborate antioxidant defence systems to prevent 
oxidative stress. In addition to their damaging effect, ROS can also operate as intracellular 
signalling molecules. Given the fact that mitochondrial ROS appear to be only generated at 
specific sites and that particular ROS species display a unique chemistry and have specific 
molecular targets, mitochondria-derived ROS might constitute local regulatory signals. 
The latter would allow individual mitochondria to auto-regulate their metabolism, shape 
and motility, enabling them to respond autonomously to the metabolic requirements of 
the cell. In this review we first summarize how mitochondrial ROS can be generated and 
removed in the living cell. Then we discuss experimental strategies for (local) detection of 
ROS by combining chemical or proteinaceous reporter molecules with quantitative live cell 
microscopy. Finally, approaches involving targeted pro- and anti-oxidants are presented, 
which allow the local manipulation of ROS levels. 
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Introduction
Reactive oxygen species (ROS) are partially reduced derivatives of molecular oxygen 
(O2) that can react with many cellular constituents including lipids, proteins and DNA. 
Depending on the type of cell and its metabolic state, mitochondria can represent a 
substantial source of ROS within healthy living cells as an unavoidable consequence of 
metabolism. Important sources of mitochondrial ROS include complex I (CI) and complex 
III (CIII) of the electron transport chain (ETC) [7,11]. Both CI and CIII generate ROS in the 
form of superoxide (O2
•-), which can be subsequently converted into other ROS including 
hydrogen peroxide (H2O2). Oxidative stress occurs when mitochondrial ROS production 
exceeds the capacity of the cell’s antioxidant systems. In addition to this toxic role, when 
produced at low levels mitochondrial ROS and its downstream products might also operate 
as intracellular signalling molecules [19,31,48–53]. A signalling function is already well 
established for reactive nitrogen species (RNS) like nitric oxide as reviewed elsewhere (e.g. 
[54]). Up to now, ROS-dependent signalling has mainly been studied using exogenous 
ROS generating systems that increase ROS throughout the cell (“global” ROS). However, 
when produced within living cells the lifetime of a certain ROS limits the distance it can 
diffuse and thereby its radius of action. This means that the direct reaction of a short-lived 
ROS like O2
•- in situ is likely restricted to a small sub-cellular volume surrounding the 
site of its generation (“local” ROS) whereas ROS with a longer half-life like H2O2 might 
be more suited for global signalling [19,31,55–58]. Therefore, when endogenously 
produced at low levels during non-pathological conditions, it is likely that primary ROS 
predominantly affect closely apposed targets and signalling by these ROS should be highly 
compartmentalized and local. Proper investigation of this mechanism requires quantitative 
experimental techniques allowing the local detection and manipulation of ROS and its 
downstream effects in the living cell. An in-depth discussion of the mechanisms involved 
in mitochondrial ROS generation and removal falls outside the scope of this review and 
is presented (e.g. [7,11,49,50,59,60]). Therefore we only provide a brief overview about 
this subject followed by a more extensive treatment of experimental strategies for live-cell 
detection and exogenous manipulation of cellular and mitochondrial ROS.
Sources of mitochondrial ROS
Types of ROS 
The primary ROS, O2
•-, is formed by the one-electron reduction of O2. The latter readily 
penetrates cells because of its ability to dissolve in the hydrocarbon core of cell membranes. 
In fact, O2 was classified as a fat-soluble molecule, as demonstrated by its olive oil/water 
partition coefficient of 4.4 at 25 °C (See the study by Sidell [61] and the references therein). 
In mitochondria, O2
•- formation is thermodynamically favourable because the reduction 
potential is high in this compartment (Eh = 68 mV), even at low [O2] (i.e. 1 µM) and high 
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[O2
•–] (200 pM [7]). The concentration of O2
•- in the mitochondrial matrix generally is 
kept low because of the action of manganese superoxide dismutase (MnSOD or SOD2), 
which converts O2
•- into hydrogen peroxide (H2O2). The latter ROS is able to diffuse through 
membranes and thereby leave the mitochondrion, although recent studies suggest that this 
might also be regulated by aquaporins [29,30].
The hydroxyl radical (OH•) is another important member of the ROS family, which can be 
formed under conditions of oxidative stress when high concentrations of O2
•- and/or H2O2 
are present. In this situation, O2
•- can stimulate H2O2 formation and the release of Fe
2+ 
from iron-sulphur (FeS)-containing proteins like CI or the TCA-cycle enzyme aconitase. 
Subsequently, the generated Fe2+ and H2O2 can react to form OH
• by the Fenton reaction. 
The OH• radical is highly reactive, as reflected by its half-life (t½) of approximately 10
-9 
s, and therefore reacts very close to its site of formation [62]. In comparison, O2
•- and 
H2O2 display much larger t½ values of 10
-6 s and 10-5 s, respectively [57]. The range of 
action of each ROS is co-determined by their free aqueous diffusion distance, which 
appears to have an upper limit of 0.16 µm for O2
•- and 0.23-0.46 µm for H2O2 [19]. In 
the mitochondrion, this distance is likely lowered by the action of ROS scavengers like 
MnSOD, ROS reactivity with nearby (bio)molecules and the viscosity of the mitochondrial 
matrix, which is somewhat higher than water [63]. Also singlet oxygen (1O2) is a member 
of the ROS family capable of biomolecule oxidation. In contrast to O2
•-, H2O2 and OH
•, 
1O2 can be formed when endogenous or exogenous photosensitizers absorb light of the 
appropriate wavelength in the presence of oxygen [55]. Light-induced 1O2 formation can 
artificially stimulate the oxidation of ROS-reporting sensor molecules and has been used to 
locally increase ROS levels.
Origins of mitochondrial ROS 
Most mitochondrial activities, including ATP generation, organelle fusion, protein import 
and metabolite/ion exchange depend on a proper proton gradient across the MIM. This 
gradient generates an inward proton-motive force (PMF), which is maintained by the action 
of 4 ETC complexes (CI-CIV). The PMF consists of both a potential difference (Dy) and 
a proton gradient (DpH), and is used by the F0F1-ATP synthase (CV) to convert ADP into 
ATP. Together, CI-CV constitute the oxidative phosphorylation (OXPHOS) system. Over 
the years, several OXPHOS complexes were implicated as relevant sources of ROS. For 
instance, ROS levels dose-dependently increased upon acute (10 min) and chronic (72 
h) treatment with specific inhibitors of CI (rotenone) and CIII (antimycin A) in human skin 
fibroblasts. Until recently it seemed clear that CII did not contribute to mitochondrial ROS 
production in healthy cells. However, a study by Quinlan et al. [64] on rat skeletal muscle 
mitochondria suggests that ROS production by CII might be relevant in vivo when multiple 
substrates feed into the Q pool and there is low energy demand. Surprisingly, although CIV 
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is one of the major cellular oxygen consuming enzymes, very high inhibition is required 
to induce aconitase activation as a measure of superoxide production [65]. Similarly, CV 
inhibition by oligomycin did not detectably increase ROS levels [19]. 
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Figure 2.1 The origins and removal of mitochondrial ROS. Generation of O2
•- by CI and CIII and the 
TCA-cycle enzyme a-KGDH is stimulated by an increase in the NADH/NAD+ ratio. O2
•- is subsequently 
reduced to H2O2 and H2O by superoxide dismutase (SOD) and GPx (glutathione peroxidase), 
respectively. The GPx reaction involves oxidation of glutathione (GSH) to GSSG and oxidation of 
reduced peroxiredoxin (Prx-red) to its oxidized form (Prx-ox). Reduction of Prx-ox is coupled to 
the conversion of reduced thioredoxin-2 (TRx-red) into oxidized thioredoxin-2 (TRx-ox). TRx-ox is 
reconverted into TRx-red by thioredoxin reductase-2 (TRxR). This reaction, as well as the conversion 
of oxidized GSH (GSSG) into GSH by GR (glutathione reductase), requires NADPH. Excessive O2
•- 
production stimulates hydroxyl radical (OH•) formation. The latter radical induces the formation of 
carbon-centered lipid radicals (L•) from polyunsaturated fatty acids (LH). These, in turn, can form lipid 
peroxyl radicals (LOO•), which are readily degraded to malondialdehyde b-hydroxyacrolein (MDA) 
and 4-hydroxynonenal (4HNE). Formation of MDA and 4HNE is counterbalanced by a cascade of 
antioxidant redox reactions (Figure adapted from [19]). 
BSO: buthionine sulfoximine, BCNU: 1,3-bis(2-chloroethyl)-1-nitrosourea, CDNB: dinitro-
chlorobenzene, DNCB: 1-chloro-2,4-dinitrobenzene, MCB: monochlorobimane.
Complex I - Evidence was provided that CI constitutes a major source of ROS in healthy 
cells (Figure 2.1; [7,19,59]). It appears that O2
•- is generated at the flavin (FMN) group in the 
NDUFV1 subunit and/or the CoQ-binding site of CI [7,11,19]. In principle, ROS can also 
be produced by CI via reverse electron transfer (RET) from CII to CI. RET was observed in 
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isolated mitochondria respiring on the CII substrate succinate and is prevented by inhibition 
of CI using rotenone, which inhibits CI at the Q binding site [66,67]. However, CI inhibition 
by rotenone in living cells generally results in higher instead of lower ROS levels [65,68–70]. 
This suggests that RET might not significantly contribute to mitochondrial ROS formation 
in healthy cells, although this likely depends on the cell type, rotenone concentration and 
incubation time [19]. In addition to superoxide, it was recently shown that CI can also 
produce hydrogen peroxide directly, presumably from two distinct sites [71].
Complex III - In addition to CI also CIII can generate mitochondrial ROS [11,72,73]. In contrast 
to CI, CIII generates superoxide both in the mitochondrial matrix and the intermembrane 
space [23,74], the latter of which was suggested to be transported to the cytosol through 
voltage-dependent anion channels [75]. Although CIII-derived ROS production has been 
established in isolated mitochondria, this is less clear in intact cells and tissues. Experiments 
in isolated nerve terminals revealed that only very high levels of CIII inhibition (70-80%) 
lead to detectable increases in H2O2 generation [65]. In contrast, a 16% inhibition of CI 
sufficed to increase H2O2 levels, suggesting that during physiological conditions CI is a 
more important ROS source than CIII and CIV in these cells [59]. In human skin fibroblasts, 
CIII inhibition with antimycin A acutely increased ROS generation with an EC50 value of 2.9 
nM [19]. In most mammalian cell lines this concentration fully inhibits respiration, again 
suggesting that ROS production by CIII is of particular relevance only under pathological 
conditions. Indeed, CIII dysfunction has been regularly associated with increased ROS 
production [21,76]. However, a potential regulatory role of CIII-derived ROS is emerging in 
cellular processes such as cardioprotective preconditioning, adipocyte differentiation [77] 
and especially hypoxia adaptation [76,78].
α-Ketoglutarate dehydrogenase - Also α-ketoglutarate dehydrogenase (α-KGDH) can 
significantly contribute to mitochondrial ROS production (Figure 2.1; [59,79–81]). α-KGDH 
catalyzes an important step of the TCA cycle, namely the conversion of α-ketoglutarate, 
coenzyme A and NAD+ into succinyl-CoA, NADH and CO2. Mammalian α-KGDH consists 
of three enzymes: α-ketoglutarate dehydrogenase (E1), dihydrolipoamide succinyltransferase 
(E2), and dihydrolipoamide dehydrogenase (E3 or Dld). The latter enzyme also constitutes 
part of the pyruvate dehydrogenase (PDH) enzyme complex. Evidence was provided that 
the E3/Dld enzyme can generate O2
•-. The E3/Dld enzyme contains a flavin group that 
normally donates electrons to NAD+. However, when [NAD+] is low (i.e. when the NADH/
NAD+ ratio is high), electrons can be directly transferred to O2 to form O2
•-. Interestingly, 
α-KGDH is inhibited by its own product succinyl-CoA, by a high NADH/NAD+ ratio and by 
a high dihydrolipoate/lipoate ratio. Conversely, α-KGDH is activated by low concentrations 
of ionic calcium (Ca2+) and matrix ADP [80,82]. This suggests that the increased ROS levels 
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that are generally observed in rotenone-treated cells might be (partially) due to stimulation 
of ROS generation by α-KGDH via the rotenone-induced increase in mitochondrial NADH/
NAD+ ratio. 
Other mitochondrial ROS sources - In principle, mitochondrial ROS can also originate 
from several other mitochondrial sources [19,83–86] including P66Shc, amine oxidase and 
α-glycerophosphate dehydrogenase (α-GPDH). Of these, α-GPDH, located on the outer 
surface of the MIM, appears to be the most important. In mitochondria from brown adipose 
tissue (BAT) and Drosophila, α-GPDH-mediated electron transport from α-glycerophosphate 
to coenzyme Q is associated with ROS production (see the review by Murphy [7] and the 
references therein). However, the physiological significance of this process is unclear, as 
α-GPDH is expressed at relatively low levels in most mammalian tissues, although it may 
be more important in the brain [83]. 
Removal of mitochondrial ROS
Mitochondrial ROS can induce oxidative stress if it exceeds the capacity of ROS detoxifying 
systems. Alternatively, “normal” ROS production can induce oxidative stress under 
conditions where the antioxidant capacity is reduced. Within the mitochondrial matrix, 
O2
•- is either spontaneously dismutated into H2O2 or via a two-electron reaction catalysed 
by the tetrameric MnSOD (Figure 2.1). Using isolated mitochondria, evidence was provided 
that cytochrome-c (cyt-c) can also be involved in the reduction of O2
•- and is regenerated by 
the action of cyt-c oxidase [87,88]. In the cytosol, O2
•- dismutation is predominantly taken 
care of by copper-zinc-SOD (CuZnSOD or SOD1), which presence was also demonstrated 
in the mitochondrial intermembrane space (IMS) [89]. In most mammalian cell types 
H2O2 is primarily broken down by catalases (CATs), glutathione peroxidases (GPx) and 
peroxiredoxins (Prx) [7,90,91]. 
CAT catalyses the conversion of 2 molecules of H2O2 into H2O and O2 and is mainly expressed 
in peroxisomes, whereas mitochondria have very low levels of this enzyme. Therefore, 
mitochondria appear to be more important cellular source of H2O2 than peroxisomes. In the 
cytosol and mitochondria GPx-mediated conversion of H2O2 into H2O is directly coupled 
to the oxidative formation of GSSG from glutathione (GSH). GSH is regenerated from GSSG 
by the action of glutathione reductase (GR), which requires NADPH (Figure 2.1). 
Another mechanism to convert H2O2 into H2O involves the formation of oxidated Prx, 
which is converted back again into reduced Prx by the oxidation of thioredoxin-2 (TRx) 
(Figure 2.1). The latter requires NADPH and the action of thioredoxin reductase-2 (TRxR 
[7,19]). Although GPxI is considered to be one of the major contributors to H2O2 removal in 
mitochondria, PrxIII is 30-fold more abundant in mitochondria of HeLa cells [92]. Another 
Prx isoform (PrxV) is also present in mitochondria and its overexpression protects against 
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oxidative damage [93]. As explained above, excessive O2
•- production can also stimulate 
OH• formation. OH• induces the formation of carbon-centered lipid radicals (L•) from poly-
unsaturated fatty acids (LH). These, in turn, can form lipid peroxyl radicals (LOO•), which 
are readily degraded to malondialdehyde b-hydroxyacrolein (MDA) and 4-hydroxynonenal 
(4HNE) (Figure 2.1). Formation of MDA and 4HNE is counterbalanced by a cascade of 
antioxidant redox reactions (for more details: see [7,19,49]).
Glutathione (GSH) is one of the most important non-enzymatic antioxidants which further 
include ascorbic acid (vitamin C), α-tocopherol (vitamin E), vitamin A and its precursor 
b-carotene, carotenoids, flavonoids and lipoic acid [49,94]. The ratio of GSH to GSSH is a 
good determinant of the thiol redox state of the cell, and under normal conditions reduced 
GSH is the more abundant form in the cytosol, nucleus and mitochondria. Since GSH is 
synthesized in the cytosol, mitochondria have to import it across the MIM [49]. GSH can 
act as an antioxidant in several ways, for instance: (i) GSH is a cofactor of GPx (see above), 
(ii) GSH can directly neutralize OH•, (iii) GSH can regenerate vitamins C and E to their 
active forms [49]. In cells, the most important vitaminic antioxidant is vitamin E, which 
is lipid-soluble (octanol/water partition coefficient, LogP=10.7; source: pubchem.ncbi.
nlm.nih.gov) and exists in 8 different forms (4 tocopherols and 4 tocotrienols). Of these, 
α-tocopherol seems to have the highest activity in trapping lipid peroxyl radicals (LOO•) 
and thereby preventing the propagation of lipid peroxidation. α-Tocopherol is present in 
relatively low concentrations in mitochondria of which 22% resides in the MIM and 78% 
in the mitochondrial outer membrane (MOM [95]). In theory, also vitamin C can react with 
lipid peroxyls in its ascorbate form. However, vitamin C is hydrophilic (LogP=-1.8) and 
therefore unlikely to be involved in the direct prevention of lipid peroxidation. However, 
vitamin C is capable of recycling vitamin E to its reduced form [96,97]. Finally, also CoQ 
has been recognized as a lipid-soluble mitochondrial antioxidant. Due to its location in 
the MIM, CoQ appears to primarily act in the prevention of lipid peroxidation but it is also 
capable of preventing protein oxidation. When reduced, CoQ can regenerate vitamin E 
from the α-tocopheroxyl radical [98].
Detection and manipulation of mitochondrial ROS
Detection of mitochondrial ROS
Mitochondrial and cellular function are intricately linked. Therefore experimental 
approaches are needed that allow the analysis of ROS generation and ROS-induced 
signalling and/or stress in living cells. We here discuss fluorescence reporter molecules 
suited for live cell studies that are compatible with epifluorescence and/or confocal laser 
scanning microscopy (CLSM). The focus will be mainly on fluorescent ROS probes that 
we have used for live cell analysis in our laboratory but we also discuss some promising 
novel ROS reporters. In principle, two types of reporter molecules can be distinguished: (i) 
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chemical reporter molecules, which are loaded into the cell using specific cell incubation 
(“loading”) protocols, (ii) proteinaceous reporter molecules (i.e. proteins) that are introduced 
into the cell by stable or transient transfection. 
Detection of mitochondrial ROS - Chemical ROS reporters
Hydroethidine - O2
•- is the initial ROS produced in mitochondria. Due to the relatively 
small t½ of O2
•- and its rapid conversion by SODs, quantitative detection of O2
•- is not 
trivial. A frequently used chemical reporter for superoxide detection is hydroethidine (HEt) 
and its mitochondria-targeted variant Mito-HEt (a.k.a. MitoSOX™-red), which consists of 
a HEt molecule linked to a cationic triphenylphosphonium (TPP+) group [37]. Both HEt 
and Mito-HEt easily cross phospholipid bilayers. The initial oxidation of non-fluorescent 
HEt and Mito-HEt appears to involve two steps: (i) generation of a radical (HE•+) and (ii) 
successive oxidative formation of two positively charged fluorescent products: ethidium 
(Et+) and 2-hydroxyethidium (2-HO-Et+ [36]). Importantly, only the formation of 2-HO-Et+ 
is specific for O2
•-. To discriminate between Et+ and 2-OH-Et+ fluorescence in living cells, 
excitation/emission wavelengths of 396/580 nm (only 2-OH-Et+) and 510/580 nm (Et+ and 
2-OH-Et+) can be used [37]. Similar to tetramethylrhodamine (TMRM) or rhodamine-123 
(R123), the extent of mitochondrial Mito-HEt accumulation depends on its extracellular 
concentration, the potential difference across the plasma membrane (DV) and Dy [99]. 
Because of its positive charge Mito-HEt preferentially accumulates ~1000 fold within the 
mitochondrial matrix. This accumulation, together with its rapid rate of reaction with O2
•- 
(4⋅106 M-1⋅s-1) should enable Mito-HEt to compete with MnSOD for O2
•- and allow specific 
detection of mitochondria-generated O2
•- [37]. Of note, also 2-HO-Et+ and Et+ are cations 
and therefore will accumulate in the mitochondrial matrix (see below). However, in case of 
HEt the origin of its oxidation is more difficult to establish than for Mito-HEt since HO-Et+ 
and/or Et+ can be formed in, for instance, the cytosol and then move to the mitochondrial 
matrix and/or nucleus. 
In a previous study [69], we assessed the localization and intensity of HEt oxidation 
products in human skin fibroblasts using epifluorescence microscopy. To this end, we used 
a protocol in which cells were incubated with 10 µM HEt for 10 min at 37o C to allow HEt 
oxidation, followed by thoroughly washing the cells to remove excess HEt. To measure 
fluorescence, cells were illuminated by 490 nm excitation light using a monochromator 
for 100 ms. During this time period fluorescence emission was directed by a dichroic 
mirror (525DRLP) through a 565 long pass emission filter (565ALP) onto a CoolSNAP HQ 
monochrome charge-coupled device (CCD) camera. Image acquisition at 0.2 Hz did not 
increase the fluorescence signal for at least 10 minutes [69]. This indicates that excess HEt 
was effectively removed, fluorescent HEt oxidation products did not leak out of the cell, 
and photobleaching and/or photoactivation did not occur during this time period. Using 
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the above approach, and considering the in vitro spectral properties of Et+ and 2-OH-Et+ 
[36], the contribution of 2-OH-Et+ to the total fluorescence signal is expected to be ~ 2-fold 
higher than that of Et+. HEt-oxidation products were detected in mitochondrial tubules and 
the nucleus (nucleoli; Fig. 2.2A). Individual cells always displayed a higher nuclear than 
mitochondrial fluorescence, compatible with the increased fluorescence quantum yield 
upon DNA-binding of Et+ and 2-OH-Et+ [36] and/or a higher nuclear viscosity. However, 
both in cells from patients with isolated nDNA-encoded CI deficiency and rotenone-treated 
fibroblasts, nuclear and mitochondrial Et+/2-OH-Et+ signals increased always proportionally 
[69,100]. This means that either signal can be used to quantify Et+/2-OH-Et+ fluorescence. 
Protonophore-induced dissipation of Dy induced a rapid decrease in tubular fluorescence 
and concomitant increase in the nuclear fluorescence signal, indicating translocation 
of Et+/2-OH-Et+ from the mitochondrial to the nuclear compartment (Fig. 2.2B; [100]). 
This means that Et+/2-OH-Et+ is (partially) retained in the mitochondrial matrix in a Dy-
dependent manner. Therefore it is important that when reduced mitochondrial Et+/2-OH-Et+ 
signals are involved, Dy is also quantified in parallel experiments. An approach allowing 
proper quantification of Dy, also in the presence of DV alterations, has been described 
elsewhere [101]. 
To compare HEt and Mito-HEt, human control fibroblasts were cultured in the presence of 
vehicle (CT) or rotenone (R; 100 nM) for 72 h. Next, cells were incubated with 10 µM HEt 
or Mito-HEt for 10 min at 37oC and images were acquired using illumination times of 100 
ms and 500 ms for HEt and Mito-HEt, respectively. We used spectral settings allowing (i) 
combined detection of Et+ and 2-OH-Et+ (490 nm excitation, 580 nm emission) or, (ii) more 
specifically 2-OH-Et+ (405 nm excitation, 580 emission) (Fig. 2.3). Cells stained with HEt or 
Mito-HEt displayed fluorescence signals in cytosolic tubular structures (i.e. mitochondria) 
as wel as nucleoli (Fig. 2.3A). Fluorescence signals obtained with 405 nm excitation 
were much lower (i.e. closer to the background signal) than with 490 nm excitation. This 
suggests that the extent of O2
•--specific 2-OH-Et+ formation is over-estimated when 490 nm 
excitation is used. Analysis of a large quantity of cells from multiple experiments revealed 
an identical rotenone-induced fluorescence increase (to ~220% of CT) for 405 and 490 
nm excitation in HEt-stained cells (Fig. 2.3B; left panel). In case of Mito-HEt, the rotenone-
induced fluorescence increase was generally less (to ~140-175% of CT) than for HEt and 
significantly lower for 405 nm excitation than for 490 nm (Fig. 2.3B; right panel). These 
results suggest that a large fraction (~50%) of HEt-detectable ROS in rotenone-treated 
fibroblasts (using 490 nm excitation) consists of O2
•- originating from mitochondria. 
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Figure 2.2 Quantification of ROS, cellular lipid peroxidation and thiol redox environment in human 
skin fibroblasts. (A) Typical confocal fluorescence image of human skin fibroblasts incubated with 
10 µM hydroethidine (HEt) for 10 min (37°C). Fluorescence signals arise from the ROS-stimulated 
formation of ethidium (Et+) and/or 2-hydroxyethidium (2-HO-Et+), and were detected in both nucleoli 
and a widespread network of tubular structures in the cytosolic compartment. The white box depicts 
a magnified view of the cell marked with an asterisk. (B) Upon addition of the mitochondrial 
uncoupler carbonylcyanide-p-trifluoromethoxy-phenylhydrazone (FCCP; 1 µM), staining of the 
cytosolic tubular structures was lost and Et+/2-HO-Et+ translocated to the nucleus. (C) Typical confocal 
fluorescence images of a human skin fibroblast prestained with 1 µM of 5-(and-6)-chloromethyl-
2′,7′-dichlorodihydrofluorescein (CM-H2DCF) for 10 min (37°C). Fluorescence arises from the 
ROS-stimulated formation of CM-DCF, which occurs linearly over time. By measuring the rate of 
fluorescence increase at different time points, the level of CM-DCF-inducing ROS can be determined. 
(D) Typical confocal fluorescence image of human skin fibroblasts incubated with the fluorescent 
lipid peroxidation probe C11-BODIPY581/591 (4 µM, 30 min, 37°C). Upon oxidation, the red emitting 
form of the dye (590 nm) is converted into a green emitting form (520 nm), which results in an 
increase in green-to-red emission ratio. (E) Typical epifluorescence image of human skin fibroblasts 
expressing cytosolic roGFP1 (cyt-roGFP1), a fluorescent proteinaceous thiol redox sensor. The latter 
was expressed using a baculoviral transduction system. The fluorescence emission ratio of roGFP1 
after excitation at 400 nm (oxidized state) and 480 nm (reduced state) is a measure of the ambient 
thiol redox environment. (F) Same as panel E but now for the mitochondrial-matrix-targeted variant of 
roGFP1 (mit-roGFP1). Used fibroblast cell lines: #5120 (panel A,B,C); #5067 (panel E), #5170 (panel 
F) [76]. 
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Figure 2.3 Comparison of the fluorescence signals of hydroethine (HEt) and mitochondria-targeted 
HEt (Mito-HEt) in human skin fibroblasts. (A) Typical epifluorescence images of human skin fibroblasts 
stained with HEt or Mito-HEt. Fluorescence arises from the ROS-stimulated formation of ethidium (Et+) 
and/or 2-hydroxyethidium (2-HO-Et+) and images were acquired to allow combined detection of Et+ 
and 2-OH-Et+ (490 nm excitation) or preferentially 2-OH-Et+ (405 nm excitation). Individual images 
in this panel were linearly contrast-stretched for visualization purposes. (B) Effect of rotenone (R) 
treatment (100 nM, 72 h) on fluorescence signals in cells stained with HEt (left panel) or Mito-HEt 
(right panel). In this figure, significant differences between control- (CT`) and rotenone-treated cells 
are marked by V*** (p<0.001), error bars indicate standard-error of the mean and numerals reflect the 
number of cells analyzed in at least two independent experiments. Used fibroblast cell line: #5120.
CM-H2DCFDA - The oxidative conversion of non-fluorescent 2’,7’-dichlorodihydrofluorescein 
(H2DCF) into fluorescent 2’,7’-dichlorofluorescein (DCF) has been widely applied to measure 
oxidant levels in living cells. This compound is typically loaded into cells in the form of 
a membrane-permeant diacetate ester (DA), which inside the cell results in a membrane 
impermeant product. Still, DCF has been shown to be prone to passive leakage across the 
plasma membrane, which limits the duration of cell observation after loading. Therefore, 
a DCF variant with chloromethyl groups (CM-H2DCF) was developed with greatly reduces 
passive dye leakage [102]. By attaching esterase-cleavable diacetate (DA) groups to CM-
H2DCF, its membrane permeability was improved also for this compound. The resulting 
5-(and-6)-chloromethyl-2′,7′-dichlorodihydrofluorescein diacetate (CM-H2DCFDA) is 
rapidly taken up by cells. Intracellularly, it is converted into non-fluorescent CM-H2DCF by 
esterase action and subsequently oxidized by intracellular oxidants into highly fluorescent 
CM-DCF. The levels of CM-DCF-forming ROS can be reliably determined by measuring the 
rate of CM-DCF formation (see Fig. 2.2C; [102,103] and the explanation below). 
In human skin fibroblasts acute application of H2O2 stimulated CM-DCF formation [102–
104]. Interestingly, H2O2 but also O2
•-, Fe(III), Gpx and cyt-c were unable to stimulate 
fluorescent DCF formation from H2DCF in a cell free system [105]. In contrast, when 
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horseradish peroxidase, Fe(II), CAT, CuZnSOD, xanthine oxidase, ONOO-, or nitric 
oxide were present DCF formation was stimulated [105–107]. Together, these results are 
compatible with the idea that intact cells contain catalysts, like transition metal ions, heme 
peroxidases, and/or CuZnSOD that enable the H2O2-induced formation of CM-DCF. In 
this respect, evidence was provided that H2O2 stimulates CM-DCF formation through a 
peroxide-catalyzed reaction [108]. 
From a chemical point of view, it was proposed that the reaction mechanism for the formation 
of CM-DCF from CM-H2DCF involves two main steps [109]: (i) conversion of CM-H2DCF 
into CM-DCFH•/CM-DCF•- stimulated by CO3
•-, NO2
• and/or peroxidase-like catalysts 
involving conversion of GS• into GSH, (ii) formation of CM-DCF stimulated by generation 
of O2
•- from O2. The mechanism also involves three other (side) reactions: (iii) conversion 
of CM-DCF into a phenoxyl radical (CM-DCF-O•) stimulated by CO3
•-, NO2
• and/or 
peroxidase-like catalysts, (iv) light-induced formation of “DCF*” and (v) back-conversion of 
DCF* into CM-DCFH•/CM-DCF•- from CM-DCF paralleled by formation of GS• from GSH. 
Reactions iv and v are compatible with the observation that laser light can stimulate CM-
DCF formation [102]. In this sense, evidence has been provided that photo-oxidation of CM-
DCF is stimulated by 1O2 generated upon irradiation with laser light with l>300 nm [110]. 
However, 1O2 is unable to directly enhance CM-DCF formation but induces formation of 
CM-DCFH•/CM-DCF•-, possibly via reactions iv and v in the above mechanism. Next, CM-
DCFH•/CM-DCF•- is converted into CM-DCF (reaction i) paralleled by formation of O2
•-. Our 
findings in human skin fibroblasts show that the relative contribution of the photo-oxidation 
process is minimal at the lowest practical laser intensity of 34 µW (488 nm, measured at 
the aperture of the objective). To maximize the sensitivity of fluorescence detection at this 
low laser intensity, we used a 500 nm long-pass (LP) instead of a band-pass emission filter. 
Furthermore, we applied optimal black level and brightness settings, whereas the signal-
to-noise ratio was improved by real time image averaging [102]. We further observed that 
when the above imaging approach was used, CM-DCF fluorescence increased linearly with 
time during maximally 200 s. This means that during this time the oxidative conversion of 
CM-H2DCF to CM-DCF proceeds according to a zero-order reaction, given by: [CM-DCF]
(t) = VCM-DCF⋅t + [CM-DCF]0 with [CM-DCF](t) being the recorded CM-DCF fluorescence 
signal, VCM-DCF being the rate of fluorescence increase and [CM-DCF]0 being the CM-DCF 
fluorescence signal at the beginning of the recording (t=0). From this equation, it follows 
that VCM-DCF is independent of [CM-H2DCF] and therefore solely determined by the steady-
state oxidant level [102]. The zero-order model predicts that VCM-DCF increases as a function 
of [CM-DCF]0. Indeed, VCM-DCF changed proportionally with [CM-DCF]0 in both healthy and 
patient fibroblasts from patients with isolated CI deficiency [102]. Also in the presence of 
H2O2, VCM-DCF and [CM-DCF]0 increased to the same extent. Beyond a measuring time of 
200 s, however, the increase in CM-DCF fluorescence started to deviate from linearity. This 
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may suggest that CM-DCF, once formed in sufficient quantities, stimulates the conversion 
of CM-H2DCF into CM-DCF. Alternatively, cellular oxidant levels might increase upon 
prolonged laser illumination, thereby accelerating the formation of CM-DCF. Our results 
demonstrate that normalization of the CM-DCF time trace (i.e. dividing by [CM-DCF]0) is 
not appropriate, since this would lead to underestimation of VCM-DCF at higher [CM-DCF]0. 
In addition, they show that the rate of CM-DCF formation (VCM-DCF) is constant and therefore 
solely determined by the level of cellular oxidants.
The lack of specificity of CM-DCF formation makes it difficult to identify the nature of 
oxidants detected by the probe [109,111]. Therefore, the formation of CM-DCF in cellular 
systems can best be considered as a marker of cellular oxidant levels rather than as a direct 
reporter of a specific ROS/RNS species [102]. In human skin fibroblasts, rotenone-treatment 
readily increased the rate of Et+/2-OH-Et+ formation without affecting the rate of CM-DCF 
formation [100], suggesting that the formation of Et+/2-OH-Et+ and CM-DCF is stimulated 
by different types of ROS and/or in different cellular compartments. The latter is compatible 
with the fact that CM-H2DCF has a very low reactivity towards O2
•- [109].
Dihydrorhodamine 123 - Dihydrorhodamine 123 (DHR123) is a reduced rhodamine that 
is unreactive towards O2
•- and H2O2 in the absence of catalysts [109]. Fluorescent R123 is 
directly formed in the presence of OH•, CO3
•-, NO2
•, hypochlorous acid (HClO), ONOO-
, Fe2+ and cyt-c [109,112]. In this respect, also DHR123 constitutes a marker of overall 
oxidant levels. In cells, formation of R123 can be monitored using 488 nm excitation light 
and emission detection >500 nm [69]. Given the cationic nature of R123, it is important to 
also quantify Dy in parallel experiments (see above) when a reduced cellular R123 staining 
is encountered.
C11-BODIPY581/591 - An indirect means to measure mitochondrial ROS production in living 
cells is through assessing the extent of lipid peroxidation. A suitable reporter molecule for 
this purpose is the fatty acid analogue C11-BODIPY581/591 (Fig. 2.2D), which is insensitive to 
O2
•-, nitric oxide and hydroperoxides [113]. Upon oxidation, the red emitting reduced form 
of the dye (595 nm) is converted into a green emitting oxidized form (520 nm), which results 
in an increase in green-to-red emission ratio [39]. We have quantified lipid peroxidation 
in human skin fibroblasts by confocal microscopy using an excitation wavelength of 488 
nm, a 560DM dichroic mirror and appropriate band-pass filters (535D20 and 580LP [69]). 
Upon treatment with rotenone, the green/red C11-BODIPY581/591 emission ratio increased 
2-fold. However, in the presence of the mitochondria-targeted MIM-embedded antioxidant 
MitoQ (see below), rotenone was unable to stimulate C11-BODIPY581/591 oxidation. These 
data demonstrate that lipid peroxidation is stimulated by rotenone and that this effect of 
rotenone is completely blocked by MitoQ. Fluorescence recovery after photobleaching 
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(FRAP [114]) analysis revealed that the laser bleach pulse (488 nm) increased the level 
of oxidized (green) C11-BODIPY581/591 (Fig. 2.4A). This suggests that high-intensity laser 
illumination induces oxidation of C11-BODIPY581/591 and/or membrane lipids. Next, the 
FRAP dynamics of the red-emitting form and the FLIP (fluorescence loss in photobleaching) 
dynamics of the green emitting form in a region of interest (ROI) distal to the FRAP region 
were analysed (Fig. 2.4B). This revealed a similar (slow) mobility for the red- and green-
emitting forms of C11-BODIPY581/591 compatible with their localization in membranes. 
When cells were treated with hydrogen peroxide (H2O2), the C11-BODIPY
581/591 green/red 
emission ratio was increased, indicative of lipid peroxidation (Fig. 2.4C). Whereas C11-
BODIPY581/591 distributes throughout all cellular membranes, the novel lipid peroxidation 
probe MitoPerOx targets specifically to mitochondrial membranes [40]. In this case, 
attaching a positively charged TPP+ group to C11-BODIPY581/591 enabled us to study lipid 
peroxidation within the matrix-facing leaflet of the inner membrane, which is one of the 
most important aspects of mitochondrial oxidative damage.
Detection of mitochondrial ROS - Proteinaceous ROS reporters
Protein-based ROS reporter molecules have the distinct advantage that they can be 
selectively expressed in different cell compartments (e.g. nucleus, ER lumen, mitochondrial 
matrix, MIM, MOM, golgi lumen, golgi membrane, plasma membrane) by N- or C-terminally 
fusing them to specific targeting sequences [115]. For mitochondrial matrix expression, the 
N-terminal targeting sequence of subunit VIII of cytochrome-c oxidase (Cox8) is frequently 
used (MSVLTPLLLRGLTGSARRLPVPRAKIHSLGDP). For several reporter molecules, 2-3 
subsequent Cox8 targeting sequences are needed to ensure proper targeting and efficient 
expression [115–117]. In addition to targeting sequences, proteinaceous reporters can also 
be fused to specific ROS-generating or ROS-detoxifying proteins of interest allowing local 
detection. In the latter case, it should be investigated whether steric hindrance or folding 
interference between the protein and the reporter molecule is present. To minimize the 
chance of steric hindrance, a linker between the protein of interest and reporter molecule is 
generally used. Such a linker should be flexible, soluble, resistant to proteolysis and display 
no secondary structure or aggregation [118]. In this respect, Miyawaki and coworkers 
constructed a series of DNA plasmids that facilitate the fusion of coding sequences for any 
two protein domains with a DNA linker that encodes a triple repeat of the amino-acid linker 
Gly-Gly-Gly-Gly-Ser (i.e. [(GGGGS)3] [119]). Below we discuss protein-based reporters for 
detection of O2
•-, H2O2 and thiol redox status.
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Figure 2.4 Properties of the lipid peroxidation sensor C11-BODIPY581/591 in human skin fibroblasts. 
(A) Analysis of the mobility of C11-BODIPY581/591 by fluorescence recovery after photobleaching 
(FRAP) analysis using confocal microscopy. A FRAP and background (B) region of interest (ROI) were 
defined in the pre-bleach image and fluorescence recovery was measured over time for the red and 
green emitting forms of C11-BODIPY581/591. (B) Oxidation of C11-BODIPY581/591 by the laser bleach 
pulse resulted in a reduction in fluorescence of the red emitting form of the dye (590 nm) and an 
increase in fluorescence of the green emitting form (520 nm). FRAP kinetics for the red and FLIP 
(fluorescence loss in photobleaching) kinetics for the green form of C11-BODIPY581/591 were similar 
and yielded a time constant in the range of minutes, compatible with its localization in membranes. 
FRAP and FLIP signals were fitted using a mono-exponential model (Y=Y0+A1⋅e
-t/Tmono). (C) When cells 
were treated with hydrogen peroxide (H2O2), the C11-BODIPY
581/591 green/red emission ratio was 
increased, indicative of lipid peroxidation. In this figure, significant differences between vehicle- (CT) 
and H2O2-treated cells are marked by ***(p<0.001), error bars indicate standard-error of the mean and 
numerals reflect the number of cells analysed in at least two independent experiments. Used fibroblast 
cell line: #5120 [76].
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cpYFP - A circularly permuted YFP (cpYFP), previously used as a core component of the 
ratiometric Ca2+ indicator Pericam [120], was presented as a specific reporter of O2
•- 
[121]. In this study, cpYFP was targeted to the mitochondrial matrix (mt-cpYFP) using 
the cytochrome c oxidase subunit IV (Cox4) targeting sequence with the aim to measure 
O2
•- in this compartment. Interestingly, it was observed that the mt-cpYFP fluorescence 
signal displays transient all or none “flashes”. However, in a following commentary several 
points of concern have been raised regarding the O2
•--specificity of cpYFP [122], the most 
important being that the total removal of O2 did not completely abolish mt-cpYFP flashes. 
Moreover, mt-cpYFP flashes were absent in the presence of the CIII-inhibitor antimycin 
A, which is demonstrated to stimulate O2
•--generation in many different experimental 
systems. It was proposed that the changes in mt-cpYFP flashes observed in the various 
experiments might reflect changes in ATP levels, rather than O2
•-, and as such are linked to 
the energization state of mitochondria [122]. The latter explanation might relate to previous 
findings, revealing that fluctuations in free or Mg2+-bound ATP can affect the signal output 
of CFP-YFP-based FRET sensors [123]. More recently, a convincing argument was raised 
toward cpYFP flashes being transient pH increases instead of superoxide flashes [124]. In 
this respect it is interesting to note that the H2O2 sensor HyPer (see next section), which 
also contains cpYFP, is insensitive to O2
•- and importantly, the fluorescence ratio of Hyper 
is also pH-dependent. This dependency is similar to that reported for ratiometric Pericam, 
which exhibited pH-induced changes in fluorescence ratio between pH 6 and pH 10 [120]. 
Therefore measurements with cpYFP or HyPer should be accompanied by parallel pH 
quantification [38]. The latter could be carried out using chemical reporters in the cytosol 
(e.g. BCECF, SNARF-1) or mitochondria-targeted protein-based pH sensors like “pHluorins” 
[125] or “pHlameleons” [126]. Taking such an approach, it was finally suggested that mt-
cpYFP flash events reflect a burst in ETC-dependent O2
•- production that is coincident with 
a modest increase in matrix pH, the latter also strongly regulating flash activity [127]. 
HyPer – HyPer is a fluorescent ratiometric ROS sensor in which a cpYFP is inserted into the 
regulatory domain of the E. coli transcription regulator OxyR [38]. OxyR contains an H2O2-
sensitive domain (amino acids 80-310) and a DNA-binding domain (amino acids 1-79). 
Upon oxidation by H2O2, the reduced form of OxyR is converted into an oxidized DNA-
binding form. As a result, dramatic conformational changes occur in the regulatory domain 
of OxyR [128]. HyPer was generated by inserting cpYFP between residues 205 and 206 
of the OxyR regulatory domain. Importantly, cpYFP fluorescence was demonstrated to be 
very sensitive to conformational changes of an attached protein[120]. HyPer displays two 
excitation peaks at 420 nm (reduced form) and 500 nm (oxidized form) and a single emission 
peak at 516 nm. Upon H2O2 application, the HyPer fluorescence emission following 420 
and 500 nm excitation decreases and increases, respectively. Recently, the dynamic range 
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of HyPer was increased 2-fold [129] without losing its fast oxidation/reduction dynamics 
[130]. HyPer was rapidly oxidized by submicromolar [H2O2] even in highly reducing 
intracellular environments [128]. Quantitatively, the minimal [H2O2] required to induce 
a detectable change in HyPer fluorescence in mammalian cells was ~ 5 µM. Importantly, 
HyPer was demonstrated to be specific for H2O2 and did not react with O2
•-, GSSG, nitric 
oxide, and ONOO- [38], allowing the use of the 500/420 HyPer signal ratio as a measure of 
[H2O2]. As argued in the previous section, HyPer is also pH-sensitive and therefore its use 
should be accompanied by pH measurements. When targeted to mitochondria (mt-HyPer), 
local bursts in mt-HyPer ratio were observed during Dy oscillations in apoptotic HeLa 
cells [38]. Interestingly, the latter study revealed that H2O2 production can be confined 
to single depolarized mitochondria. This is compatible with the calculated small range of 
action of this ROS [19] and was proposed to be due to the fast dilution of mitochondria-
generated H2O2 in the cytosol and/or the action of cytosolic CAT [38]. HyPer has been 
successfully applied to measure [H2O2] in different cell systems [128,131,132] and cell 
compartments [133,134], although the possible influence of the glutathione system should 
also be considered in the interpretation of HyPer ratio changes [135]. 
roGFPs - Reduction-oxidation-sensitive GFPs (roGFPs) have been generated by substitution 
of surface-exposed residues of GFP with cysteines in appropriate positions to form disulfide 
bonds [136]. RoGFPs display two fluorescent excitation maxima whose relative amplitudes 
depend on the state of oxidation. In cells, the reduced and oxidized forms of roGFP1 are 
specifically excited at 480 and 400 nm respectively. Fluorescence emission of both roGFP1 
forms is detected at 530 nm. This means that the 400/480 ratio of roGFP1 can be used as 
a measure of roGFP1 oxidation status. In our research [20] we used cytosolic (Fig 2.2E; 
cyt-roGFP1) and mitochondria-targeted variants (Fig. 2.2F; mt-roGFP1) of roGFP1 (i.e. GFP 
with mutations C48S, S147C and Q204C [137]). Both roGFP1 variants were introduced 
into human skin fibroblasts by means of baculoviral transfection. To visualize roGFP1-
expressing cells we used a similar epifluorescence system as for HEt (see above), with 
alternating 300 ms excitation at 400 and 480 nm using a monochromator. Fluorescence 
was detected by guiding the emission light via a dichroic mirror (525DRLP) through a 535 
band-pass filter (535DF25) onto the CCD camera. Quantification of cyt-roGFP1 and mt-
roGFP1 signals is illustrated in figure 2.5. 
In cyt-roGFP1-transfected cells (Fig. 2.5A), fluorescence in the cytosol (continuous ROIs), 
nucleus (dotted ROIs) and background fluorescence (ROI marked “B”) were quantified for 
both wavelengths. The background-corrected individual wavelength signals of roGFP1 (Fig. 
2.5B) were used to calculate the roGFP1 ratio for the different ROIs as a function of time 
(Fig. 2.5C). To establish the extent of roGFP1 oxidation, ratios were calibrated by successive 
addition of 1 mM H2O2 and 10 mM dithiothreitol (DTT) to fully oxidize (100% oxidation) 
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and reduce (0% oxidation) the probe, respectively [20,136]. H2O2 gradually increased 
the fluorescence emission ratio to a maximum reached within 350 s, whereas subsequent 
addition of DTT rapidly reduced this ratio to below pre-H2O2 levels. Higher concentrations 
of H2O2 and DTT caused no further change in fluorescence emission ratio, indicating 
that the probe was maximally oxidized and reduced, respectively [20]. A similar analysis 
was carried out with mt-roGFP1 (Fig. 2.5D-F). No difference was observed between the 
roGFP1 oxidation status in the nucleus and cytosol of resting cells. However, comparison 
of figure 2.5C and figure 2.5F reveals that the extent of roGFP1 oxidation was higher in 
the mitochondrial matrix than in the cytosol of healthy human skin fibroblasts [20]. In 
agreement with previous findings in HeLa cells [136] the results in figure 2.5 demonstrate 
that mt-roGFP1 is initially neither fully oxidized nor fully reduced in the mitochondrial 
matrix of human skin fibroblasts. This means that the redox potential of these mitochondria 
lies within the effective range of roGFP1, allowing studies of redox changes in these cells.
roGFP2-Orp1 – A less pH sensitive alternative for HyPer to measure intracellular [H2O2] 
was developed while studying peroxidase redox relays. Reaction of the peroxiredoxin Orp1 
(or Gpx3) with H2O2 results in an intramolecular disulfide bond that is subject to reduction 
by Trx. In yeast, however, a redox relay occurs by oxidation of the transcription factor 
Yap1 instead of Trx. This same mechanism seems to hold true if Orp1 is fused to roGFP2. 
The roGFP2-Orp1 fusion protein enables specific and sensitive real-time measurements of 
intracellular H2O2 under physiologically relevant conditions. This response is similar to, 
but somewhat slower than HyPer. This can be explained by the fact that the Orp1 disulfide 
bond requires a redox equilibration between thiol-disulfide pairs of two protein domains, 
whereas the conformational change in HyPer is conferred through a single disulfide bond 
[138].
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Manipulation of mitochondrial ROS
Until recently, mitochondrial ROS were mostly associated with oxidative damage and 
pathology. However, evidence is accumulating that they can also function as regulatory 
molecules thus playing an important role in normal cell and organismal physiology. As 
already mentioned in the introduction, cellular ROS-induced damage and -signalling has 
often been studied using exogenous ROS generating systems that increase ROS throughout 
the cell (“global” ROS). However, given the physicochemical properties of the various ROS, 
it is likely that different ROS have a different range of action that might be limited to a 
small sub-cellular volume surrounding the site of its generation (“local” ROS; see also the 
section about HyPer above). Gaining a proper understanding of ROS-induced damage and 
-signalling therefore requires techniques that allow (combined) local detection of ROS (see 
previous section) and local manipulation of ROS. The amount of (local) ROS in a cell 
depends on the balance between: (i) its generation and (ii) its removal by antioxidants. 
Experimental approaches to manipulate this balance are described below. 
Manipulation of mitochondrial ROS - Targeted pro-oxidants
Proteinaceous pro-oxidants - In principle, a genetically-encoded photosensitizer should 
be suited to generate ROS in different cellular compartments including mitochondria. The 
first example of such a photosensitizer is a red fluorescent protein derived from the non-
fluorescent and non-phototoxic chromoprotein anm2CP20 in hydrozoa jellyfish [139]. 
This modified protein, called KillerRed (KR), can be visualized in living cells using low-
intensity excitation at 515-560 nm and emission detection at 555-700 nm [140]. High 
intensity illumination of KR at 515-560 nm will then result in photoactivation and ROS 
generation. Expression of KR in different mitochondria and cell compartments might be 
suited for studying the effects of (local) ROS generation at specific cell locations. Obviously, 
this is only feasible after careful investigation of possible side-effects of KR-activation (e.g. 
lipid peroxidation) and optimization of the KR photoactivation protocol. In comparison to 
enhanced green fluorescent protein (EGFP), KR phototoxicity is at least 1000-fold higher and 
its light-induced ROS production can be used for chromophore-assisted light inactivation 
(CALI [140]) of a KR-attached protein. This might for instance be applied to inactivate 
proteins involved in ROS homeostasis (e.g. SODs), provided that endogenous non-FP-
labelled SODs can be largely exchanged by their over-expressed FP-coupled counterparts. 
Proper mitochondrial targeting of KR requires the presence of two mitochondrial targeting 
sequences. Unfortunately, KR forms dimers that might affect the function of KR-fused 
proteins. The latter can possibly be overcome by using a tandem version leading to internal 
dimerization of KR [140].
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Cell penetrating peptides - Cell penetrating peptides (CPPs) can cross the plasma membrane 
and thereby introduce cargo like proteins, nucleic acids, small molecule therapeutics 
and fluorescent quantum dots into the cell [141]. Part of the CPPs are also mitochondria-
penetrating peptides (MPPs) because they specifically accumulate in mitochondria [142]. 
Similar to TPP+-linked compounds currently identified MPPs have both cationic and 
lipophilic properties, which facilitates permeation of the MIM and mitochondrial targeting. 
MPPs enter the cell via a direct uptake mode thereby bypassing endocytosis and avoiding 
endosomal/lysosomal sequestration [142,143]. MPPs are able to deliver negatively 
charged and zwiterionic small molecules, but do require a certain level of lipophilicity 
of the cargo. A member of the MMP family, TO-FrFK, was used to study oxidative stress 
responses triggered by mitochondria-generated ROS in living HeLa and MRC-5 cells. TO-
FrFK contains a thiazole orange (TO) moiety, which generates singlet oxygen (1O2) upon 
photoactivation [144].
Manipulation of mitochondrial ROS - Targeted antioxidants
The levels, localization and/or activities of cellular antioxidants are essential in determining 
which biological responses are initiated by ROS [32,57,145]. Given the importance of 
oxidative stress due to mitochondria-generated ROS during pathological conditions, 
considerable effort has been put into the development of proteinaceous and chemical 
compounds that reduce ROS levels and/or prevent ROS-induced damage. Use of these 
compounds allows site-specific blocking of (the effects of) mitochondrial ROS, but also 
scavenging of specific types of ROS in, for instance, rotenone- and vehicle-treated control 
cells [69,146]. Below we briefly discuss some of these compounds in more detail. 
Proteinaceous antioxidants - To specifically reduce mitochondrial O2
•- and H2O2 levels, 
overexpression of the mitochondrial SOD (MnSOD) and mt-CAT has been performed 
[147–149]. Also CuZnSOD, that normally resides in the cytosol and the mitochondrial 
intermembrane space, was expressed in the mitochondrial matrix by fusing it to a 
mitochondrial targeting sequence [148]. 
TPP+-linked chemical antioxidants - In analogy to mito-HEt and applying a concept pioneered 
by Skulachev and coworkers to investigate Dy (e.g [150,151]), antioxidant moieties such 
as CoQ or vitamin E can be targeted to the mitochondrial matrix by conjugating them to 
lipophilic cations like TPP+ via an alkyl chain [146,152]. A series of mitochondria-targeted 
antioxidants was developed to selectively decrease O2
•- (MitoSOD), H2O2 (MitoPeroxidase), 
Fe2+ (MitoTEMPOL) and lipid peroxidation (MitoQ10 and MitoE2). 
The first TPP+-linked compound contained the antioxidant moiety of α-tocopherol (MitoE2). 
Here the subcript 2 indicates that the linking alkyl chain has a length of 2 carbon atoms. 
Detection and manipulation of mitochondrial ROS in mammalian cells  |  41
2
Structurally, MitoE2 strongly resembles a TPP
+-coupled form of Trolox (6-hydroxy-2,5,7,8-
tetramethylchroman-2-carboxylic acid), which is a water-soluble antioxidant derived from 
α-tocopherol. MitoE2 proved more effective than its non-targeted variant in preventing 
peroxidation of mitochondrial lipids [146]. 
The TPP+-linked form of CoQ (MitoQ10) is reduced by CII, but not CI, into its active ubiquinol 
form. This regeneration makes MitoQ10 a far better antioxidant than MitoE2. Because MitoQ 
is almost entirely adsorbed into the matrix face of the inner membrane, it can prevent 
lipid peroxidation as was shown in isolated mitochondria. In agreement with this finding, 
MitoQ10 fully prevented the rotenone-induced increase in C11-BODIPY
581/591 oxidation (i.e. 
lipid peroxidation) without affecting the rotenone-induced increase in HEt oxidation [69].
In an effort to generate stronger antioxidants, plastoquinone (a chloroplast ubiquinone) was 
coupled to TPP+ [153]. When compared to CoQ, plastoquinone has methyl groups instead of 
methoxy groups, whereas the methyl group of CoQ is replaced by a hydrogen atom. Based 
upon its membrane-permeability, plastoquinonyl-decyl-TPP+ (a.k.a. SkQ1) was selected for 
further research. It was reported that [SkQ1] acted as an antioxidant between 25 and 800 
nM, whereas at higher concentrations it displayed pro-oxidant properties. In comparison, 
this range was estimated between 300 and 500 nM for MitoQ10. The antioxidant activity of 
SkQ1 was regenerated in the mitochondrion and it effectively prevented peroxidation of the 
mitochondrial lipid cardiolipin and ROS-induced apoptosis. 
Importantly, to rule out antioxidant-independent effects, one should always run parallel 
experiments using the TPP+ moiety with the corresponding alkyl chain length, since high 
concentrations have been shown to elicit bioenergetic responses consistent with OXPHOS 
inhibition [154].
Mitochondria-targeted peptides - Given their cationic nature, MitoE2, MitoQ10, SkQ1 and 
all other TPP+-based antioxidants are taken up by mitochondria in a Dy-dependent manner. 
This makes them probably less efficient under conditions of (highly) depolarized Dy. 
Interestingly, a novel class of cell-permeable small peptides (“SS-peptides”) with intrinsic 
antioxidant properties were designed, and which were taken up by mitochondria in a 
manner that was largely Dy-independent [155,156]. SS-peptides are water soluble, stable in 
aqueous solution, designed to resist degradation by peptidases and consist of an alternating 
aromatic-cationic motif with basic amino acids like arginine and lysine. SS-02 (i.e. Dmt-D-
Arg-Phe-Lys-NH2; Dmt=2’,6’-dimethyltyrosine) and SS-31 (D-Arg-Dmt-Lys-Phe-NH2) were 
demonstrated to localize to the MIM. Although the reason for this mitochondrial targeting 
is currently unknown, there might be an electrostatic interaction between the cationic 
peptides and the anionic MIM lipid cardiolipin. Replacement of the tyrosine residue by 
a phenylanaline eliminated the H2O2, OH
• and ONOO- scavenging activities of the SS 
peptide, suggesting that the phenolic tyrosine group mediates antioxidant activity. In this 
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respect, it is already known that dimethyltyrosine is a potent scavenger of oxyradicals. It is 
thought that SS-02 and SS-31 prevent lipid peroxidation by scavenging of OH• [155,156].
Another approach to specifically deliver molecules to the mitochondria involves use of 
the antibacterial membrane disruptor, gramicidin S (GS). Given the similarities between 
bacterial membranes and the MIM, it might be possible to re-engineer GS in such a 
way that it becomes a mitochondria-targeting moiety to which “cargo” compound can 
be attached. This is illustrated by the molecule “XJV-5-131” [157], which contains: (i) as 
cargo a ROS scavenger like the stable nitroxide radical TEMPOL, and (ii) as mitochondrial 
targeting moiety a portion of the membrane-active portion of GS. TEMPOL undergoes 
redox recycling, oxidizes free iron thereby preventing Fenton reactions, and also exhibits 
SOD-mimetic activity [152,157]. Unfortunately, GS-based compounds can also interfere 
with natural redox defence mechanisms and mitochondrial respiration by reacting with 
antioxidants and MitoQ [158]. 
Conclusion
There is still much controversy about how different mitochondrial ROS generating systems 
contribute to cellular and mitochondrial ROS levels, redox signalling and oxidative damage 
during healthy and pathological conditions. This arises from the fact that a large amount 
of different model systems (e.g. isolated proteins, individual mitochondria and intact 
primary or cancer cells) and experimental approaches (e.g. different metabolic conditions, 
used OXPHOS inhibitors, different ways to stimulate ROS production, different reporter 
molecules) have been used to investigate ROS and redox homeostasis. Additionally, 
ROS can act as signalling and/or damaging molecules depending on the experimental 
conditions. The complex mitochondrial physiology, in combination with the central role of 
these organelles in cellular survival, requires a genesis between data obtained with isolated 
mitochondria and living cells. Therefore approaches are needed that allow the detection and 
manipulation of specific types of ROS. Largely based upon our own practical experience, 
we here reviewed: (i) fluorescence microscopy techniques allowing assessment of (specific) 
ROS and/or its downstream consequences at the cellular and mitochondrial level, and (ii) 
approaches for manipulation of (specific) ROS and/or its downstream consequences. Proper 
analysis of ROS homeostasis in living cells requires the combined use of multiple ROS 
reporter molecules in parallel experiments, assessment of non-ROS-related parameters that 
can induce artifacts (e.g. Dy, pH) and inclusion of conditions known to affect mitochondrial 
ROS generation as positive and negative controls (e.g. OXPHOS inhibitors, mitochondrial 
uncoupling, O2 depletion). To differentiate between local (mitochondrial) and global 
(cellular) ROS effects, results obtained with local manipulations have to be compared with 
those obtained using ROS generating systems and non-targeted antioxidants that affect 
cellular ROS levels. 
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Abstract
Mitochondria are semi-autonomous organelles, which are central to cellular energy 
production and signal transduction. Given the tight integration between mitochondrial 
and cellular physiology, experimental strategies are required to study mitochondrial 
(dys)function in living cells. For this purpose one can use various chemical and protein-
based fluorescent reporter molecules (probes), which are introduced into the cell using 
specific incubation protocols or transfection techniques. These probes include reporters to 
monitor mitochondrial membrane potential (Dy), cytosolic and mitochondrial free calcium 
concentration, cytosolic and mitochondrial pH, glucose, ATP and reactive oxygen species. 
However, proper interpretation and quantification of the above readouts is not trivial. 
Here we present validated protocols for computer-assisted quantification of mitochondrial 
morphology and Dy and for detection of mitochondrial and cellular superoxide using 
hydroethidine.
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Introduction
Mitochondria are organelles that are among the prime suppliers of cellular energy in the 
form of ATP in most mammalian cells. Mitochondria are also crucially involved in cellular 
Ca2+ homeostasis, redox signalling, induction of programmed cell death and generation 
of reactive oxygen species (ROS) [19]. Individual mitochondria can move through the 
cell, and mitochondria can mix their content by continuous fusion and fission events. 
Depending on the cell type, metabolic state, cell-cycle phase and differentiation stage, 
mitochondria display different motility patterns and a variety of morphologies ranging from 
spherical objects, elongated filaments and/or interconnected (sub)network [19,159]. Each 
mitochondrion consists of a matrix compartment that is surrounded by a highly folded 
mitochondrial inner membrane (MIM) and an outer membrane (MOM). Embedded within 
the MIM lies the oxidative phosphorylation system, which consist of the electron transport 
chain (ETC) and F0F1-ATP synthase [16]. The ETC consists of four complexes (CI, CII, CIII 
and CIV), which extract electrons from NADH (at CI) and FADH2 (at CII). Subsequently, the 
electrons are transported to CIII and CIV by ubiquinone and cytochrome-c, respectively. 
The energy that is generated by the electron transport is used to pump protons across the 
MIM, thereby establishing an inward proton-motive force (PMF) consisting of an electrical 
(Dy) and chemical (DpH) component. The energy stored in the proton gradient is used by 
a fifth complex (CV) to facilitate the synthesis of ATP. In general, proper mitochondrial 
functioning requires the presence of a sufficiently inside negative Dy across the MIM (150-
180 mV). Therefore, DΨ can be considered as a key estimator of “mitochondrial health”. 
In contrast, mitochondrial ROS production is in general viewed purely as a hallmark of 
mitochondrial dysfunction. However, ROS are also increasingly recognized as important 
signalling molecules [51,52,160]. Mitochondria are a significant source of ROS in both 
physiology and pathology, even though they might not be the main cellular producers 
[161]. The primary ROS superoxide (O2
•-) is produced by membrane-bound parts of the 
respiratory chain and a number of soluble mitochondrial proteins. Although O2
•- cannot 
traverse membranes and has only limited reactivity with biological targets, it might function 
as a redox signal in mitochondria [7,22,77]. 
Live cell imaging of mitochondrial function
Fluorescent biosensors for cellular and mitochondrial function (a.k.a. “probes” or “reporter 
molecules”) can be divided in two groups: (i) chemical fluorescent probes, which are 
introduced into the cell using a specific “loading” protocol, and (ii) protein-based 
(“proteinaceous”) fluorescent sensors, which are translated by the cell after introduction of 
sensor’s DNA by cell-transfection. Chemical probes have two advantages over proteinaceous 
sensors: (i) They can be introduced into the cell with relative ease, and, (ii) they stain all 
cells in a relatively equal intensity. Proteinaceous sensors, however, can be more efficiently 
targeted to intracellular compartments like mitochondria. 
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Here, we describe the critical loading procedures and methods to measure mitochondrial 
morphology and Dy and O2
•--associated ROS using live cell microscopy. Each section 
is preceded by some background information followed by the protocols describing our 
strategy to non-invasively study these key mitochondrial parameters.
Mitochondria-specific staining & quantification of the mitochondrial 
membrane potential
Ideally, the applied staining should exclusively label mitochondria. We have used a 
monomeric green fluorescent protein GFP (AcGFP1) targeted to the mitochondrial matrix 
by attaching an N-terminal cytochrome-c oxidase subunit 8 (cox8) leader sequence 
(mito-AcGFP1). Using this protein-based probe has the distinct advantage that its staining 
is independent of Dy, also allowing mitochondrial labeling and proper visualization 
under conditions that Dy is (partially) depolarized. We have generated insect viruses 
(baculoviruses) for expression of mito-AcGFP1 in primary cells, yielding mitochondria-
specific fluorescence signals [47]. If a mitochondrial label with a red fluorescence is 
required, a mitochondria targeted variant of a red fluorescent protein (tagRFP) can be used. 
Alternatively, mitochondrial morphology in living cells can be determined using chemical 
cations, which accumulate in the mitochondrial matrix in a Dy dependent manner. These 
cations include rhodamine 123 (R123), TMRE (tetramethyl rhodamine ethyl ester) and 
TMRM (tetramethyl rhodamine methyl ester). We used the latter molecule for simultaneous 
quantification of mitochondrial shape, position and Dy for individual mitochondria 
[47,99]. Importantly, TMRM concentrations need to be as low as possible (< 100 nM) to 
prevent artifacts like cytosolic staining, fluorescence auto-quenching, phototoxic effects 
and inhibition of mitochondrial respiration [47,162]. 
Lipophilic cationic molecules, such as rhodamines, rhodamine derivatives and 
carbocyanines, can freely diffuse across membranes. Due to their positive charge these 
molecules sequester in the negatively charged mitochondrial matrix according to the 
Nernst equation. Therefore these cations are also called “Nernstian dyes” [99]. However, 
toxicity and specificity of the different probes should be taken into consideration during 
visualization of mitochondrial function in living cells. R123 is a fluorescent marker for 
mitochondria, which sequesters in the mitochondrial matrix in a Dy dependent manner 
at approximately 4000:1 ratio relative to the cytoplasm [43,44,163]. R123 undergoes a 
spectral red-shift of 11 nm and its fluorescence can be quenched at high concentrations 
in energetically coupled mitochondria [163]. The latter phenomenon also can occur for 
TMRM and means that R123/TMRM fluorescence intensity increases, instead of decreases 
upon Dy depolarization. Evidence has been provided that the extent of dequenching 
can be used as a sensitive measure of Dy [164]. The presence of probe dequenching 
can be demonstrated by adding (e.g. pipetting) of the protonophore carbonyl cyanide-p-
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trifluoromethoxyphenylhydrazone (FCCP; 1 µM) to R123/TMRM-stained cells. When FCCP 
induces an increase in mitochondrial R123/TMRM fluorescence, followed by a decrease, 
probe dequenching is present. When FCCP only induces a decrease in mitochondrial R123/
TMRM fluorescence, probe dequenching is absent. Because the FCCP effect can occur 
rapidly, time-lapse experiments need to be carried out using a short image acquisition interval 
(~ 1s). In our research we have exclusively used TMRM in the absence of dequenching to 
obtain steady-state mitochondrial fluorescence signals that are positively correlated to Dy. 
Both R123 and TMRM also redistribute across the plasma membrane according to the 
Nernst equation. R123 can bind proteins and redistributes slowly, whereas TMRM quickly 
redistributes across the membranes. This makes TMRM less toxic and ideal to monitor fast 
depolarization events that would be missed by R123. However, fast redistribution of TMRM 
is more dependent on the plasma membrane potential (DV). Ideally, TMRM recordings of Dy 
should therefore be paralleled by DV measurements. For this purpose, an elegant method 
was presented based on the combined use of a plasma membrane potential indicator (PMPI) 
and TMRM in cerebellar granule neurons [101].
Materials
• Human skin fibroblasts of a low passage number cultured in medium 199 (Invitrogen, 
Breda, Netherlands) + 10% fetal calf serum (Greiner Bio-One, Alphen a/d Rijn, 
Netherlands) + 1% penicillin/streptomycin (Invitrogen) on a glass cover-slip (ø24 mm, 
Menzel GmbH, Braunschweig, Germany) or disposable incubation chamber (Willco 
Wells BV, Amsterdam, Netherlands). 
Note: Human skin fibroblasts are particularly suitable for visualizing and subsequent 
computer-assisted quantification of mitochondrial morphology due to their flat appearance. 
We advise not to analyse mitochondrial morphology of less flat cells, such as HEK293 cells, 
with this method, but to use an appropriate alternative [165]. 
• 5x HEPES buffer: 662.2 mM NaCl, 50 mM HEPES, 21.06 mM KCl, 6.1 mM MgCl2. 
Note: We store a large volume of 5x HEPES buffer at 4°C, which can be stored for at least 
6 months. 
• 1x HEPES-Tris buffer: 10 mM HEPES, 132 mM NaCl, 4.2 mM KCl, 1.2 mM MgCl2, 1.0 
mM CaCl2, 5.5 mM D-glucose. Adjust the pH to 7.4 using Tris-base. 
• Image analysis software like Image Pro Plus (Media Cybernetics Inc., Bethesda, MD, 
USA), Metamorph® (Molecular Devices Corporation, Palo Alto, CA, USA), or an open-
source alternative like ImageJ/FIJI (http://rsbweb.nih.gov/ij/ or http://pacific.mpi-cbg.
de/wiki/index.php/Fiji).
Mito-AcGFP1
• A baculovirus stock solution for cell transfection with cox8-AcGFP1 (mito-AcGFP1). 
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• A microscope allowing excitation with 470 nm light (monochromator) and containing 
a 505 nm dichroic mirror (Chroma Technology Corporation, Bellows Falls, VT, USA; 
XF2031) and 565 long pass emission filter (Chroma; XF3085) (Figure 3.1). 
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Figure 3.1 Automated epi-fluorescence videomicroscope. (A) Overview of the system. (B) Magnification 
of the excitation hardware and filter-wheel control hardware. (C) Magnification of the environmental 
control system. (D) Magnification of the fluorescence detection hardware. Legend: a, monochromator; 
b, motorized inverted microscope; c, CCD-camera; d, environmental control system (top=temperature, 
bottom=CO2); e, monitor part of the computer that controls the microscopy hardware; f, optic fiber to 
direct excitation light to the microscope; g, monochromator control hardware; h, filter-wheel control 
hardware; i, peristaltic pump for cell superfusion; j, emission filter-wheel; k, motorized dichroic mirror. 
TMRM
• A TMRM super stock solution (concentration + solvent). Dissolve 1 mg of TMRM 
powder (Invitrogen) in 3.99 ml DMSO to reach a concentration of 0.5 mM. Make 
aliquots of 5 µl in brown Eppendorf tubes. Storage life at -20oC is one year. 
Note: Always keep TMRM powder and solution protected from light.
• A TMRM working solution. Thaw an aliquot of TMRM superstock solution and add 495 
µl of imaging buffer to make the TMRM working solution 5 µM. Vortex and keep on ice 
during time of experiment.
• A video microscope system allowing excitation with 540 nm light (monochromator) 
and containing a 560 nm dichroic mirror (Chroma; XF2017) and 565 long pass emission 
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filter (Chroma; XF3085). The microscope should be equipped with an environmental 
control system.
Methods
Visualizing mitochondria with Mito-AcGFP1 - Baculoviral transfection [47].
1. Baculoviral expression vectors were constructed using the Gateway® Cloning 
system (Invitrogen, Breda, Netherlands). To obtain an AcGFP1-Baculo destination 
vector, the ScrfI/XbaI restriction fragment of pcDNA5/FRT/TOAcGFP destination 
vector was cloned into the ScrfI/XbaI site of the mammalian pFastBacDual 
destination vector (Invitrogen).
2. The mitochondrial targeting sequence of human cytochrome-c oxidase subunit 
8A (first 93 basepairs of the sequence NM_004074) flanked by Gateway® AttB 
sites (Invitrogen) was created using PCR. The flanked sequence was cloned 
into pDONR201 entry vector using the Gateway® BP Clonase II Enzyme Mix 
(Invitrogen). 
3. The mitochondrial targeting sequence was transferred to the AcGFP1-Baculo 
destination vector using the Gateway® LR Clonase II Enzyme Mix (Invitrogen) to 
obtain a mitochondria-targeted AcGFP1 (mito-AcGFP1). Baculoviruses were then 
produced as described in the Bac-to-Bac® Baculovirus Expression System manual 
(Invitrogen).
4. In order to express mito-AcGFP1 in human skin fibroblasts, seed the cells onto ø24 
mm cover-slips or disposable incubation chambers and cultured for 24 hours. 
Note: Seed the cells at such densities that the cells are 60-70% confluent at the time of 
imaging. This allows subtraction of the background signal.
5. Infect the cells with mito-AcGFP1 baculovirus (5-7% v/v) for 48 hours prior to 
imaging.
Note: Keep the cells in an incubator close to the microscope system from at least 1 h before 
imaging.
Visualizing mitochondria with Mito-AcGFP1 - Live cell microscopy
1. Switch on the system at least half an hour in advance to allow heating up of the 
lamp.
Note: To prevent damage, never repeatedly switch on the excitation source within a short 
period of time.
2. Wash the cells with HT buffer to remove excess culture medium.
3. Cover the cells by HT buffer and mount the cells on the microscope.
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Visualizing mitochondria with TMRM - Cell culture
1. Cells should be seeded 3 days before the measurement in different densities. 
Ideally, the density of control and patient or treated cells should be the same.
Note: Mitochondrial membrane potential measurements are very sensitive to environmental 
changes (e.g. temperature, pH). Culture the cells in separate dishes to minimize pH 
differences and transfer the cells to an incubator close to the microscope system at least 
one hour prior to imaging.
2. Load the cells with TMRM in a dish-by-dish manner.
Visualizing mitochondria with TMRM - TMRM staining (in the dark)
1. Pipette 5 µl (final concentration of 25 nM) of TMRM working solution in an 
Eppendorf tube. 
Note: Lower the concentration if the signal is too intense. If the images are used for 
automated analysis, fluorescence intensity should not exceed 256 grey values.
2. Take 1 ml of medium from the culture dish; add it to TMRM and vortex for 5 to 10 
seconds.
3. Replace the rest of the medium from the dish by the medium/TMRM solution.
4. Incubate the cells in a 37oC, 5% CO2 incubator for 25 minutes.
5. Wash the cover-slip/culture dish three times with 1 ml phosphate buffered saline 
(PBS).
6. Replace the PBS by imaging buffer and mount the cover-slip/culture dish on the 
microscope.
Note: When monitoring a Dy increase over time, it may be advisable to add the loading 
concentration of TMRM to the imaging buffer; the cytosolic TMRM concentration might 
be too low to enable TMRM fluorescence increases as a result of increased mitochondrial 
TMRM uptake.
7. Start loading of the next cover-slip/culture dish immediately, because imaging of 
TMRM signals can only occur for limited amount of time. 
Visualizing mitochondria with TMRM - Live cell microscopy
1. Select an area of interest where the mitochondrial network can be seen in focus. 
Optionally confocal stack images should be acquired in thick cells.
2. Set microscope settings to first record an image for mitochondrial mask recording 
(such as mito-AcGFP), followed by an image for TMRM. 
Note: Short illumination times (100 ms) should be applied, because light induction of TMRM 
can cause cellular photo-damage. TMRM labelling in human skin fibroblasts has previously 
shown that short acquisition times of TMRM at low- and auto-quenching concentrations 
(described below) did not alter the fluorescence intensity histogram.
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3. After acquiring 10-20 individual cells, collect a background image either by 
finding an empty field or scraping of cells in the field-of-view.
Note: This is to prevent environmental changes affecting TMRM signal quantification. 
4. For time-lapse recordings, carry out additional control experiments for photo-
bleaching.
Note: In our experience, TMRM showed no leakage in these cells for up to 15 min and 
extended illumination of TMRM did not result in photo-bleaching during 10 min recordings 
[47].
Visualizing mitochondria with TMRM - Determining auto-quenching
1. Prepare a 2 µM FCCP work solution in imaging buffer.
2. After TMRM incubation and washing, add 0.5 ml imaging buffer to the cover-slip/ 
culture dish. Mount the cover-slip/culture dish on the microscope as previous.
3. Locate an appropriate field of view and set up a time-lapse recording with an 
interval of 2 seconds. Record 10 iterations and subsequently add 0.5 ml of 2 µM 
FCCP to the cells (final concentration 1 µM). 
Note: Optionally perfusion can be used to administer FCCP, although different tubing 
should be used, since FCCP will bind most tubing materials.
4. Monitor the mean fluorescent intensity of the cell for a transient increase (auto-
quenching present) or decrease (absence of auto-quenching) of TMRM fluorescent 
intensity.
Quantifying mitochondrial position, shape and Dy by image analysis
1. The first step in image quantification is correction of the image for the background 
signal. When the background is homogeneous, background subtraction can be 
carried out by measuring the mean fluorescent intensity selecting an extracellular 
region of interest (ROI) or by subtraction of an “empty” image without cells. The 
resulting background corrected (COR) image (Figure 3.2A) is then converted to 
8-bit (256 grey values).
2. Next, the contrast in the COR image is optimized using a linear contrast stretch 
(LCS) operation to cover the full range of grey values. 
3. To highlight mitochondrial particles from the image, a top-hat spatial filter is 
applied. It is crucial to choose the proper size of the top-hat filter because its 
performance depends on the used objective and size of the mitochondrial objects. 
In case of TMRM-stained fibroblasts, imaged using a x40 objective, a top-hat filter 
with a size of 7x7 pixels has to be applied 3 times to achieve optimal results [166]. 
4. As an undesirable side effect, top-hat filtering can introduce artifacts into the 
image due to amplification of non-mitochondrial (noise) pixels. In TMRM-stained 
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fibroblasts these artifacts can be removed by applying a 3x3 median (MED) 
filter, followed by application of a threshold operation, without degradation of 
mitochondrial pixels. The resulting image is of a binary (BIN) nature, in which 
mitochondria are represented as white objects on a black background (Figure 
3.2B). 
5. This image can be used to directly assess the number and position of mitochondria 
(Figure 3.2C). Moreover, mitochondrial shape descriptors can be quantified at the 
level of individual organelles, cells or images (Figure 3.2D) as described previously 
[167].
6. By combining the BIN image with the COR image using Boolean logic (“AND”) 
a masked (MSK) image is obtained. The MSK image includes only mitochondrial 
objects, each with its individual TMRM fluorescence intensity, on a black 
background (Figure 3.2E). This allows quantification of TMRM intensity for each 
mitochondrial object as reflected by the histogram in figure 3.2F. 
Quantification of reactive oxygen species using hydroethidine
Since mitochondrial signalling and cellular function are intricately linked, it is important 
to measure mitochondrial O2
•- in the proper context – i.e. the living cell. However, it has 
proven difficult to develop fluorescent probes or sensors that are specific for O2
•- and 
sensitive enough to compete with superoxide dismutase (SOD), which converts O2
•- to 
hydrogen peroxide at an extremely high rate. For example, a recent development in O2
•- 
detection involved the use of circularly permuted YFP (cpYFP) to detect superoxide flashes 
[121,168,169]. However, critical re-evaluation of the data suggests that, under certain 
conditions, cpYFP might not only respond to changes in O2
•- levels but also to pH changes 
[122,124,127]. Quantifying the oxidation of hydroethidine (HEt) is another widely applied 
strategy to detect O2
•- in living cells. HEt is membrane-permeable and reacts with O2
•- 
to form the specific fluorescent product 2-hydroxyethidium (2-OH-Et+; Figure 3.3A). In 
addition, when HEt acts as a hydride acceptor, its oxidation leads to formation of the non-
specific fluorescent product ethidium (Et+) [35,36]. 
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Figure 3.2 Automated quantification of mitochondrial morphology and membrane potential. (A) 
Typical example of primary human skin fibroblasts (#5120), stained with the Dy sensitive cation 
TMRM. This image (COR) was acquired with the video microscopy system depicted in figure 3.1 and 
background corrected. (B) Binary (BIN) image calculated from the image in panel A, representing 
white mitochondria on a black background. (C) Automated analysis of mitochondrial position, number 
and morphology of the image in panel B using image analysis software. Each identified mitochondrial 
object is surrounded by a red line and marked by a number. In total, 300 objects were present in this 
image, meaning that each cell contained ~100 mitochondrial objects. (D) Average value (+standard 
error) of key descriptive parameters introduced previously [102] for the image in panel C. (E) Colour 
coded image obtained by masking the COR image in panel A with the BIN image in panel B. Given 
the membrane potential sensitivity of TMRM staining, this image can be used to estimate Dy. (F) 
Histogram of TMRM fluorescence intensity for the objects in panel E. 
Abbreviations: Am, area of mitochondrial object (pixels); AR, aspect ratio of mitochondrial object 
(arbitrary units); F, formfactor of mitochondrial object (arbitrary units); I, TMRM fluorescence intensity 
of mitochondrial object (grey value); dmax, maximal diameter of mitochondrial object (pixels); dmin, 
minimal diameter of mitochondrial object (pixels); Pm, perimeter of mitochondrial object (pixels); Lm, 
length of mitochondrial object (pixels); Wm, width of mitochondrial object (pixels).
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Figure 3.3 Chemical structures and excitation spectra of HEt and mito-HEt (A) HEt and mito-HEt 
specifically react with O2
•- to form the reaction product 2-OH-(mito-)Et+ and (mito-)Et+ as a nonspecific 
by-product. The inset shows the HEt- and mito-HEt-specific groups. Figure was adapted from [170]. 
(B) Fluorescence excitation (blue) and emission (red) spectra of 2-OH-Et+ (top traces) and Et+ (lower 
traces) superimposed with the excitation and emission filters used in our microscope set-up. Figure 
was adapted from Zielonka and Kalyanaraman [171].
Whereas the fluorescence excitation peaks of 2-OH-Et+ (Figure 3.3B; upper blue curve) 
and Et+ (lower blue curve) overlap at around 500 nm, 2-OH-Et+ has one additional peak at 
396 nm which has been used for more specific detection of 2-OH-Et+ [37]. Still, this assay 
should be considered semi-quantitative due to the unknown reactivity of O2
•- with SOD, the 
possible oxidation of HEt by cytochrome c and because HEt can catalyse O2
•- dismutation 
[37,172]. Although HEt oxidation can occur throughout the cell, both 2-OH-Et+ and Et+ are 
positively charged and therefore accumulate in the nucleus where they intercalate with 
nucleic acids and in the mitochondrial matrix due to the high Dy of this organelle. Utilizing 
Dy, the more mitochondria-specific O2
•- probe MitoSOX red (i.e. Mito-HEt) was designed, 
which consists of HEt extended with a cationic triphenylphosphonium (TPP) side group 
[37].
Materials
• Cells cultured on a glass coverslip (ø24 mm, Thermo Scientific, Etten-Leur, The 
Netherlands) placed in a 35-mm CellStar tissue culture dish (Sigma-Aldrich) or 
disposable incubation chamber (Willco Wells BV).
Note: Due to the positive charge of mito-HEt and the reaction products of HEt oxidation, 
the fluorescence intensity measured in the mitochondria is Dy-dependent (Figure 3.4). 
Since the mitochondrial membrane potential is very sensitive to environmental changes 
(e.g. temperature, pH), we advise to culture the cells in separate dishes and to allow cells 
to recover in an incubator close to the microscope system at least one hour prior to imaging. 
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In addition, we have noticed that HEt can react with residues on a number of glass-bottom 
culture dishes, leading to fluorescent “spots” in the background. Therefore, always check 
background levels for disturbances of that kind. 
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Figure 3.4 Localization of HEt oxidation products is dependent on the membrane potential. Addition 
of the mitochondrial protonophore carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP; 
0.5 µM) acutely induces translocation of fluorescent HEt and mito-HEt oxidation products from the 
mitochondria to the nucleus in HEK293 cells and human skin fibroblasts.
• A microscope system with the following set-up or similar; a monochromator 
(Polychrome IV, TILL Photonics) allowing excitation with 405 and/or 490 nm light, a 
525DRLP dichroic mirror (Omega Optical Inc.) and 565ALP emission filter (Omega 
Optical Inc.) and an image capturing device (f.i. CoolSNAP HQ monochrome CCD-
camera (Roper Scientific). The microscope should be equipped with an environmental 
control system to sustain cell viability
• 5x HEPES buffer: 662.2 mM NaCl, 50 mM HEPES, 21.06 mM KCl, 6.1 mM MgCl2. 
Note: We store a large volume of 5x HEPES buffer at 4°C, which can be stored for at least 
6 months. 
• 1x HEPES-Tris buffer: 10 mM HEPES, 132 mM NaCl, 4.2 mM KCl, 1.2 mM MgCl2, 1.0 
mM CaCl2, 5.5 mM D-glucose. Adjust the pH to 7.4 using Tris-base. 
Note: We advise to make the 1xHT buffer supplemented with the required substrates at 
the day of imaging. We routinely use 5.5 mM D-glucose for human skin fibroblasts and 
myoblasts/fibres, whereas HEK293 cells are imaged in HT buffer containing 25 mM 
D-glucose. In addition, one can consider supplementing pyruvate and/or glutamine. If 
necessary, the HT buffer can be stored for ~1 week at 4°C.
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Hydroethidine
• HEt stock solution (31.7 mM in DMSO): Dissolve 1 mg of HEt powder (Invitrogen) in 
100 µl DMSO. Prepare 10 µl aliquots in brown Eppendorf tubes, overlay with N2 gas 
and store at -20°C. 
Note: Always keep HEt solutions protected from light and air, since this might cause 
extracellular HEt oxidation. 
• HEt working solution (5 mM in DMSO): Thaw an aliquot of HEt stock solution and add 
53.4 µl of DMSO to yield the 5 mM HEt working solution. 
Mito-hydroethidine
• Mito-HEt working solution (500 µM in DMSO): Dissolve 50 µg of MitoSOX powder 
(Invitrogen) in 132 µl DMSO. Prepare 4 µl aliquots in brown Eppendorf tubes, overlay 
with N2 gas and store at -20°C. 
Methods
Imaging of hydroethidine oxidation
1. Seed the cells at such densities that the cells are 70-80% confluent at the time of 
imaging. This allows subtraction of the background signal. 
Note: Proper background correction close to the cells is of particular importance when 
the fluorescent signal is close to the background intensity. Such a background correction 
is not possible at a confluency higher than 80%. Therefore, adjust the seeding condition 
according to the number of days the cells are cultured.
2. Transfer the cells to an incubator close to the microscope system at least one hour 
prior to imaging.
3. Aliquot 2 µl of HEt working solution in Eppendorf tubes. 
4. Take 1 ml of medium from the culture dish, add it to the aliquotted HEt and vortex for 
5 to 10 seconds to prepare a final concentration of 10 µM. 
Note: We prefer to load the cells with HEt in the collected cell culture medium to detect ROS 
levels in the exact cell culture conditions. However, we have noticed lower fluorescence 
intensities in medium-loaded cells as compared to cells loaded with HEt in the HT buffer. 
This is possibly caused by binding of the HEt to proteins present in the medium (i.e. serum), 
but might also be due to increased fluorescence levels in HT medium (Figure 3.5A). 
5. Replace the rest of the medium from the dish by the medium/HEt solution.
6. Incubate the cells in a 37°C, 5% CO2 incubator for exactly 10 minutes. 
Note: The HEt incubation time should be determined experimentally for each cell line 
separately. To be able to semi-quantitatively measure HEt oxidation, the increase in 
fluorescence intensity from oxidation products should be linear. To that end, we mount 
unloaded cells onto the microscope system in HT buffer, start imaging every 10 seconds 
and add the required HEt in HT buffer in 1:1 ratio. We then calculate the maximum time of 
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incubation in which the increase is still linear. An incubation time of 10 min is most often 
used for HEK293 and human skin fibroblasts (Figure 3.5B). However, in some cell types 
such as primary mouse myotubes it appears to be safer to use shorter incubation times 
because the signal increase deviates from linearity within 10 minutes (Figure 3.5C). 
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Figure 3.5 HEt loading procedure in intact cells. (A) HEK293 cells were incubated with HEt for exactly 
10 minutes in the collected cell culture medium (DMEM) or washed and incubated for exactly 10 
minutes in HT buffer. HEt oxidation was measured at 490 nm. The data presented represent the mean 
± SE of two different experiments. Statistical significance was assessed using a Mann-Whitney test. 
Numerals within bars indicate the number of analysed cells. (B) Representative trace of nuclear HEt 
oxidation fluorescence intensity at 490 nm excitation light in HEK293 cells. Up to approximately 10 
minutes the increase remains linear. Note that the mitochondrial increase occurs faster in these cells 
than in the nucleus. (C) Representative trace of mitochondrial HEt oxidation fluorescence intensity at 
490 nm in myoblasts. The increase is linear during 4.5 minutes. 
7. Wash the coverslip three times with 1 ml PBS.
8. Replace the PBS by pre-warmed HT buffer and mount the coverslip in a Leiden 
chamber on the microscope [173]. When using oil-based objectives be careful to 
remove all excess buffer from the bottom of the coverslip with a tissue to avoid optical 
artifacts.
9. Start loading of a next coverslip as soon as loading of the current one is complete.
10. Preferably, take images at both 405 and 490 nm excitation. Set the exposure time to 
100 ms.
11. Record at least 10 different images, each containing ~15 cells. 
Note: When trying to image HEt oxidation at 405 nm, we advise to use the 490 nm light to 
locate cells and find a good focus, because in our experimental setup fluorescence intensity 
is higher at 490 nm than at 405nm excitation (Figure 3.6A). Moreover, we routinely only 
measure fluorescence from 490 nm excitation since, in some cell types, the 405 nm signal 
is too low for reliable quantification. However, relative changes in emission fluorescence 
observed following 405 and 490 nm excitation are similar, justifying the use of 490 nm as a 
measure of HEt oxidation [174].
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Imaging of mito-hydroethidine oxidation
1. Seed the cells at such densities that the cells are 70-80% confluent at the time of 
imaging. This allows subtraction of the background signal.
2. Transfer the cells to an incubator close to the microscope system at least one hour 
prior to imaging.
3. Thaw the 4 µl mito-HEt contents of a brown Eppendorf tube. 
4. Take 1 ml of medium from the culture dish, add it to mito-HEt and vortex for 5 to 10 
seconds to prepare a final concentration of 2 µM. 
Note: We advise to use a mito-HEt concentration that is as low as possible, but still revealing 
detectable levels of fluorescence. In theory, the positive charge accumulating in the 
mitochondrial matrix might interfere with mitochondrial bioenergetics and therefore report 
incorrect HEt oxidation values. In addition, Robinson et al. reported nuclear fluorescence 
to occur at concentrations as low as 2 µM and therefore advised to use between 0.1 and 
2.5 µM mito-HEt [37].
5. Replace the rest of the medium from the dish by the medium/mito-HEt solution.
6. Incubate the cells in a 37°C, 5% CO2 incubator for exactly 10 minutes.
7. Wash the coverslip three times with 1 ml phosphate buffered saline (PBS).
8. Replace the PBS by pre-warmed HT buffer and mount the coverslip in a Leiden 
chamber on the microscope [173]. When using oil-based objectives be careful to 
remove all excess buffer from the bottom of the coverslip with a tissue to avoid 
focusing problems.
9. Start loading of a next coverslip as soon as loading of the current one is complete.
10. Preferably, take images at both 405 and 490 nm excitation. Set the exposure time to 
500 ms.
11. Record an image sequence of one field of view, acquiring one image every 5 or 10 
seconds for a total of at least 2 minutes. 
Note: Removing excess HEt after incubation effectively removes all non-oxidized HEt and 
therefore the signal remains stable for at least 10 minutes of continuous imaging [69]. The TPP 
moiety of Mito-HEt induces accumulation of non-oxidized Mito-HEt in the mitochondrial 
matrix that is insensitive to washing. Consequently, the fluorescence signal continues to 
increase after washing and therefore we advise to measure the slope of the increase after 
loading and washing (Figure 3.6B). 
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Figure 3.6 Fluorescence intensity from 405 and 490 nm excitation and measurement of HEt versus 
mito-HE oxidation. (A) Simultaneous measurement of HEt oxidation using 405 and 490 nm excitation 
light in myoblasts. (B) Human skin fibroblasts were incubated with 10 µM HEt or 1 µM mito-HEt, 
washed, and imaged every 5 seconds using 490 nm excitation light. Staining with HEt yields end-point 
signals, whereas mito-HEt signals continue to increase in time.
Image analysis
1. Load the raw images into an image analysis program such as Metamorph® (Molecular 
Devices Corporation, Palo Alto, CA, USA), Image Pro Plus (Media Cybernetics) or the 
Open Source program ImageJ (http://rsb.info.nih.gov/ij/).
2. Draw circular regions of interest (ROIs) in: (i) a mitochondria-dense area, (ii) 
surrounding the nucleus, and (iii) just outside every cell to correct for background 
intensity. 
Note: It is sufficient to have only a portion of the cells in the field of view, since only a 
certain area of the cell and not the entire cell is measured.
3. Export the average ROI grey value to a spreadsheet program such as Excel (Microsoft) 
and calculate the background-subtracted values of the mitochondria and the nucleus 
of each cell.
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Abstract
Mitochondrial oxidative damage contributes to a wide range of pathologies, and lipid 
peroxidation of the mitochondrial inner membrane is a major component of this disruption. 
However, despite its importance, there are no methods to assess mitochondrial lipid 
peroxidation within cells specifically. To address this unmet need we have developed a 
ratiometric, fluorescent, mitochondria-targeted lipid peroxidation probe, MitoPerOx. 
This compound is derived from the C11-BODIPY581/591 probe, which contains a boron 
dipyromethane difluoride (BODIPY) fluorophore conjugated via a dienyl link to a phenyl 
group. In response to lipid peroxidation the fluorescence emission maximum shifts from 
~590 nm to ~520 nm. To target this probe to the matrix-facing surface of the mitochondrial 
inner membrane we attached a triphenylphosphonium (TPP) lipophilic cation, which leads 
to its selective uptake into mitochondria in cells, driven by the mitochondrial membrane 
potential. Here we report on the development and characterisation of MitoPerOx. We 
found that MitoPerOx was taken up very rapidly into mitochondria within cells, where 
it responded to changes in mitochondrial lipid peroxidation that could be measured by 
fluorimetry, confocal microscopy and epifluorescence live cell imaging. Importantly, the 
peroxidation sensitive change in fluorescence at 520 nm relative to that at 590 nm enabled 
the use of the probe as a ratiometric fluorescent probe, greatly facilitating assessment of 
mitochondrial lipid peroxidation in cells. 
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Introduction
The mitochondrial respiratory chain is a major source of superoxide that leads on to 
oxidative damage and disruption of the organelle, thereby contributing to a wide range of 
pathologies [7]. Probably the most important aspect of this damage is lipid peroxidation of 
the mitochondrial inner membrane [175,176]. This membrane is particularly susceptible to 
oxidative damage due to its very large surface area, proximity to the superoxide-producing 
respiratory chain and the high content of peroxidation-sensitive unsaturated fatty acids 
in its phospholipids, notably cardiolipin [175]. The propagation of lipid peroxidation 
through the inner membrane disrupts crucial components of the oxidative phosphorylation 
machinery, renders the inner membrane more permeable to protons and generates reactive 
aldehydes that can damage proteins and mitochondrial DNA. Thus elevation of lipid 
peroxidation within the mitochondrial inner membrane is a central damaging mode by 
which mitochondrial oxidative damage contributes to pathologies. Supporting this notion, 
mitochondria-targeted antioxidants that decrease lipid peroxidation, such as MitoQ, are 
therapeutically effective in animal models and in patients in a range of disorders, where 
mitochondrial oxidative damage contributes to the disorder [146,177]. 
The significance of mitochondrial lipid peroxidation is difficult to assess independently 
of that in the rest of the cell, as it requires the isolation of mitochondria or the assessment 
of cardiolipin peroxidation [175], a phospholipid that is almost exclusively found in the 
mitochondrial inner membrane and which can only be assessed ex vivo by mass spectrometry 
[178,179]. These limitations preclude real time analysis and high throughput measurements 
of mitochondrial lipid peroxidation within cells. Current techniques to report on cellular 
lipid peroxidation in real time use fluorescent probes such as C11-BODIPY581/591 [39,180] 
or cis-parinaric acid [181], but as these distribute throughout all cellular membranes it is 
difficult to assess mitochondria-specific lipid peroxidation. 
Consequently, there is a need to be able to monitor changes in mitochondrial lipid peroxidation 
selectively within living cells in real time. Herein we report that we have developed a 
mitochondria-targeted, fluorescent lipid peroxidation probe to address this issue. To do this 
we conjugated a fluorescent lipid peroxidation probe to the triphenylphosphonium (TPP) 
lipophilic cation moiety, which has been widely used to target a range of therapeutic and 
probe molecules to mitochondria in cells and in vivo [146,182,183]. The uptake of TPP 
derived compounds into mitochondria is driven by the mitochondrial membrane potential 
and can be adequately described by the Nernst equation, which indicates that for every 
60 mV of membrane potential the uptake increases 10-fold, suggesting that the membrane 
potentials that occur in vivo (160 – 180 mV) will lead to ~1,000 fold selective uptake into 
mitochondria [183]. Fluorescent probes for superoxide (MitoSOX) [37] and for hydrogen 
peroxide and peroxynitrite [184,185], as well as mass spectrometry-based probes for 
hydrogen peroxide and peroxynitrite [186], have been targeted to mitochondria within cells 
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using the TPP moiety. Furthermore, within the mitochondrial matrix most accumulated TPP 
compounds are adsorbed on to the matrix-facing surface of the inner membrane with the 
TPP moiety on the surface and the attached group inserted into the membrane [187,188]. 
Thus, a TPP-based lipid peroxidation sensitive probe will report on lipid peroxidation within 
the matrix-facing leaflet of the inner membrane, which is one of the most important aspects 
of mitochondrial oxidative damage. 
The lipid peroxidation-sensitive moiety chosen for targeting to mitochondria is based on 
the C11-BODIPY581/591 lipid peroxidation probe [39,189]. C11-BODIPY581/591 comprises 
the robust boron dipyromethane difluoride (BODIPY) fluorophore which absorbs and 
emits at convenient visible wavelengths with high quantum yield, good photostability and 
low photobleaching. In the case of the peroxidation-sensitive probe the BODIPY moiety 
is conjugated to a phenyl group via a diene linker to generate an extensive conjugated 
system that increases the fluorescence emission maximum to ~590 nm [39,189]. A further 
undecanoic acid function ensures that the probe inserts into the core of phospholipid bilayer 
[39,189]. The diene system contained within C11-BODIPY581/591 renders it susceptible to 
lipid peroxidation as it reacts with oxy, peroxy or hydroxyl radicals, but not with nitric 
oxide, superoxide, transition metals or with peroxides per se [113] and leads to cleavage 
of the diene link to give carboxylic acid derivatives [190]. The diene system also reacts 
with peroxynitrite to generate a hydroxylated derivative [190]. The oxidised products of 
C11-BODIPY581/591 display a fluorescence emission maximum at ~520 nm, similar to that of 
BODIPY itself [39] and this shift from red to green fluorescence upon oxidation has been 
used in several ways to assess lipid peroxidation. These include measuring the loss of the 
590 nm emission upon oxidation [180], or more sensitively by monitoring the increase 
in fluorescence at ~520 nm [191]. The distinct and separate emission wavelengths for the 
oxidised and unreacted compounds enable C11-BODIPY581/591 to be used as a ratiometric 
probe by measuring the ratio of the fluorescence at 520 nm to that at 590 nm. This greatly 
facilitates quantification by enabling normalisation to the extent of uptake of the probe 
into the cell or organelle [39,189] and the ratiometric analysis of lipid peroxidation can 
be applied to cell suspensions using a dual wavelength fluorimeter. Excitation at 580 nm 
and emission at 600 nm reflects the unreacted starting material while excitation at 490 nm 
and emission at 520 nm allows for the estimation of the oxidised product. Alternatively 
excitation at a single wavelength of ~490 nm and measurement of emission at both 520 
and 590 nm can be used. Finally, C11-BODIPY581/591 can be used in laser scanning confocal 
fluorescence microscopy by using the 488 nm laser line and monitoring emission at 520 nm 
for the oxidised product and by using the 568 nm laser line and monitoring emission at 590 
nm to assess the starting compound [39]. Therefore the targeting of C11-BODIPY581/591 to 
mitochondria should produce a versatile fluorescent probe that combines the advantages of 
C11-BODIPY581/591 with the selective visualisation of mitochondrial lipid peroxidation in real 
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time. The rationale behind the development of a mitochondria-targeted lipid peroxidation 
probe is illustrated in Fig 4.1A. Here we report on the synthesis and characterisation of the 
mitochondria-targeted lipid peroxidation probe MitoPerOx (Fig 4.1B) and show that it can 
be used to assess mitochondrial lipid peroxidation selectively in isolated mitochondria and 
within cells. 
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Figure 4.1(A) Schematic of MitoPerOx uptake showing its selective accumulation to the matrix-facing 
leaflet of mitochondrial inner membrane where the peroxidation-sensitive moiety penetrates into the 
membrane making it susceptible to lipid peroxidation. Upon oxidation the fluorescence emission at 
520 nm increases and that at 590 nm decreases, making the 520/590 fluorescence intensity ratio a 
marker of mitochondrial lipid peroxidation within cells. (B) The synthesis and structure of MitoPerOx 
are shown, along with the structure of the control compound MitoBODIPY and of the untargeted 
compound C11-BODIPY581/591.
Materials & methods
Chemical synthesis - MitoPerOx. To a solution of 4,4-difluoro-5-(4-phenyl-1,3-butadienyl)-
4-bora-3a,4a-diaza-s-indacene-3-propionic acid sucinimidyl ester (Invitrogen Life 
Technologies, BODIPY® 581/591 SE) (1.5 mg) in dry dichloromethane (2 ml), was added 
(2-aminoethyl)triphenylphosphonium bromide [192] (2 mg) and triethylamine (0.8 ml). The 
mixture was stood at room temperature in the dark for 18 h when HPLC analysis indicated 
complete reaction. The mixture was diluted with dichloromethane (10 ml), washed with 
water (2 x 10 ml), dried and evaporated in vacuo to give the pure product 4,4-difluoro-5-
(4-phenyl-1,3-butadienyl)-4-bora-3a,4a-diaza-s-indacene-3-(propionyl-aminoethylentriph
enylphosphonium) bromide (MitoPerOx) as a blue solid (pink in solution in methanol) (2.2 
mg, 94%). HPLC: Phenomenex Prodigy ODS(3) 5 mm 100 Å (250 x 3 mm) with a 2 x 4 
mm C18 guard column, peaks detected at 210 and 254 nm, solvents acetonitrile in water, 
with 0.1% TFA: t0=10%, t12.5=100, t15=100, t17=10, t20=10% Rt =12.59 mins 95
+% pure, lmax 
583 nm; Fluorescence: lex 586 nm lem 595 nm; HRMS m/z found: 680.2835, calcd. for 
C42H38BF2N3OP
+ 680.2815 [M]+. 1H NMR (500 MHz, CD2Cl2): δ 8.84 (1H, bs, NH), 7.84-
7.74 (9H, m, H3’’’, H4’’’), 7.72-7.66 (6H, m, H2’’’), 7.47 (2H, d, J = 8Hz Ph2), 7.34 (2H, t, 
68  |  CHAPTER 4
J = 8Hz, Ph3), 7.27 (1H, bt, J = 8Hz, Ph4), 7.19 (1H, m, H1’), 7.15 (1H, dd, J = 10, 16Hz, 
H2’), 7.11 (1H, dd, J = 10, 16Hz, H3’),7.07 (1H, s, H5), 7.02 (1H, d, J = 5Hz, H3), 6.96 
(1H, d, J = 5Hz, H7), 6.87 (1H, d, J = 5Hz, H2), 6.84 (1H, d, J = 16Hz, H4’), 6.43 (1H, 
d, J = 5Hz), 3.67 (4H, m, H5’’, 6’’), 3.17 (2H, t, J = 8Hz, H1’’) and 2.57 (2H, t, J = 8Hz, 
H2’’). 13C NMR (125 MHz, CDCl3): δ 172.56 (C3’’), 161.06 (C9), 155.53 (C1), 138.25 (C1’), 
137.38 (C4’), 137.07 (Ph1), 136.66 (C4), 135.52 (d, JC4P = 2Hz, C4’’’), 135.39 (C6), 133.95 
(d, JC3P = 8Hz, C3’’’), 130.74 (d, JC2P = 9Hz, C2’’’), 130.26 (C3), 129.85 (C7), 129.26 (C3’), 
129.06 (Ph3), 128.80 (Ph4), 127.24 (Ph2), 125.49 (C5), 122.99 (C2’), 118.58 (C8), 118.10 
(d, JCP = 69Hz, C1’’’), 117.05 (C2), 34.13 (C2’’), 33.53 (C5’’), 24.70 (C1’’) and 22.94 (d, JCP 
= 39Hz, C6’’). 
Chemical synthesis - MitoBODIPY. Following the published method [193], 
2,4-dimethylpyrrole (0.92 ml, 0.85 g, 8.9 mmol) was combined with 6-bromohexanoyl 
chloride (946 mg, 4.43 mmol) [194] in dry degassed dichloromethane (100 ml) under a 
nitrogen atmosphere and heated to reflux for 3 hours. After cooling to room temperature, an 
additional volume of dry dichloromethane (50 ml) was added followed by triethylamine (3.2 
ml, 2.3 g, 23 mmol) and the reaction stirred for 15 minutes. Boron trifluoride etherate (6 mL, 
6.8 g, 47 mmol) was then added and the reaction stirred overnight at room temperature. The 
reaction mixture was washed with water (2x) and dried (MgSO4). After concentration in vacuo, 
the residue was dissolved in minimum dichloromethane and chromatographed on silica 
gel. Elution with dichloromethane/petroleum ether (50:50) gave the product [2-[6-bromo-
1-(3,5-dimethyl-2H-pyrrol-2-ylidene-κN)hexyl]-3,5-dimethyl-1H-pyrrolato-κN]difluoro-T-
4-boron (bromohexylBODIPY) (615 mg, 35 %) which has been recently reported [195]. 
BromohexylBODIPY (0.157 g, 396 mmol) was combined with triphenylphosphine (0.55 
g, 2.1 mmol) and heated as a melt at 90oC in a sealed tube under argon for 6 hours. After 
cooling, the residue was dissolved in minimum dichloromethane and excess diethyl ether 
was added to precipitate the salt. This dissolution-precipitation process was repeated 4 
times to isolate [2-[1-(3,5-dimethyl-2H-pyrrol-2-ylidene-κN)-6-triphenylphosphinohexyl]-
3,5-dimethyl-1H-pyrrolato-κN]difluoro-T-4-boron bromide (MitoBODIPY) (0.111 g, 43 %). 
HRMS m/z found: 579.2895, calcd. for C36H39BF2N2P
+ 579.2913 [M]+. 1H NMR (500 MHz, 
CDCl3): 7.81-7.66 (m, 15H), 6.01 (s, 2H), 3.62 (m, 2H), 2.98 (m, 2H), 2.49 (s, 6H), 2.37 (s, 
6H), 1.88 (m, 2H), 1.65 (m, 4H). 31P NMR 24.64
Absorption: (dichloromethane) lex 501 nm (e 111500) lem 509 nm.
Characterisation of MitoPerOx - Stock solutions of MitoPerOx were made up in ethanol 
or DMSO, flushed with argon and stored as aliquots at -20oC prior to use. Reactions were 
carried out in absolute ethanol or in KCl buffer (120 mM KCl, 10 mM HEPES and 1 mM 
EGTA, pH 7.2 (KOH). UV/Visible spectra were obtained using a Shimadzu UV-2501PC 
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spectrophotometer. Fluorescence spectra were obtained using a Shimadzu RF-301PC 
fluorimeter (excitation and emission slit widths of 3 nm and scan speed setting of fast) 
in 2.5 ml ethanol or KCl buffer. For mitochondrial suspensions changes in fluorescence 
intensity over time were followed at excitation wavelength of 485 nm and at an emission 
wavelength of 520 nm. 
 
Mitochondrial preparations and incubations - Isolated rat liver mitochondria were prepared 
at 4oC in 250 mM sucrose, 10 mM TRIS and 1 mM EGTA (pH 7.4) by homogenisation and 
differential centrifugation [196]. The protein content was assessed by the biuret assay using 
BSA as a standard. Ion-selective electrodes selective for the TPP component of MitoPerOx 
and MitoBODIPY were constructed as previously described [197,198], and inserted into 
a thermostated and stirred 3 ml chamber. Linoleic acid peroxide was made as described 
[199]. For this linoleic acid (Sigma, 0.1 g) was dissolved in 10 ml ethanol and mixed with 
100 ml 50 mM sodium borate buffer (pH 9) to which was added 2 mg soybean lipoxygenase 
(BioChemika/Sigma 7.9 U/mg). The mixture was incubated at 23˚C until the absorbance at 
233 nm due to the linoleic acid diene peroxide had reached a stable maximum (~70 min). 
At this point the mixture was adjusted to pH ~ 3 with 1 M HCl and the linoleic peroxide was 
extracted into diethyl ether, dried over sodium sulfate and the solvent was evaporated under 
vacuum. The residue was dissolved in ethanol, the concentration of the linoleic acid diene 
peroxide was determined at 233 nm (e = 27.4 x 103 M-1cm -1: [200]) and a stock solution of 
~ 7 mM was prepared in ethanol. 
Cell culture - All cells were incubated at 37oC in a humidified 95% air and 5% CO2 
environment and culture media were supplemented with 10% (v/v) foetal calf serum 
(FCS), 100 U/ml penicillin and 100 µg/ml streptomycin. C2C12 cells [mouse myoblast 
cell line; European Collection of Animal Cell Cultures (ECACC)] were cultured in low 
glucose (1000 mg/L D-glucose) Dulbecco’s modified Eagle’s medium (DMEM; Invitrogen) 
and were maintained at sub-confluence (< 80%) to prevent cell differentiation. Primary 
human skin fibroblasts were cultured in M199 medium (Life Technologies) and obtained 
from biopsies according to the appropriate institutional review boards. Human embryonic 
kidney (HEK293) were cultured in DMEM with 4.5 g/L glucose and 2 mM L-glutamine. 
Analysis of cell uptake of MitoPerOx by confocal microscopy - To assess uptake of 
MitoPerOx into mitochondria within cells, H2C9 cells were seeded at 15,000 cells/
chamber in 8-chamber borosilicate coverslips (Lab-Tek) and allowed to adhere overnight. 
Media was removed by aspiration, and cells were washed twice in phosphate-buffered 
saline (PBS) before the addition of test compounds in phenol red-free DMEM (Invitrogen). 
Cells were then incubated at 37oC before imaging. Confocal imaging was conducted on a 
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Zeiss LSM 510 Meta inverted confocal microscope (Oberkochen, Germany) with a 63x oil 
immersion objective lens, 488 and 543 nm laser lines and 505/530BP and 560LP filter sets. 
To visualize mitochondria, MitoTracker Green (Invitrogen) was added to cells at 200 nM 
and incubated for 5 minutes at 37oC. MitoTracker Green was chosen because its excitation 
and emission wavelengths are furthest removed from those of the BODIPY fluorophore.
Quantification of mitochondrial lipid peroxidation in living cells - Cells were seeded on 
24 mm coverslips (Omnilabo International, Breda, The Netherlands) placed in 35 mm Cell 
Star tissue culture dishes (Sigma) 2 days before the experiment and loaded with 100 nM 
MitoPerOx in culture medium for 30 minutes in the dark at 37 °C in a dish by dish manner. 
After incubation, cells were washed three times using PBS and finally maintained in a 
colourless HEPES-Tris buffer (132 mM NaCl, 10 mM Hepes, 4.2 mM KCl, 1 mM MgCl2, 
1 mM CaCl2 and 25 mM D-glucose, adjusted to pH 7,4 with Tris salt). The cover slips are 
placed in a temperature controlled (37° C) stage of an inverted microscope (Axiovert 200 
M, Carl Zeiss, Jena, Germany) using a x40 1.3 NA F Fluar oil-immersion objective (Carl 
Zeiss). For image acquisition, MitoPerOx was excited using a monochromator (Polychrome 
IV, TILL Photonics, Gräfelfing, Germany) at 488 nm for 200 ms directed to the cells by a 
505DRLPXR (Omega Optical Inc) dichroic mirror. Emission was captured through 510BW40 
(Omega Optical Inc) and 565ALP (Omega Optical Inc) emission filters for the oxidized 
and reduced forms of MitoPerOx, respectively. Images were captured every 5 minutes and 
analysed using Image-Pro Plus 5.1 by masking the mitochondrial network as described 
before [99] and measuring the mean mitochondrial intensity per cell of each image view.
Results & Discussion
Synthesis and characterization of MitoPerOx - MitoPerOx was synthesized readily in 
one step and in good yield from a commercially available precursor (BODIPY® 581/591 SE, 
Invitrogen Life Technologies) by reaction with 2-aminoethyltriphenylphosphonium (Fig. 
4.1B). The UV/visible absorption spectra in ethanol or aqueous solution show the expected 
intense visible absorbance of the BODIPY moiety in the 500 – 600 nm range that increases 
in organic solvent (Fig. 4.2A). In the UV range there are absorbance peaks at 334 nm and at 
267 nm (TPP) (Fig. 4.2A, expanded section). A fluorescence emission spectrum generated 
by excitation at 495 nm in aqueous solvent shows emission at 515 nm and 545 nm while 
in ethanol a further large emission peak at 590 nm dominates (Fig. 4.2B). Oxidation of 
MitoPerOx by cumene hydroperoxide/CuSO4 greatly increased fluorescence emission at 
520 nm and decreased that at 590 nm (Fig. 4.2C). Therefore the fluorescence emission of 
MitoPerOx increases in hydrophobic environments and upon oxidation the emission at 520 
nm increases dramatically while that at 590 nm decreases, indicating that MitoPerOx is a 
potential ratiomeric, fluorescent lipid peroxidation probe. 
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Figure 4.2 (A) Visible absorption spectra of MitoPerOx (1 µM) in ethanol or KCl buffer. A further UV 
absorption spectrum of 10µM MitoPerOx in ethanol is also shown. (B) Fluorescence emission spectrum 
of 1µM MitoPerOx in ethanol or KCl buffer. Excitation 495 nm. (C) Fluorescence emission spectrum 
of 1µM MitoPerOx in ethanol after incubation for 67 h with 2 mM cumene hydroperoxide/500 µM 
CuSO4. 
Uptake of MitoPerOx by mitochondria - To see if MitoPerOx was taken up selectively 
by mitochondria, we first measured its interaction with isolated mitochondria. Using an 
ion-selective electrode that responds to the TPP moiety of MitoPerOx, extensive binding 
of MitoPerOx to de-energised mitochondria was evident, with some further uptake upon 
energisation with succinate (Fig. 4.3A). However, upon uncoupling the mitochondria with 
FCCP, there was little release of MitoPerOx (Fig. 4.3A). To see if this behaviour was due to 
the hydrophobic BODIPY moiety, we also assessed the uptake of a similar TPP derivative, 
MitoBODIPY (Fig. 4.3B). This showed essentially identical behaviour to MitoPerOx with 
isolated mitochondria. The excessive binding and lack of release from mitochondria upon 
deenergisation is presumably due to the hydrophobicity of the TPP modified BODIPY 
compounds. The octanol:water partition coefficient for C11-BODIPY581/591 at pH 7.4 is high 
(Log P = 2.53) and under these conditions its binding to biological phospholipid bilayers is 
even greater (Log P = 4.34) [113]. Other highly hydrophobic TPP derivatives show similar 
behaviour to MitoPerOx when incubated with isolated mitochondria, making the extent of 
membrane potential-dependent uptake by isolated mitochondria difficult to assess [201]. 
However, these compounds were still rapidly taken up by mitochondria within cells [202]. 
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Figure 4.3(A) Mitochondrial accumulation of MitoPerOx assessed by an ion selective electrode. An 
ion selective electrode was inserted into a stirred chamber containing 3 ml KCl buffer at 37ºC. Five 
additions of 1 µM MitoPerOx were added to calibrate the electrode response. Then rotenone (4 µg/ml) 
and mitochondria (2 mg protein/ml) were added, followed by succinate (10 mM) FCCP (500 nM). (B) 
Mitochondrial accumulation of MitoBODIPY assessed by an ion selective electrode. The experiment 
was carried out as in A, but in this case the mitochondrial concentration was 1 mg protein/ml. (C) 
Uptake of MitoBODIPY into live cells assessed by confocal fluorescence microscopy. C2C12 cells 
were incubated with MitoTracker Red and then MitoBODIPY 50 nM was added and its uptake into 
mitochondria followed in real time over 1.5, 3 and 4.5 min using confocal microscopy. Scale bar = 
20 µm. (D-F) H9C2 cells were seeded at 15,000/chamber on 8-chamber borosilicate coverslips, and 
grown overnight at 37 ̊C. Scale bar = 10 mm. (D) Cells were incubated with 25 nM MitoPerOx for 2h 
40 min, followed by 200 nM Mitotracker Green for 5 min. (E) Cells incubated with 25 nM MitoPerOx 
for 15 min. (F) Cells incubated with 50 nM MitoPerOx for 45 min, followed by 10 µM FCCP for 15 
min.
In order to assess the uptake of MitoPerOx by mitochondria within cells we first examined 
the uptake of the simpler chemical MitoBODIPY to avoid any complications resulting from 
oxidation of the peroxidation-sensitive moiety of MitoPerOx during uptake. We found 
that MitoBODIPY was very rapidly taken up by mitochondria within cells, as shown by 
confocal imaging of live cells (Fig. 4.3C). Significant amounts of MitoBODIPY were seen 
within mitochondria only 1.5 min after addition to the incubation medium and it strongly 
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co-localised with the mitochondrial marker MitoTracker Red. Effectively no MitoBODIPY 
was detected elsewhere in the cell in this experiment. As expected from the isolated 
mitochondrial work (Fig. 4.3B), addition of FCCP after uptake did not greatly reverse 
the uptake (data not shown). MitoPerOx itself was also found to be rapidly taken up by 
mitochondria in cells, co-localising with the mitochondrial marker MitoTracker Green (Fig. 
4.3D). As before, addition of FCCP after uptake of MitoPerOx had very limited effect on 
efflux of the compound from the mitochondria (Fig. 4.3F). Therefore MitoPerOx is very 
rapidly and selectively taken up by mitochondria within cells with no localisation to other 
parts of the cell. 
This selective mitochondrial localisation contrasts with C11-BODIPY581/591 which is present 
in membranes throughout the cell and indicates that MitoPerOx is a mitochondria-selective 
probe. In addition to its selective localisation, the concentration of MitoPerOx that was 
required to give mitochondrial labelling was only 100 – 200 nM, ~100-fold lower than 
the 10 µM of C11-BODIPY581/591 that is routinely used for cell labelling. Finally, the uptake 
of MitoPerOx into mitochondria was very rapid compared to C11-BODIPY581/591 and there 
was no need to wash off excess MitoPerOx because, due to its rapid and selective uptake, 
it could just be added to the incubation and then left to equilibrate. 
Assessment of lipid peroxidation in isolated mitochondria - We next assessed whether 
MitoPerOx responded to lipid peroxidation within isolated mitochondria (Fig. 4.4). The 
spectrum of MitoPerOx in a suspension of mitochondria (Fig. 4.4A) was similar to that of 
MitoPerOx in ethanol, rather than in water, presumably due to its adsorption to the surface 
of the mitochondrial inner membrane and insertion of the fluorophore into the hydrophobic 
membrane core. Oxidation of the mitochondrial suspension with cumene hydroperoxide 
and copper(II) led to the oxidation of MitoPerOx as evidenced by the dramatic increase 
of fluorescence at ~520 nm while that at ~590 nm decreased slightly (Fig. 4.4A). The 
emission from MitoPerOx in mitochondria at 520 nm was low and stable in the absence of 
oxidation, but rapidly increased upon induction of lipid peroxidation (Fig. 4.4B). Therefore, 
for mitochondrial suspensions, the emission at 520 nm is sufficiently sensitive and stable to 
be used alone, facilitating and simplifying analysis of mitochondrial lipid peroxidation with 
standard fluorimeters.
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Figure 4.4 Fluorescence emission spectrum of mitochondria (0.5 mg protein/ml) in KCl buffer at 
37˚C in the presence of rotenone (4 µg/ml), succinate (10 mM) and 200 nM MitoPerOx. (A) The 
excitation wavelength was 495 nm and scanning emission spectra were taken after 10 min in the 
absence of further additions (control) or in the presence of 2 mM cumene hydroperoxide and 500µM 
CuSO4 (oxidised). (B) Time course of fluorescence emission in the presence (oxidised) or absence 
(control) of cumene hydroperoxide (100 µM)/CuSO4 (25 µM) measuring emission at 520 nm with 
excitation 495 nm. (C) Time course of fluorescence emission in the presence of 70 µM linoleic acid 
hydroperoxide (LAH) or 100 µM menadione and 1 µM MitoPerOx measuring emission at 520 nm with 
excitation 495 nm. (D) Time course of fluorescence emission in the presence of various concentrations 
of LAH and 1 µM MitoPerOx measuring emission at 520 nm with excitation 495 nm. (E) Time course 
of fluorescence emission in the presence of 50 µM LAH, 1 µM MitoPerOx ± 5µM MitoQ.
To explore the use of MitoPerOx as a probe of mitochondrial lipid peroxidation further, we 
next assessed the response of MitoPerOx fluorescence to the addition to a mitochondrial 
suspension of linoleic acid hydroperoxide (LAH), which incorporates into phospholipid 
bilayers and there initiates lipid peroxidation. Addition of LAH induced the rapid oxidation 
of MitoPerOx (Fig. 4.4C), and this oxidation was concentration dependent (Fig. 4.4D). 
In contrast menadione (Men), which generates superoxide within mitochondria by 
redox cycling, had little effect on MitoPerOx oxidation (Fig. 4.4C) and is consistent with 
MitoPerOx being particularly sensitive to lipid peroxidation but not superoxide. To confirm 
that the changes in MitoPerOx fluorescence were due to mitochondrial lipid peroxidation, 
we inhibited lipid peroxidation using the mitochondria-targeted antioxidant MitoQ and 
found that this completely prevented MitoPerOx oxidation by LAH (Fig. 4.4E). These data 
are consistent with MitoPerOx reporting on lipid peroxidation within the mitochondrial 
inner membrane. 
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Using MitoPerOx to assess mitochondrial lipid peroxidation within cells - The above 
data suggest that within cells the ratio of the 520 nm and 590 nm fluorescence emission 
should enable the sensitive ratiometric analysis of mitochondrial lipid peroxidation. 
To assess this we first measured the fluorescence emission spectrum of MitoPerOx in a 
suspension HEK293 cells and found the expected emission peak at 590 nm (Fig. 4.5A, 
right panel). On exposure of the cells to hydrogen peroxide to induce lipid peroxidation, 
the emission at 520 nm increased while that at 590 nm decreased slightly, consequently 
the 520 nm/590 nm emission ratio responded to mitochondrial lipid peroxidation (Fig. 
4.5A). Extending this to human skin fibroblasts, we used fluorescence live cell microscopy 
to assess lipid peroxidation (Fig. 4.5B and C). This again showed mitochondria-selective 
uptake of MitoPerOx as assessed by widefield fluorescence microscopy prior to addition of 
the oxidant (Fig. 4.5B). To assess mitochondrial lipid peroxidation we analysed the intensity 
of the mitochondrial network of each of four cells in the 520 nm and 590 nm image over 
the course of 90 minutes. Under normal incubation conditions, without addition of any 
oxidising reagents, there was no oxidation of MitoPerOx, demonstrating that the probe is 
resistant to artifactual photooxidation or photobleaching. When the cells were then exposed 
to hydrogen peroxide to initiate mitochondrial lipid peroxidation there was a statistically 
significant increase in the 520 nm/590 nm fluorescence ratio after 5 min (p < 0.05). Over 
the next hour this increased to about 30% over basal (Fig. 5C). Similar results were obtained 
with HEK293 cells (data not shown). 
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Figure 4.5 Oxidation of MitoPerOx within cells. (A) To assess the fluorescence spectrum one to 
two million HEK293 cells were incubated in HEPES-Tris buffer with 100 nM MitoPerOx for 30 min 
in a shaking heatblock at 37°C. Subsequently, cells were washed twice in HEPES-Tris buffer and 
resuspended in 1 ml. Emission spectra were measured on a Shimadzu fluorimeter using 488 nm 
excitation. A baseline emission spectrum was taken for the HEPES-Tris buffer and set to 0. Then 
emission spectra were taken for the cells loaded with MitoPerOx and then 15 and 30 min after 
addition of 500 µM H2O2. The superimposed green and orange fields indicate the 520 nm and 590 nm 
emission filters, respectively, that were used for widefield microscopy. This means that the MitoPerOx 
ratio is measured with less sensitivity by microscopy than when using the fluorimeter. The ratio of the 
emission at 520 nm to 596 nm is shown in the bar graph. (B) Live cell fluorescence microscopy of 
human skin fibroblasts, observing the masked ratio in pseudocolour over the course of 90 minutes. (C) 
The ratio of the emission at 520 and 590 was assessed over 35 min for the four cells depicted in panel 
B after which the cells were exposed to 500 µM hydrogen peroxide to monitor mitochondrial lipid 
peroxidation. Data are normalised to the starting value and a statistically significant difference from 
the ratio at 35 minutes was calculated using a paired t-Test (* = p<0.05, ** = p<0.01).
Conclusions
Since its introduction, the fluorescent probe C11-BODIPY581/591 has proven useful for 
assessing lipid peroxidation within cells in real time. However, as it distributes throughout 
the cell the assessment of specific mitochondrial lipid peroxidation has required more 
specialised techniques [69]. Here we have developed a mitochondria-targeted lipid 
peroxidation probe that has a number of advantages over C11-BODIPY581/591 for the analysis 
of mitochondrial lipid peroxidation. The major advantage is that MitoPerOx is taken up 
selectively into mitochondria so it only reports on mitochondrial membranes, in contrast 
to all membranes within the cell. Furthermore, its location on the matrix-facing surface of 
the inner membrane means that it is responding at the heart of pathological mitochondrial 
oxidative damage. The use of the TPP cation for targeting, means that MitoPerOx is taken 
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up into mitochondria within a few minutes of addition to the incubation medium, in 
contrast to the far slower permeation of C11-BODIPY581/591 itself [189]. Furthermore, the 
accumulation of MitoPerOx means that a 100-fold lower concentration is required than for 
C11-BODIPY581/591 and there is no necessity for extensive probe preloading and washing 
[189]. 
There is the possibility that high concentrations of oxidised MitoPerOx within mitochondria 
may undergo excimer formation which would red shift the emission spectrum, potentially 
increasing emission at 590 nm and thereby masking the oxidation 520/590 signal ratio 
[113,203]. However this does not seem to occur in our experiments, as when very high 
concentrations of the oxidised form of C11-BODIPY581/591 undergo excimer formation this 
leads to a distinctive increase in emission at 545 and 590 nm, generating peaks that are 
considerably larger than the oxidised emission peak at 520 nm [113]. Even under the most 
oxidising conditions in our experiments with mitochondria (e.g. Fig. 4.4A) these peaks were 
not evident. In the cell experiments the concentrations used were lower and the oxidation 
conditions were considerably milder, hence excimer formation does not seem to impact 
on the interpretation of our results. To conclude, we have generated a useful mitochondria-
targeted lipid peroxidation probe for assessing mitochondrial lipid peroxidation in a range 
of cell models. 
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Abstract
The mitochondrial oxidative phosphorylation (OXPHOS) system consists of four electron 
transport chain (ETC) complexes (CI-CIV) and the FoF1-ATP synthase (CV), which sustain ATP 
generation via chemiosmotic coupling. The latter requires an inward-directed proton-motive 
force (PMF) across the mitochondrial inner membrane (MIM) consisting of a proton (DpH) 
and electrical charge (Dy) gradient. CI actively participates in sustaining these gradients via 
trans-MIM proton pumping. Enigmatically, at the cellular level genetic or inhibitor-induced 
CI dysfunction has been associated with Dy depolarization or hyperpolarization. The 
cellular mechanism of the latter is still incompletely understood. Here we demonstrate that 
chronic (24 h) CI inhibition in HEK293 cells induces a proton-based Dy hyperpolarization 
in HEK293 cells without triggering reverse-mode action of CV or the adenine nucleotide 
translocase (ANT). Hyperpolarization was associated with low levels of CII-driven O2 
consumption and prevented by co-inhibition of CII, CIII or CIV activity. In contrast, chronic 
CIII inhibition triggered CV reverse-mode action and induced Dy depolarization. CI- and 
CIII-inhibition similarly reduced free matrix ATP levels and increased the cell’s dependence 
on extracellular glucose to maintain cytosolic free ATP. Our findings support a model in 
which Dy hyperpolarization in CI-inhibited cells results from low activity of CII, CIII and 
CIV, combined with reduced forward action of CV and ANT.
Mitochondrial hyperpolarization during chronic complex I inhibition  |  81
5
Introduction
Mitochondria are double-membrane organelles involved in numerous cellular processes 
like apoptosis induction, reactive oxygen species (ROS) generation, adaptive thermogenesis, 
ion homeostasis and innate immune responses [18]. Classically, mitochondria also act 
as key suppliers of cellular energy by providing the machinery that generates ATP from 
the energy stored in NADH and FADH2. The latter two molecules are generated by the 
glycolysis pathway in the cytosol (NADH) and the tricarboxylic acid (TCA) cycle in the 
mitochondria (NADH and FADH2), and are oxidized at complex I (CI) and complex II 
(CII) of the electron transport chain (ETC), respectively. The released electrons are then 
transported to complex III (CIII) by coenzyme Q (CoQ) and subsequently to complex IV 
(CIV) by cytochrome c (cyt c). At the latter complex, the electrons react with molecular 
oxygen (O2) to form water. Electron transport is energetically coupled to the translocation 
of protons from the mitochondrial matrix across the mitochondrial inner membrane (MIM) 
at CI, CIII and CIV. This results in an inward-directed proton-motive force (PMF) across the 
MIM that consists of a chemical (DpH) and inside-negative electrical gradient (Dy). 
Protons are allowed to flow back into the mitochondrial matrix via the FoF1-ATP-synthase 
(CV) to drive the synthesis of ATP from ADP and inorganic phosphate (Pi). Together with 
CV, the four complexes of the ETC constitute the oxidative phosphorylation (OXPHOS) 
system. By reverse-mode action CV can also hydrolyse ATP and expel protons from the 
mitochondrial matrix thereby sustaining Dy [204]. This mechanism requires that ATP is 
transported from the cytosol to the mitochondrial matrix by reverse-mode action of the 
mitochondrial adenosine nucleotide translocase (ANT) or is generated by mitochondrial 
substrate-level phosphorylation [205]. 
A sufficiently large PMF is not only required to sustain ATP production but also is of 
crucial importance for mitochondrial fusion, protein import, metabolite exchange with the 
cytosol, and apoptosis induction (e.g. [4,5,6,7,8]). In this sense, Dy can be considered as 
an important functional readout of mitochondrial health.
Mitochondrial dysfunction is a hallmark of (rare) metabolic disorders and also associated 
with normal human aging, neurodegeneration, certain forms of cancer and metabolic 
syndrome [17,18,207–212]. Aberrations in Dy have been observed in a wide variety of 
cells with inherited OXPHOS dysfunction. For instance cells with CV malfunction displayed 
Dy hyperpolarization (i.e. the MIM was more inside-negative; [213,214]). In case of CI, 
we demonstrated that its partial enzymatic deficiency (i.e. residual CI activities between 
18-75% of lowest controls) was associated with a minor decrease in Dy (depolarization) 
in primary skin fibroblasts from patients with inherited CI deficiency [15,215]. Similarly, 
Dy depolarization was observed in healthy primary skin fibroblasts when CI was partially 
and specifically inhibited by chronic treatment (72 h) with the CI inhibitor rotenone (ROT) 
[19,69]. In contrast, CI enzymatic deficiency was associated with Dy hyperpolarization 
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in immortalized mouse embryonic fibroblasts (MEFs) derived from whole-body knockout 
mice lacking the key CI subunit NDUFS4 [216]. Also in neurons, glial-like cells and 
their undifferentiated stem cells genetic CI dysfunction was accompanied by Dy 
hyperpolarization [217]. Interestingly, whereas the Dy of CI-deficient neurons seemed to 
be sustained by CV reverse-mode action, CV ran in forward mode in CI-deficient stem cells 
suggesting a cell type-specific regulation [217]. Compatible with these findings, specific 
CI inhibition (4 h) by a submaximal concentration of ROT induced Dy hyperpolarization 
in 143B osteosarcoma cells [218]. However, in these cells Dy depolarized when ROT was 
used at higher concentrations (>100 nM) and/or at longer incubation times. In contrast, Dy 
hyperpolarization was induced when ROT was used at higher concentrations (i.e. >100 nM) 
and shorter incubation times (i.e. 30 min - 2 h) in Leishmania donovani promastigotes [219], 
coronary artery smooth muscle cells [220] and neutrophils, but not in peripheral blood 
mononuclear leukocytes [221]. Taken together, it appears that CI functional impairment 
triggers Dy hyperpolarization in a manner that (co)depends on the cell-type, inhibitor 
concentration and duration of inhibitor treatment. 
This study aims to gain insight into the mechanism underlying Dy hyperpolarization 
during chronic CI dysfunction. As a model system we used HEK293 cells in which Dy 
hyperpolarization was triggered by chronic (24 h) incubation with the CI inhibitor ROT. 
Analysis of this model suggests that Dy hyperpolarization during reduced CI activity requires 
low activity of CII, CIII and CIV in combination with greatly reduced forward activity of CV 
and the ANT. 
Materials and Methods
Generation of inducible HEK293 cell lines stably expressing cytosolic or mitochondria-
targeted SypHer variants - Gateway® Entry vectors were generated by recombining 
Gateway-adapted PCR products containing the sequence encoding cyto-HyPer and 
mito-HyPer from pHyPer-cyto and pHyPer-dMito vectors (Evrogen, Moscow, Russia) with 
pDONR201 (Invitrogen, Breda, The Netherlands). A Gateway-adapted tag-less pcDNA/
FRT/TO Destination vector was created by recombining the acGFP1-Destination vector 
[63,222,223] with a BacMamVSV-Destination vector [224]. To create constructs encoding 
the pH sensor SypHer, the mito-HyPer and cyto-HyPer Entry vectors were mutated at a critical 
cysteine residue by site-directed mutagenesis as described previously [41]. These new Entry 
vectors were recombined with the Gateway-adapted pcDNA/FRT/TO Destination vector to 
obtain mito-HyPer, mito-SypHer, cyto-HyPer and cyto-SypHer expression vectors. Flp-In 
T-REx293 cells (Invitrogen) were stably transfected with the expression vectors described 
above using the Superfect Transfection Reagent (Qiagen, Venlo, The Netherlands) and 
cultured for selection in the presence of 200 µg/ml hygromycin (Calbiochem, Brunschwig, 
Amsterdam, The Netherlands) and 50 µg/ml blasticidin (Invitrogen). To induce expression 
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of the biosensor, 1 µg/ml doxycyclin (Sigma-Aldrich, Zwijndrecht, The Netherlands) was 
added to the culture medium, followed by incubation for 24 h.
Generation of inducible HEK293 cell lines stably expressing cytosolic or mitochondria-
targeted variants of ATeam 1.03 and “dead-ATeam” - The ATeam sequence was isolated 
from pcDNA3-AT1.03 and pcDNA3-mito-AT1.03 vectors [45], and selection markers 
and acGFP1 were removed from the acGFP1-Destination vector by digestion. The ATeam 
sequence was then ligated into the remaining Destination vector to obtain the pcDNA5/
FRT/TO/cyto-ATeam and pcDNA5/FRT/TO/mito-ATeam expression vectors. Flp-In T-REx293 
cells (Invitrogen) were stably transfected as described above. “Dead” ATeam was expressed 
in the cells using baculoviral transduction. To this end, the pcDNA3-AT1.03R122K/R126K vector 
[45] was subcloned into cyto-ATeam and mito-ATeam Entry vectors using EcoRV and EcoRI 
to obtain a mutated ATP-unresponsive ATeam. Next, we recombined the Entry vectors with 
a Gateway-adapted BacMamVSV-Destination vector to obtain baculoviruses as described 
before [216]. Flp-In T-REx293 cells were seeded 48 h before imaging, and transfection was 
induced by the addition of 7% v/v baculovirus. The “dead” ATeam transfected cells were 
imaged and analyzed in the same way as the ATeam stable cell lines.
Cell culture and inhibitor treatment - Flp-In
 
T-REx
.
293 cells were cultured in DMEM 
containing 25 mM glucose, 2 mM L-glutamine, 10% (v/v) fetal calf serum and 1% penicillin/
streptomycin in a humidified atmosphere containing 5% CO2 at 37°C. Prior to transfection, 
parental Flp-In TREx cells were cultured in the presence of 50 µg/ml blasticidin and 100 µg/
ml Zeocin (Invitrogen). For fluorescence microscopy, 100,000 cells were seeded on 24-mm 
coverslips (Thermo Scientific, Etten-Leur, The Netherlands) placed in 35-mm CellStar tissue 
culture dishes (Sigma-Aldrich) or 35-mm glass-bottom culture dishes (Fluorodish, World 
Precision Instruments, Berlin, Germany) two days before imaging. For respirometry, the 
cells were grown to 80% confluence. One day after seeding, cells were treated with ROT, 
piericidin A (PA) or antimycin A (AA) for 24 h and compared with vehicle (0.1% ethanol)-
treated (CT) cells.
High-resolution respirometry - Culture medium was collected, and cells were trypsinised, 
washed and resuspended to approximately one million cells/ml in the collected culture 
medium. Two ml of this suspension was used to measure cellular oxygen consumption. 
Oxygen consumption was measured at 37°C using a two-chamber Oxygraph (Oroboros 
Instruments, Innsbruck, Austria) using an established protocol [225]. For inhibitor titration 
experiments, cells were allowed to respire for 10 minutes (routine respiration), after which 
ETC inhibitors were added in subsequent 1-µl volumes. As a control, identical additions 
were carried out using a vehicle (ethanol) solution. 
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For analyses in permeabilized cells, 1-1.5 million cells were resuspended in mitochondrial 
respiration medium [226] and, following baseline recording, CI-dependent respiration (10 
mM glutamate, 2 mM malate, 1 mM ADP) was initiated by permeabilization with 2 mg/ml 
saponin. Then a maximum of 10 mM succinate was added (titration) to measure CI+CII, and 
respiration of CII substrates only was assessed by the addition of 100 nM ROT. Following 
determination of residual oxygen consumption using 2.5 mM AA, maximum CIV-dependent 
respiration was measured using 2 mM ascorbate and 0.5 mM TMPD. Finally, the integrity of 
the mitochondrial outer membrane (MOM) was tested using 10 mM cyt c.
Fluorescence imaging of free ATP levels - Free ATP levels were quantified using a 
fluorescence resonance energy transfer (FRET)-based reporter protein (‘ATeam’ 1.03). This 
sensor is comprised of the e subunit of the bacterial FoF1-ATP synthase sandwiched between 
cyan- and yellow-fluorescent protein variants [45]. The coverslips were washed with PBS, 
covered with HEPES-Tris (HT) buffer (containing 132 mM NaCl, 10 mM HEPES, 4.2 mM 
KCl, 1 mM MgCl2, 1 mM CaCl2 and 25 mM D-glucose, adjusted to pH 7.4 with Tris) and 
mounted in an incubation chamber that was placed on the temperature-controlled (37°C) 
stage of an inverted microscope (Axiovert 200M, Carl Zeiss, Jena, Germany) equipped with 
a x40 1.3 NA Fluar oil-immersion objective. The cyan fluorescent protein (CFP) of ATeam 
was excited at a wavelength of 430 nm, and the yellow fluorescent protein (YFP) was excited 
at 435 nm for 300 ms using a monochromator (Polychrome IV, TILL Photonics, Gräfelfing, 
Germany) and a 455DRLP dichroic mirror (Omega Optical Inc., Brattleboro, VT, USA). 
CFP and YFP emissions were directed through 480AF30 and 535AF26 (Omega) emission 
filters, respectively, and captured using a CoolSNAP HQ monochrome CCD camera (Roper 
Scientific, Évry, France). Microscopy hardware was controlled using Metafluor 6.0 software 
(Universal Imaging Corporation, Downingtown, PA, USA). Ten fields of view were routinely 
analysed per coverslip. In time-lapse measurements a superfusion system [227] was used 
with a flow rate of 1.5 ml/min, and images were captured at an interval of 6 seconds. 
Images were analysed using MetaMorph 6.1 (Universal Imaging Corporation).
Fluorescence imaging of cytosolic and mitochondrial pH - Mitochondrial and cytosolic pH 
were measured in Flp-In T-Rex 293 cells stably overexpressing the pH sensor SypHer. The 
latter was excited at 420 nm and 470 nm during 200 ms, directed by a 505DRLPXR (Omega) 
dichroic mirror. Emission signals were captured using a 535AF45 (Omega) emission filter 
using the microscopy system described above. Ten-fifteen fields of view were routinely 
analysed per coverslip.
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Fluorescence imaging of mitochondrial membrane potential - Flp-In
 
T-Rex
 
293 cells were 
incubated with 50 nM of tetramethyl rhodamine methyl ester (TMRM; Invitrogen) in collected 
culture medium for 25 minutes at 37°C and 5% CO2 in the dark. The coverslips were 
then washed with PBS and imaged in HT buffer. Images were acquired on the microscope 
system described above using a 540-nm excitation wavelength directed for 100 ms by a 
560DRLP (Omega) dichroic mirror through a 565ALP (Omega) emission filter. For each 
coverslip, 10-25 fields of view were routinely acquired and analysed using MetaMorph 6.1 
(Universal Imaging Corporation). For time-lapse measurements, the images were recorded 
at 2-second intervals (carbonyl cyanide-4-trifluoromethoxyphenyl-hydrazone; FCCP) or 
6-second intervals (oligomycin A; OLI or bongkrekic acid; BA).
Fluorescence imaging of mitoAcGFP1 - Stable Flp-In. T-REx.293 cell lines expressing cox8-
AcGFP1 [222] were excited at 488 nm for 300 ms, directed by a 505DRLPXR (Omega) 
dichroic mirror. Emission signals were captured using a 515ALP (Omega) emission filter 
using the microscopy system described above. Ten fields of view were routinely analysed 
per coverslip.
Imaging of NAD(P)H autofluorescence - NAD(P)H autofluorescence was measured by 
excitation at 360 nm during 1000 ms using a 430DCLP (Omega) dichroic mirror and 
510BW40 (Omega) emission filter. The above microscopy system was used for image 
acquisition. 
Fluorescence imaging of intracellular ROS production using hydroethidine - Flp-In. 
T-REx.293 cells were incubated with 10 µM hydroethidine (HEt; Molecular Probes, Leiden, 
The Netherlands) in harvested culture medium for 10 minutes at 37°C and 5% CO2 in the 
dark in a dish-by-dish manner. The reaction was terminated by thoroughly washing the 
cells with PBS to remove unoxidized HEt [69], and the cells were covered in HT buffer. To 
quantify the fluorescent HEt oxidation products, the cells were excited for 100 ms at 490 
nm. Emitted fluorescent light was directed to the cells using a 525DRLP dichroic mirror 
(Omega) through a 565ALP emission filter (Omega) onto the CCD-camera. Ten fields of 
view were analyzed per coverslip. 
Immunocytochemistry - The cells were fixed using 4% formaldehyde in PBS for 15 minutes 
and permeabilized in 0.5% Triton X-100 in PBS for 20 minutes. After washing with 0.05% 
(v/v) Tween-20 in PBS, the cells were blocked in blocking buffer containing 2% (w/v) 
bovine serum albumin (BSA), 2% (v/v) normal goat serum (NGS), 0.1% (v/v) Triton X-100, 
0.05% (v/v) Tween-20, and 100 mM glycine in PBS for 30 minutes. To determine tubulin 
morphology, the cells were incubated with the primary antibodies mouse anti-beta-tubulin 
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(1:300, E7 IgG1). This antibody was developed by Michael Klymkowsky and obtained from 
the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD 
and maintained by The University of Iowa, Department of Biological Sciences, Iowa City, 
IA 52242. Bound anti-beta-tubulin was visualized with AlexaFluor-488-labeled goat anti-
mouse IgG1 (1:200; Molecular Probes). The cells were sealed using Vectashield mounting 
medium containing 4’,6-diamidino-2-phenylindole (DAPI), which stains all nuclei (Vector 
Laboratories, Burlingame, CA, USA) and visualized using a Zeiss Axiophot2 fluorescence 
microscope with Axiocam MRm CCD camera.
Electrophysiology - Electrophysiological measurements of plasma membrane resting 
potential were performed using the perforated patch technique (50 mM b-escin, Sigma-
Aldrich) [228]. Data acquisition was performed using an EPC-9 amplifier and PatchMaster 
software (HEKA electronics, Lambrecht, Germany). Pipettes were pulled from thin-walled 
borosilicate glass (Harvard Apparatus) and had resistance between 2 and 3 MW, when filled 
with pipette solution (120 mM KCl, 25 mM NaCl, 1 mM CaCl2, 1 mM MgCl2, 3.5 mM 
EGTA, 10 mM HEPES, adjusted to pH 7.3 using KOH). A perforated patch was generally 
obtained within 15 minutes following the establishment of the gigaseal. Plasma membrane 
resting potentials were obtained by injecting zero current in the current clamp-recording 
mode.
Data analysis and statistics - Curve fitting was performed using Origin Pro 6.1 (OriginLab 
Corp., Northampton, MA, USA). Additional image processing and analysis was carried out 
using Image Pro Plus 6.3 software (Media Cybernetics, Silver Spring, MD, USA). Unless 
stated otherwise, data is presented as mean ± SE (standard error). Statistical significance was 
assessed using a Kruskal-Wallis 2-way ANOVA following Dunn’s multiple comparison test, 
or a Mann-Whitney t-test using Graphpad Prism 5 software (GraphPad Software Inc., La 
Jolla, CA, USA). Asterisks indicate statistical significance: *p<0.05, **p<0.01 and ***p<0.001.
Results
Acute rotenone treatment dose-dependently and incompletely inhibits O2 consumption 
in intact cells - Triggered by experimental evidence in the literature (see Introduction) we 
first investigated whether it was possible to induce Dy hyperpolarization in HEK293 cells 
by chronic treatment with the CI inhibitor ROT. However, when used at inappropriately 
high concentrations ROT can also display off-target effects on the cellular tubulin network. 
This might indirectly affect mitochondrial function (e.g. [19,218,229–232]). To avoid 
this potential problem we first determined the lowest ROT concentration that maximally 
inhibited cellular O2 consumption when acutely added to intact cells (Fig. 5.1A). Up to a 
concentration of 1 µM, ROT was unable to fully block respiration (i.e. down to the level 
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of residual O2 consumption; “ROX”). Similar results were obtained with the CI-specific 
inhibitor PA (Fig. 5.1A). Compatible with a previous binding study [233], PA displayed a 
somewhat lower IC50 than ROT. In contrast to ROT and PA, acute treatment with the CIII 
inhibitor AA (Fig. 5.1A) fully inhibited cellular O2 consumption. Based upon these results, 
we decided to use a 100 nM ROT concentration during chronic cell treatment (24 h). Control 
experiments revealed that this treatment regime did not induce alterations in cell shape/size 
and organisation of the cellular tubulin network as detected with immunocytochemistry 
methods (data not shown).
Chronic rotenone treatment incompletely inhibits O2 consumption in intact and 
permeabilized cells - Similar to acute ROT addition, chronic ROT treatment greatly 
reduced cellular O2 consumption (Fig. 5.1B; grey bars vs. black bars). This O2 consumption 
was insensitive to CV inhibition by OLI or mitochondrial uncoupling (FCCP). However, 
addition of ROT+AA slightly but significantly reduced O2 consumption, suggesting that 
still some ETC activity remains in ROT-treated cells. To further dissect how chronic ROT 
treatment impacts on ETC-mediated O2 consumption we analysed the effect of chronic ROT 
treatment in permeabilized cells (Fig. 5.1C; grey bars). Using CI- (glutamate+malate), CII- 
(succinate+ROT) and CI+CII-selective (glutamate+malate+succinate) substrate conditions 
we observed that CI-dependent respiration was reduced (but not absent) and CII-dependent 
respiration was normal in ROT-treated cells. In contrast, cells chronically treated with AA 
(100 nM, 24 h) displayed greatly reduced O2 consumption when respiring on CI or CII 
substrates. 
Chronic rotenone treatment induces Dy hyperpolarization and increases DpH - Chronic 
ROT treatment dose-dependently increased mitochondrial TMRM fluorescence compatible 
with a hyperpolarized (more negative) Dy (Fig. 5.1D and 1E). Whereas a similar increase 
was observed in cells chronically treated with PA, chronic AA treatment reduced 
mitochondrial TMRM fluorescence (suggesting Dy depolarization). Since the extent of 
mitochondrial TMRM accumulation also depends on the membrane potential of the plasma 
membrane (DV), it is of crucial importance to determine whether ROT treatment induces DV 
hyperpolarization [101]. Electrophysiological analysis revealed that chronic ROT treatment 
did not significantly alter DV whereas AA induced a depolarization (Fig. 5.1F). These results 
argue against a mechanism where Dy hyperpolarization in ROT-treated cells is caused by 
DV hyperpolarization. 
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Figure 5.1 Chronic complex I inhibition decreases cellular O2 consumption and increases the 
mitochondrial membrane potential. (A) Stepwise inhibition of CI (ROT or PA) and CIII (AA) decreases 
the O2 consumption of intact HEK293 cells in cell culture medium. Data points were fitted using a 
logistic model (R2>0.99) to calculate IC50 values. Each data point reflects the mean of 4 (ROT) or 
1-6 independent measurements (AA and PA). (B) O2 consumption of CT and 100 nM ROT-treated 
(24 h) intact HEK293 cells in culture medium. Basal O2 consumption (“Routine”), OLI-inhibited O2 
consumption (“Leak”), FCCP-induced maximal O2 consumption (ETS) and ROT- and AA-induced 
residual O2 consumption (ROX) are indicated. Each bar reflects the mean of 10 (CT) or 8 (ROT) 
independent experiments. Statistical significance was assessed using a Wilcoxon matched-pairs signed 
rank test. (C) CI (glutamate+malate and ADP), CI+CII (glutamate+malate+succinate and ADP) and CII-
driven (+succinate and ROT) O2 consumption in permeabilized HEK293 cells chronically treated 
(24 h) with vehicle (CT), 100 nM ROT or 100 nM AA (normalized on CIV-dependent respiration). O2 
consumption on CIV substrates (2 mM ascorbate and 0.5 mM TMPD) was similar for all conditions 
(not shown). (D) Typical example of TMRM-stained HEK293 CT cells and regions of interest (‘m’) for 
analysis of mitochondrial TMRM fluorescence intensity. (E) Effect of chronic treatment with ROT, PA 
or AA on mitochondrial TMRM fluorescence intensity. (F) The resting plasma membrane potential of 
inhibitor-treated (100 nM, 24 h) cells, measured by patch-clamping in two independent experiments. 
(G) Effect of chronic 100 nM ROT and AA treatment on mitochondrial GFP fluorescence intensity in 
mito-AcGFP1 expressing HEK293 cells after 24 h (N=2). Numerals indicate the number of individual 
experiments (panel C) or cells (panel E, F and G) analysed. 
Since we used epifluorescence microscopy, and given the fact that TMRM is a single-
excitation/single-emission reporter molecule, changes in mitochondrial and/or cellular 
volume and/or thickness can also affect TMRM fluorescence intensity. In this way, 
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ROT-induced cellular and/or mitochondrial swelling might lead to an increased TMRM 
signal. We argued that if this would be the case, the emission intensity of another single-
excitation/single-emission (but Dy-independent) reporter molecule (i.e. a mitochondria-
targeted GFP) should also be increased. However, ROT did not increase and AA did not 
significantly decrease the mitochondrial fluorescence signal of mito-AcGFP1 (Fig 5.1G). 
This makes it highly unlikely that the ROT-induced increase in mitochondrial TMRM signal 
is due to cellular and/or mitochondrial swelling. Finally, to rule out interference of TMRM 
fluorescence autoquenching we performed time-lapse recordings to analyse the kinetics 
of the mitochondrial TMRM signal during protonophore (FCCP) application (Fig. 5.2A). 
Instead of a temporary increase in TMRM fluorescence (associated with autoquenching), 
FCCP induced a rapid fluorescence drop in vehicle (CT), ROT, AA and PA-treated cells 
(Fig 5.2A). This demonstrates the absence of TMRM autoquenching in our experiments. 
Taken together, our results support the conclusion that chronic CI inhibition induces Dy 
hyperpolarization in HEK293 cells. 
Chronic rotenone treatment does not induce matrix acidification - FCCP induced a 
faster mitochondrial TMRM release in CI-inhibited cells (Fig. 5.2B), suggesting that Dy 
hyperpolarization is proton-dependent. To determine whether ROT treatment affected 
mitochondrial and cellular pH homeostasis we created two HEK293 cell lines stably 
expressing cytosolic and mitochondria-targeted variants of the pH-sensing protein 
“SypHer” (Fig. 5.2C), the fluorescence emission ratio of which increases as a function of pH 
[41]. Importantly, cyto- and mito-SypHer display identical pH-dependent changes in their 
emission ratio signal [41] allowing their quantitative comparison. In CT cells the pH within 
the mitochondrial matrix (pHmito) was more alkaline than the pH in the cytosol (pHcyto; Fig. 
5.2D) reflecting the presence of a matrix-directed PMF across the MIM. ROT treatment 
reduced pHcyto but did not alter pHmito, whereas AA treatment reduced both pHcyto and pHmito 
(Fig. 5.2E). We calculated the difference between the mitochondrial and cytosolic SypHer 
fluorescence for each condition and used this number as a semi-quantitative readout of the 
pH difference across the MIM (DpH). This difference was increased in ROT-treated cells 
and reduced in AA-treated cells (Fig. 5.2F), suggesting that the differential effects of these 
inhibitors on Dy are (partially) the result of a change in trans-MIM proton gradient. 
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Figure 5.2 Effect of chronic complex I and complex III inhibition on mitochondrial and cytosolic 
pH homeostasis. (A) Effect of acute addition of the uncoupler FCCP on the mitochondrial TMRM 
fluorescence intensity in cells treated with vehicle- (CT), 100 nM ROT, 100 nM AA or 100 nM PA for 
24 h. (B) Rate of FCCP-induced decay determined using a linear fit to the curve (C) Typical images of 
CT cells expressing mitochondrial or cytosolic variants of the pH-sensing protein SypHer. (D) Steady-
state fluorescence ratios of cells expressing Mito- or Cyto-SypHer. (E) Effect of 24 h 100 nM ROT or 
100 nM AA treatment on the mito- and cyto-SypHer ratio. (F) Value of DpH, calculated by subtracting 
the cyto-SypHer from the mito-SypHer ratio presented in panel E. Numerals indicate the number of 
individual cells analysed.
Chronic rotenone treatment does not induce reverse-mode action of complex V and 
the ANT - If ROT-induced Dy hyperpolarization is primarily proton-based, it might result 
from an increased trans-MIM proton flux out of the matrix and/or a reduced trans-MIM 
proton influx into the matrix. Under conditions of ETC inhibition, Dy hyperpolarization has 
been linked to reverse-mode action of CV and consumption of ATP [204,205,234]. When 
substrate-level phosphorylation cannot provide enough ATP to fuel CV reverse-mode action 
Dy will further depolarize. To counterbalance this effect also the ANT can operate in reverse 
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to bring in ATP and negative charge from the cytosol into the mitochondrial matrix [205]. 
Inhibition of CV (using OLI) or the ANT (using BA) did not induce Dy depolarization in CT 
and ROT-treated cells (Fig. 5.3). BA similarly affected Dy in AA-treated cells whereas OLI 
induced Dy depolarization. Of note, in these experiments TMRM was also present outside 
the cell to allow for increased mitochondrial TMRM uptake during Dy hyperpolarization. 
Qualitatively, these results suggest that: (i) CV and ANT operate in forward mode in CT cells, 
(ii) CV nor ANT reverse-mode action is involved in sustaining Dy in ROT-treated cells, and 
(iii) CV operates in reverse-mode and ANT operates in forward mode in AA-treated cells.
Time (s) Time (s) Time (s)
M
it
o
c
h
o
n
d
ri
a
l
T
M
R
M
 s
ig
n
a
l 
(%
)
50 nM TMRMext 50 nM TMRMext 50 nM TMRMext
10 µM OLI or 25 µM BA 10 µM OLI or 25 µM BA 10 µM OLI or 25 µM BA
0.5 µM FCCP 0.5 µM FCCP 0.5 µM FCCP
0 200 400 600 800
20
40
60
80
100
120
140
160
180
200
CT
OLI
OLI
OLI
BA BA
BA
0 200 400 600 800
ROT
0 200 400 600 800
AA
Intact cells: 24 hr treatment
Figure 5.3 Chronic CI inhibition does not induce CV reverse mode. Typical qualitative effects induced 
by acute application of the CV-inhibitor oligomycin (OLI, 10 mM) or the ANT inhibitor bongkrekic acid 
(BA, 25 mM) on mitochondrial TMRM fluorescence in vehicle- (CT), ROT- or AA-treated cells (100 nM, 
24 h). To facilitate visual inspection, the average pre-treatment signal was used for normalization and 
each curve is the average of 5-6 cells.
Chronic rotenone treatment lowers mitochondrial free ATP levels - Above we provided 
evidence that ROT treatment greatly decreases cellular O2 consumption and hyperpolarizes 
Dy, accompanied by an increase in DpH. Moreover, the differential effects of CV inhibition 
(OLI) on Dy in ROT- and AA-treated cells (Fig. 5.3) suggests that also steady-state 
mitochondrial ATP levels, which depend on the balance between ATP production, ATP 
consumption and ANT-mediated exchange, might be differentially affected. In CT cells, 
CV inhibition decreases cellular respiration by >70%, indicating that these cells contain 
an active mitochondrial ATP production supported by CV forward operation (Fig. 5.1B; 
black bars). CV inhibition did not depolarize, but in contrast to CT cells also did not clearly 
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hyperpolarize Dy in ROT-treated cells. This suggests that CV activity might be reduced. 
Therefore it appears that in ROT-treated cells the driving force of the PMF is uncoupled 
from CV-mediated ATP production. To address this hypothesis we generated two HEK293 
cell lines stably expressing cytosolic and mitochondria-targeted variants of the ATP-sensing 
protein “ATeam” (Fig. 5.4A), the fluorescence emission ratio of which increases as a function 
of free ATP concentration [45]. As controls, we expressed cytosolic and mitochondria-
targeted variants of an ATP-insensitive ATeam variant (“dead ATeam” [45]) using a 
baculoviral expression system. In CT cells the fluorescence emission ratio of mito-ATeam 
was lower than that of cyto-ATeam (Fig. 5.4B; black bars), whereas these ratios were lower 
but identical for dead mito-ATeam and dead cyto-ATeam (white bars). This demonstrates 
that both cyto- and mito-ATeam variants bind ATP and that [ATP]m is lower than [ATP]c in 
HEK293 cells. The mito-ATeam emission ratio was reduced in ROT- and AA-treated cells 
(Fig. 5.4C; left panel). These treatments did not decrease the emission ratio of dead mito-
ATeam (Fig. 5.4C; right panel). Taken together, this demonstrates that [ATP]m is reduced in 
ROT- and AA-treated cells. Although ROT- and AA-treatment did not alter the emission ratio 
of cyto-ATeam (data not shown), suggesting that [ATP]c is not affected, we did not use this 
data since [ATP]c might be far above the ATP affinity of this sensor [235]. However, when 
glucose (GLU) in the extracellular medium was replaced by an equimolar amount of the 
competitive hexokinase inhibitor 2-Deoxy-D-Glucose (2DG) the cyto-ATeam ratio in CT 
cells dropped within 15 minutes to that of dead cyto-ATeam (Fig. 5.4D). This means that 
cytosolic ATP was fully depleted within this time period. Upon 2-DG application [ATP]c 
decreased much faster in ROT- and AA-treated cells than in CT cells (Fig. 5.4E). These 
results, in combination with the observed low O2 consumption values, demonstrate that 
inhibitor-treated cells are more glycolysis-dependent than CT cells for maintaining their 
[ATP]c. Taken together, these data suggest that CV is less involved in residual mitochondrial 
ATP production in CI-inhibited cells, despite the presence of a substantial PMF.
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Figure 5.4 Effect of chronic complex I and complex III inhibition on mitochondrial and cytosolic ATP 
homeostasis. (A) Typical images of CT cells expressing mitochondrial or cytosolic variants of the ATP-
sensing protein “ATeam” (scale bar 50 µm). (B) Steady-state fluorescence ratios of CT cells expressing 
Mito- or Cyto-ATeam and its ATP-insensitive variant “Dead ATeam”. (C) Effect of ROT or AA treatment 
on the fluorescence ratio signal of mito- and cyto-ATeam and dead ATeam. (D) Effect of replacement 
of extracellular glucose (GLU) by the glycolysis inhibitor 2DG, and vice versa, on the fluorescence 
ratio of cyto-ATeam. (E) Rate of decrease of the cyto-ATeam ratio upon replacement of GLU by 2DG 
as determined by a linear fit. (F) Rate of increase of the cyto-ATeam ratio upon replacement of 2DG by 
GLU as determined by a linear fit. Numerals indicate the number of individual cells analysed. Error 
bars reflect SD.
Chronic inhibition of complex II, III or IV prevents rotenone-induced Dy hyperpolarization 
- The above results argue against involvement of CV and ANT reverse-mode action in 
ROT-induced Dy hyperpolarization. Moreover, because [ATP]m is decreased and oxygen 
consumption is reduced, it seems that CV is less active in CI-inhibited cells. This hypothesis 
is supported by our result that Dy was most sensitive to FCCP-induced proton leak in ROT- 
or PA-treated cells (Fig. 5.2B). This suggests that activity of other ETC complexes (CII, CIII 
and CIV) is required to allow ROT-induced Dy hyperpolarization. Chronic inhibition of CII 
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(MALO), CIII (AA) or CIV (KCN) resulted in reduced mitochondrial TMRM fluorescence 
compatible with Dy depolarization (Fig. 5.5). For the purpose of comparison, we have 
included the data for 100 nM ROT and AA from Fig. 5.1E in Fig. 5.5. Interestingly, ROT-
induced Dy hyperpolarization was prevented by chronic co-inhibition of CII (ROT+MALO), 
CIII (ROT+AA) or CIV (ROT+KCN) (Fig. 5.5), suggesting that activity of these complexes 
plays an essential role in the hyperpolarization mechanism. 
Inhibition of CII alone and CI+CII reduced mitochondrial TMRM fluorescence to a similar 
extent, whereas inhibition of CI+CIII and CI+CIV were less efficient (Fig. 5.5). Since in ROT-
treated cells CII-driven respiration is unchanged compared to CT (Fig. 5.1C) but respiration 
on endogenous substrates is low (Fig. 5.1B), it seems that CII activity drives a low level of 
electron transport in ROT-treated cells. Therefore we conclude that CII plays a key role in 
sustaining Dy hyperpolarization in ROT-treated cells by fuelling electron transport to CIII 
and CIV.
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Figure 5.5 The involvement of other ETC complexes in CI-induced hyperpolarization. (A) Effect of 
co-inhibition of CII (using MALO), CIII (AA) or CIV (using KCN) on mitochondrial TMRM fluorescence 
intensity in ROT-treated HEK293 cells (24 h treatments). N.b.: the data for 100 nM ROT (bar 2) and 
100 nM AA (bar 5) were duplicated from figure 5.1E. (B) Mitochondrial NAD(P)H autofluorescence 
in inhibitor-treated cells. (C) Mitochondrial intensity of hydroethidium (HEt) oxidation products 
in inhibitor-treated cells. Numerals indicate the number of individual cells analysed in at least 3 
independent experiments.
Chronic CIII inhibition is associated with CI reverse-mode action - In spite of CV reverse-
mode action in AA-treated cells, Dy became significantly depolarized. According to a 
theoretical model both CV and CI operate in reverse during AA-induced CIII inhibition [234]. 
Compatible with this idea is the fact that combined inhibition of CI and CIII normalized 
mitochondrial TMRM accumulation with respect to CIII inhibition alone (Fig. 5.5A). The 
above model further suggests that CI reverse-mode action is associated with CI-mediated 
NADH generation and increased CI-mediated ROS production by reverse electron transfer 
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(RET) from CII to CI. Indeed, inhibition of CI+CIII decreased NAD(P)H autofluorescence 
(Fig. 5.5B) and the level of HEt-oxidizing ROS (Fig. 5.5C) relative to CIII inhibition alone. 
These results suggest that Dy depolarization and decreased pHmito in CIII-inhibited cells 
results from the combined effect of reverse-mode action of CI (further depolarizing) and CV 
(repolarizing; Fig 5.6C). 
Discussion
Chemical or mutation-induced inhibition of the mitochondrial ETC reduces proton efflux 
across the MIM and is generally associated with (partial) Dy depolarization [19,236]. 
However, various (patho)physiological conditions including mitochondrial CI deficiency 
have been linked to Dy hyperpolarization [216–221], the mechanism of which is incompletely 
understood. Here we demonstrate that chronic (24 h) treatment with the mitochondrial CI 
inhibitor ROT induces Dy hyperpolarization in HEK293 cells. This model system was used 
to study the mechanism of mitochondrial hyperpolarization during chronic CI dysfunction. 
Acute treatment of HEK293 cells with the CI inhibitors ROT or PA dose-dependently but 
not completely inhibited cellular O2 consumption. In contrast, inhibition of CIII using AA 
fully blocked cellular O2 consumption. Following chronic ROT treatment (100 nM; 24 
h), cells still displayed ROT and/or AA-sensitive respiration, suggesting that also after this 
time period cellular O2 consumption was not fully inhibited. Using this chronic treatment 
regime, we did not observe off-target effects of ROT on cell shape/size and organisation of 
the cellular tubulin network. Analysis of permeabilized cells revealed that ROT- and AA-
treated cells displayed lower O2 consumption when respiring on CI-selective substrates. In 
contrast, ROT-treated cells exhibited normal O2 consumption when respiring on CI+CII- or 
CII-selective substrates whereas these parameters were greatly reduced in AA-treated cells. 
These results suggest that the greatly reduced O2 consumption in ROT-treated cells occurs 
mainly via CII-mediated substrate oxidation and subsequent electron transport to CIII and 
CIV. In addition, some residual CI activity might contribute to the minor portion of ROT-
sensitive O2 consumption. In case of AA, its full inhibition of O2 consumption is compatible 
with the very low rates on CI, CII and CI+CII-selective substrates. 
Single cell microscopy analysis was used to quantify accumulation of the Dy-dependent 
fluorescent cation TMRM within the mitochondrial matrix. It was found that chronic ROT 
and PA treatment dose-dependently increased the mitochondrial TMRM fluorescence 
signal. Chronic treatment with 100 nM AA, a concentration that fully blocked cellular O2 
consumption, induced a decrease in this signal. Importantly, the intensity of the mitochondrial 
TMRM fluorescence not only depends on Dy but also can be affected by the potential of the 
plasma membrane (DV), changes in mitochondrial and/or cellular volume and/or thickness, 
and TMRM autoquenching. However, control experiments revealed that these “artifacts” 
were not responsible for the observed ROT-induced Dy hyperpolarization. In case of AA 
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treatment a significant DV depolarization was observed suggesting that the reduced TMRM 
accumulation under these conditions might be overestimated. In the light of the above, 
we conclude that the ROT-induced increase in mitochondrial TMRM accumulation truly 
reflects Dy hyperpolarization that is associated with CI inhibition. It appears that this 
hyperpolarization is CI-specific, since it was dose-dependently increased by ROT or PA and 
not induced by chronic inhibition of the other ETC complexes. When cells were cultured 
in the chronic presence of ROT+AA, ROT+MALO or ROT+KCN, no Dy hyperpolarization 
was observed. This suggests that Dy hyperpolarization in ROT-treated cells requires activity 
of these complexes, supporting our above conclusion that CII-mediated substrate oxidation 
and electron transport to CIII and CIV sustains the greatly reduced O2 consumption in these 
cells. In addition, we currently cannot exclude the contribution of electron entry at CIII 
by for instance glycerol-3-phosphate dehydrogenase or electron-transferring flavoprotein 
dehydrogenase. ROT- and PA-inhibited cells were particularly sensitive to chemical 
uncoupling by FCCP. This demonstrates that Dy is (partially) carried by protons under these 
conditions and primed us to quantify mitochondrial and cellular pH using the protein-
based sensor SypHer. The SypHer analysis demonstrated that pHmito>pHcyto, indicative of an 
inward directed trans-MIM proton gradient, allowing forward-mode (i.e. ATP producing) 
action of CV. The latter is compatible with our observation that CT cells displayed an OLI-
sensitive O2 consumption meaning that their mitochondria were actively producing ATP. 
Whereas chronic ROT-treatment decreased pHcyto, pHmito was unaffected, suggesting a lack 
of net proton accumulation into the mitochondrial matrix. In case of AA, both pHmito and 
pHcyto became more acidic. Semi-quantitative calculation of DpH revealed that this gradient 
was increased in ROT-treated and slightly decreased in AA-treated cells, suggesting that a 
difference in DpH might contribute to Dy hyperpolarization and depolarization. 
In healthy cells, net Dy not only depends on ETC activity but also on forward- or reverse-
mode action of CV and the ANT. For instance, we recently demonstrated that a greatly 
reduced CV expression and CV maximal activity was linked to Dy hyperpolarization in 
fibroblasts of patients with TMEM70 mutations [214]. Qualitative experiments revealed that 
acute inhibition of CV using OLI does not induce Dy depolarization in CT or ROT-treated 
cells. In contrast, acute CV inhibition rapidly depolarized Dy in AA-treated cells. These data 
demonstrate that CV runs in reverse-mode in AA-treated cells whereas this is not the case 
in CT and ROT-treated cells. CV reverse-mode action in AA-treated cells likely is fuelled 
by ATP derived from mitochondrial substrate-level phosphorylation [3, 48]. Our current 
results are supported by a previous study where we investigated immortalized embryonic 
fibroblasts of NDUFS4-/- mice, a genetic model of CI deficiency [216]. In these cells we also 
observed that Dy hyperpolarization in NDUFS4-/- MEFs was maintained in absence of CV 
reverse-mode action. Acute ANT inhibition by BA did not induce Dy depolarization in CT 
and ROT- or AA-treated cells, meaning that the ROT- and AA-induced effects on Dy in these 
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cells do not involve ANT reverse-mode action. We propose that the increased dependency 
of AA-treated cells on extracellular glucose to sustain their [ATP]c might reflect a lack of 
mitochondrial ATP production and transport to the cytosol. In this sense, ROT-treated cells 
appeared slightly less dependent on extracellular glucose, compatible with reduced activity 
of CV and the ANT. 
Conclusions
Taken together, our results support a model (Fig. 5.6B), in which ROT-induced CI inhibition 
greatly reduces but not completely blocks cellular O2 consumption. This residual O2 
consumption (CIV activity) is associated with substrate oxidation (CII activity) and proton 
efflux (CIII and CIV activity). ROT-treated cells displayed a very low residual O2 consumption, 
Dy hyperpolarization and an increased DpH. This strongly suggests that also CV and 
ANT activity (both running in forward mode) are greatly reduced. The latter effect might 
be enhanced by the drop in cytosolic pH, known to inhibit CV and ANT activity during 
lactate accumulation in glycolytic cells [205]. Both ROT- or AA-treated cells displayed a 
similarly reduced mitochondrial free ATP concentration ([ATP]m). In ROT-treated cells, this 
drop likely results from reduced CV/ANT forward mode action. In case of AA-treatment the 
lower [ATP]m arises from CV reverse-mode action, the lack of ANT reverse mode action, 
and the inability of substrate level phosphorylation to meet the ATP demand of CV (Fig. 
5.6C). We postulate that in ROT-treated cells Dy hyperpolarization is the net result of: (i) a 
greatly reduced matrix proton efflux (CIII and CIV), (ii) a greatly reduced proton influx (via 
CV) (iii) a low-level ANT-mediated influx of positive charge, and (iv) an increase in DpH due 
to cytosolic acidification. The latter was also observed in AA-treated cells and likely results 
from upregulation of the glycolysis pathway [237]. 
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Figure 5.6 Proposed mechanism for Dy hyperpolarization and depolarization in HEK293 cells during 
chronic complex I or complex III inhibition. For details, see Discussion.
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Mitochondrial complex I and complex III inhibition 
increase ROS levels without inducing oxidative 
damage in HEK293 cells
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Abstract
Live cell imaging studies employing inhibitors of complex I (CI) and III (CIII) of the 
mitochondrial oxidative phosphorylation (OXPHOS) system indicate increased rates of 
reactive oxygen species (ROS) production. However, both the origin and chemical nature of 
these ROS as well as their subcellular levels and potential targets have yet to be completely 
elucidated.
Here, we use HEK293 cell lines inducibly expressing cytosolic and mitochondrial-targeted 
variants of the H2O2-selective reporter molecule HyPer and its H2O2-insensitive but pH-
sensitive derivative SypHer and show that separate inhibition of CI (100 nM rotenone) 
and CIII (100 nM antimycin A) for 24 h increases cytosolic but not mitochondrial H2O2 
levels without affecting cell viability. Cells loaded with C11-BODIPY581/591 and MitoPerOx 
showed the absence of any effect on total and/or mitochondrial lipid peroxidation and 
neither was there an effect on protein carbonylation as revealed by Oxyblot analysis. 
Protein expression of the cytosolic (CuZnSOD) and mitochondrial (MnSOD) antioxidant 
superoxide dismutases was not altered.
Together, these data indicate that separate inhibition of CI and CIII specifically increases 
the cytosolic H2O2 level but that this increase is not associated with oxidative damage and 
cell death.
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Introduction
The mitochondrial electron transport chain (ETC) consists of four multiprotein complexes 
(CI-IV) that couple the transport of electrons to the generation of an electrochemical 
proton gradient across the mitochondrial inner membrane (MIM). This gradient sustains 
an inward-directed proton motive force (PMF) that is used by complex V (CV) to produce 
mitochondrial ATP. Together with the ETC complexes and the two mobile electron carriers, 
coenzyme Q and cytochrome c, CV constitutes the oxidative phosphorylation (OXPHOS) 
system [16]. OXPHOS dysfunction, both due to mutations in OXPHOS subunits or chemical 
inhibition, is often associated with increased production of mitochondrial reactive oxygen 
species (ROS), which, if not sufficiently counterbalanced by the cell’s antioxidant defence 
systems, increases the risk of oxidative damage and cell death [12–15,19]. Increased ROS 
levels have been implicated in the aetiology of many human disorders including OXPHOS-
related diseases such as isolated CI deficiency [18] and detailed information about the 
origin and chemical nature of these ROS, their interconversion and (sub)cellular levels and 
their possible targets is essential for the rational development of therapeutic intervention 
strategies. While ROS quantification in isolated mitochondria generally yields consistent 
results, proper interpretation of live-cell ROS measurements still remains challenging. 
This relates to the fact that ROS of different chemical nature are produced at multiple 
sites, display different ranges of action, are interconverted or detoxified by a variety of 
(local) antioxidant systems and last but not least are difficult to identify [109,174,238]. 
Another level of complexity is that all these variables depend on cell type and experimental 
conditions. For instance, primary muscle or skin fibroblasts isolated from a mouse model 
with isolated CI deficiency (NDUFS4-/- mice; [239]) showed increased oxidation of the 
ROS reporter molecule hydroethidine (HEt; [240]). In agreement with this result, oxidation 
of HEt and 5-(and-6)-chloromethyl-2’,7’-dichlorodihydro-fluorescein (CM-H2DCF) was 
found to be increased in primary skin fibroblasts of patients with inherited CI deficiency 
[100,240–243]. In sharp contrast, however, primary neuronal cell lines and immortalized 
mouse embryonic fibroblasts from NDUFS4-/- mice did not display increased ROS levels 
[216,244]. 
The occurrence of oxidative damage depends on the chemical properties and the (sub)
cellular level of the ROS produced. In CI-deficient patient fibroblasts the observed increase 
in HEt and CM-H2DCF oxidation was not paralleled by alterations in thiol redox status and 
cellular lipid peroxidation [20,245]. This indicates that the levels of the ROS responsible 
for the oxidation of these probes, together with their specific properties, are not sufficiently 
increased to detectably alter these cellular parameters. On the other hand, they might be 
high enough to exert a signalling role [19,31,48–53]. Importantly, the lack of understanding 
of the physiological role of the more subtle changes in (sub)cellular ROS levels precludes 
the development of treatment approaches aimed at normalizing increased ROS levels.
102  |  CHAPTER 6
Of all ETC-linked and non ETC-linked pathways that contribute to ROS production in 
isolated mitochondria, CI are CIII are considered the most important [7,11,50,64,246]. 
Evidence was provided that the chemical CI inhibitor rotenone (ROT) stimulates superoxide 
(O2
•-) production at the NADH oxidizing flavin group and/or at the CoQ-binding site of CI 
[11]. However, when the PMF is sufficiently large, CI can generate large quantities of O2
•- 
via reverse electron transfer (RET) from CII to CI that is inhibited by ROT [7,67]. Moreover, 
it was recently demonstrated that CI can also directly catalyse hydrogen peroxide (H2O2) 
formation [71]. Whereas O2
•- produced by CI is released only in the mitochondrial matrix, 
inhibition of the Qi site of CIII with antimycin A (AA) in the presence of reduced coenzyme 
Q10 releases large amounts of O2
•- from the Qo site into both the mitochondrial matrix and 
the intermembrane space (IMS; [11,73]). Nonetheless, under physiological conditions CI 
was proposed to constitute the main source of mitochondrial O2
•- [7,247,248]. 
The aim of this study was to characterise ROS generation as a consequence of CI and 
CIII inhibition (using ROT and AA, respectively) and its possible impact on cell viability, 
superoxide dismutase (SOD) expression, cellular and mitochondrial lipid peroxidation and 
protein carbonylation in a human cell line (HEK293). We demonstrate that under conditions 
that these inhibitors completely inhibit cellular oxygen consumption, the magnitude of the 
accompanying increase in ROS levels is not sufficient to cause detectable cell damage, thus 
favouring a signalling role.
Materials & methods
Generation of inducible HEK293 cell lines stably expressing cytosolic and mitochondrial-
targeted variants of HyPer and SypHer - Gateway® Entry vectors were generated by 
recombining Gateway-adapted PCR products containing the sequence encoding cyto-
HyPer and mito-HyPer from pHyPer-cyto and pHyPer-dMito vectors (Evrogen, Moscow, 
Russia) with pDONR201 (Invitrogen, Breda, The Netherlands). A Gateway-adapted tag-less 
pcDNA/FRT/TO Destination vector was created by recombining the acGFP1-Destination 
vector [63,222,223] with a BacMamVSV-Destination vector [224]. Recombining the 
HyPer Entry vectors with this Destination vector using the LR Clonase II Enzyme Mix 
(Invitrogen) resulted in the pcDNA5/FRT/TO/mito-HyPer and pcDNA5/FRT/TO/cyto-HyPer 
expression vectors. To create constructs encoding the pH sensor SypHer, the mito-HyPer 
and cyto-HyPer Entry vectors were mutated at a critical cysteine residue by site-directed 
mutagenesis as described previously [41]. These new Entry vectors were also recombined 
with the Gateway-adapted pcDNA/FRT/TO Destination vector to obtain mito-SypHer and 
cyto-SypHer expression vectors. Flp-In T-REx293 cells (Invitrogen) were stably transfected 
with the expression vectors described above using the Superfect Transfection Reagent 
(Qiagen, Venlo, The Netherlands) and cultured for selection in the presence of 200 µg/
ml hygromycin (Calbiochem, Brunschwig, Amsterdam, The Netherlands) and 50 µg/ml 
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blasticidin (Invitrogen). To induce expression of the biosensor, 1 µg/ml doxycyclin (Sigma-
Aldrich, Zwijndrecht, The Netherlands) was added to the culture medium, followed by 
incubation for 24 h.
Cell culture and inhibitor treatment - Flp-In
 
T-REx
.
293 (HEK293) cells were cultured in 
DMEM containing 25 mM glucose, 2 mM L-glutamine, 10% (v/v) fetal calf serum and 1% 
penicillin/streptomycin in a humidified atmosphere containing 5% CO2 at 37°C. Prior to 
transfection, parental Flp-In TREx cells were cultured in the presence of 50 µg/ml blasticidin 
and 100 µg/ml Zeocin (Invitrogen). For fluorescence microscopy, 100,000 cells were 
seeded on 24-mm coverslips (Thermo Scientific, Etten-Leur, The Netherlands) placed in 35-
mm CellStar tissue culture dishes (Sigma-Aldrich) two days prior to imaging to reach 70% 
confluency at the day of imaging. For the determination of superoxide dismutase protein 
levels, cells were grown to ~80% confluency. One day after seeding, cells were treated with 
ROT or AA for 24 h and compared with vehicle (0.1% ethanol)-treated (CT) cells.
Fluorescence imaging of hydroethidine oxidation - Cells were incubated with 10 µM 
HEt (Invitrogen) in harvested culture medium for 10 minutes at 37°C and 5% CO2 in the 
dark. The HEt oxidation reaction was terminated by thoroughly washing the cells with PBS 
to remove excess HEt. Subsequently, the cells were covered by a colourless HEPES-Tris 
(HT) buffer (containing 132 mM NaCl, 10 mM Hepes, 4.2 mM KCl, 1 mM MgCl2, 1 mM 
CaCl2 and 25 mM D-glucose, adjusted to pH 7.4 with Tris salt). To quantify fluorescent HEt 
oxidation products, coverslips were mounted in an incubation chamber that was placed on 
the temperature-controlled (37°C) stage of an inverted microscope (Axiovert 200M, Carl 
Zeiss, Jena, Germany) equipped with a Zeiss x40 1.3 NA Fluar objective. The cells were 
excited for 100 ms at 490 nm using a monochromator (Polychrome IV, TILL Photonics, 
Gräfelfing, Germany). Fluorescence light from the cells was directed onto a CoolSNAP HQ 
monochrome CCD-camera (Roper Scientific, Vianen, The Netherlands) using a 525DRLP 
dichroic mirror (Omega Optical Inc., Brattleboro, VT, USA) and a 565ALP emission filter 
(Omega Optical Inc). The hardware was controlled using Metafluor 6.0 software (Universal 
Imaging Corporation, Downingtown, PA, USA). Ten random fields of view were routinely 
analysed per coverslip using MetaMorph 6.1 software (Universal Imaging Corporation). For 
time-lapse experiments involving carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone 
(FCCP), images were recorded every 6 seconds.
Fluorescence imaging of HyPer and SypHer - Five to ten minutes prior to imaging, cells 
were covered in HT buffer. HyPer and SypHer were alternatingly excited at 420 nm and 
470 nm for 200 ms, both directed by a 505DRLPXR dichroic mirror (Omega Optical Inc.). 
Emission signals were directed through a 535AF45 (Omega Optical Inc.) emission filter 
104  |  CHAPTER 6
onto the CCD camera. 10-15 Random fields of view were routinely analysed per coverslip 
using MetaMorph 6.1 software (Universal Imaging Corporation). 
Quantification of lipid peroxidation in living cells - Cellular and mitochondria-specific 
lipid peroxidation were assessed using the C11-BODIPY581/591 (Invitrogen) and MitoPerOx 
[40] biosensor, respectively. Cells were washed with PBS, covered with HEPES-Tris 
buffer (see above) and mounted onto the inverted microscope. C11-BODIPY581/591 and 
MitoPerOx display similar spectral properties and were excited at 488 nm for 200 ms 
using a 505DRLPXR dichroic mirror (Omega Optical Inc.). Emission signals were detected 
using 510BW40 (oxidized form) and 565ALP (non-oxidized form) emission filters (Omega 
Optical Inc). Using these settings, 10-15 random fields of view were routinely analysed per 
coverslip using MetaMorph 6.1 software (Universal Imaging Corporation). 
Superoxide dismutase protein levels - Cells (1-1.5x106) were harvested in ice-cold PBS. The 
cell suspension was centrifuged for 5 minutes at 1500g and snap-frozen in liquid nitrogen. 
Cells were homogenized in three freeze-thaw cycles at -20°C. Following a boiling step for 
5 minutes at 95°C in sample buffer, the samples were separated on a 10% SDS-PAGE gel. 
Next, the proteins were electrophoretically transferred to a PVDF membrane (Millipore, 
Amsterdam, The Netherlands). After blotting, the membranes were blocked for 45 minutes 
with one part Odyssey blocking buffer (Li-Cor, Lincoln, NE, USA) and one part 0.1% v/v 
Tween-20 containing PBS (PBS-T). The blots were rinsed twice with PBS-T and incubated 
with polyclonal anti-MnSOD (1:2500; ITK diagnostics bv), polyclonal anti-CuZnSOD 
(1:2000; ITK Diagnostics bv), anti-Na,K-ATPase-α subunit [249], polyclonal anti-Porin 
(1:1000; Calbiochem) or monoclonal anti-b-Actin (1:100,000; Sigma). For detection, 
IRDye 680-Conjugated Goat Anti-Mouse IgG, Highly Cross Adsorbed (Li-Cor) and IRDye 
800CW-Conjugated Goat Anti-Rabbit IgG (Li-Cor) secondary antibodies were used. IRDye 
fluorescence was quantified using an Odyssey Imaging system (Li-Cor).
Protein carbonylation assay - At 40-60% confluence, cells were treated with 100 nM ROT 
or 100 nM AA. After 24 h cells were harvested by centrifugation (5 min, 1000g) and the cell 
pellet was washed once with 1 ml PBS + 1 mM DTT and resuspended in 10 mM Tris-EDTA 
buffer with 10 µg/ml DNase. After three freeze/thaw cycles in liquid nitrogen the suspension 
was stored at -20°C. Protein carbonyl levels were determined by immunoblotting using the 
Oxyblot assay kit from Millipore (Temecula, CA, USA) with some slight modifications; 10 µl 
samples (~50 µg protein) were denatured with 10 µl 12% SDS and then derivatised with 20 
µl 2,4-dinitrophenylhydrazine (DNPH) to the corresponding 2,4-dinitrophenylhydrazone 
(DNP). After 15 min at RT the reaction was stopped with 15 µl Neutralization buffer and the 
samples were diluted 2 times with 2x SDS-sample buffer, further neutralized with TRIS and 
20-40 µl was run on a 10% SDS-PAGE gel.
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Data analysis – Curve fitting was performed using Origin Pro 6.1 (OriginLab Corp., 
Northampton, MA, USA). Unless stated otherwise, data is presented as mean ± SE (standard 
error). Statistical significance was assessed using a Kruskal-Wallis 2-way ANOVA following 
Dunn’s multiple comparison test, or a Mann-Whitney t-test using Graphpad Prism 5 software 
(GraphPad Software Inc., La Jolla, CA, USA). Statistical significance is indicated by asterisks: 
*P<0.05, **P<0.01 and ***P<0.001.
Results
Chronic inhibition of CI or CIII increases hydroethidine oxidation - O2
•- is among the 
primary mitochondrial ROS generated and is rapidly converted into H2O2 by SOD action. 
In contrast to H2O2, O2
•- cannot freely traverse membranes due to its negative charge. This 
means that O2
•- is likely to remain close to its (mitochondrial) site of generation until it 
is converted by SODs, reacts with biological entities or with a sensor molecule such as 
HEt. HEt is a non-fluorescent reporter molecule that becomes fluorescent when oxidized 
by ROS [36]. Due to their positive charge, HEt oxidation products accumulate in the 
mitochondrial matrix and the nucleus (nucleoli; [241]). To stimulate mitochondrial ROS 
production, HEK293 cells were incubated with varying concentrations of ROT or AA for 24 
h. Subsequent measurement of the rate of HEt oxidation revealed that after a short start-up-
phase this rate remained linear in control (CT), ROT- and AA-treated cells during at least 
10 minutes of incubation with 10 µM HEt (Fig 6.1A). This linearity indicates a 0th-order 
reaction meaning that the rate of increase reflects the level of HEt-oxidizing ROS [102] and 
that this level can be assessed by end-point measurement. In subsequent measurements, the 
HEt oxidation rate was determined after 10 min of HEt incubation. ROT treatment induced 
a small but significant decrease in the nuclear and mitochondrial HEt oxidation signal 
compared to CT when used at 0.1 nM, followed by a dose-dependent increase for higher 
concentrations (Fig 6.1B). AA-treated cells also displayed a linear and proportional increase 
in HEt oxidation but only up to an inhibitor concentration of 10 nM (Fig. 6.1B). At higher 
concentrations the nuclear fluorescence signal increased more than the mitochondrial 
signal, leading to a leftward deviation from the fitted line.
Changes in mitochondrial membrane potential affect mitochondrial HEt fluorescence 
- Since HEt oxidation products are positively charged, ROT- or AA-induced changes 
in mitochondrial membrane potential (Dy) could potentially affect the mitochondrial 
fluorescence intensity. For instance, Dy depolarization in primary human skin fibroblasts 
using the protonophore FCCP induced translocation of HEt oxidation products from the 
mitochondrial to the nuclear compartment [69]. The latter phenomenon was also observed 
in HEK293 cells, where acute FCCP application reduced the mitochondrial fluorescence 
signal of HEt oxidation products in HEt-loaded cells and in parallel increased this signal in 
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the nuclear compartment (Chapter 3). We previously demonstrated that AA (100 nM, 24 
h) induced a pronounced Dy hyperpolarization in HEK293 cells [250]. This is compatible 
with the leftward deviation from the fitted line in AA-treated cells (Fig. 1B). In the same 
study, we showed that ROT (100 nM, 24 h) induced a mild Dy hyperpolarization in these 
cells. Apparently, this mild Dy hyperpolarization was not sufficient to change the relative 
distribution of the HEt oxidation products, as indicated by the absence of any deviation 
from the fitted line. 
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Figure 6.1 Hydroethidine (HEt) oxidation, cell viability and SOD protein levels in CI- and CIII-
inhibited cells. (A) Increase in fluorescence signal of HEt oxidation products in a mitochondrial (Mit) 
and nuclear (Nuc) region of interest (inset: n,m, scalebar 25 mm) in the presence of 10 µM HEt (arrow). 
Cells were pretreated (24 h) with vehicle (CT), the CI-inhibitor ROT (100 nM) or the CIII-inhibitor AA 
(100 nM). Each trace reflects the average signal of 6-14 individual cells and the straight lines represents 
a linear fit to the data (R>0.99). (B) The mitochondrial vs. the nuclear HEt signal after 24 h ROT or AA 
treatment. The HEt data represents the mean of >40 cells normalized to the nuclear fluorescence of 
the control (CT) in at least two independent experiments. A linear fit was calculated for the ROT data 
(R=0.97; dotted lines indicate 95% confidence). (C) Representative phase-contrast images of HEK293 
cells incubated with different concentrations of ROT or AA. (D) Western blot analysis of MnSOD and 
CuZnSOD protein levels. MnSOD was normalized to Porin protein levels, CuZnSOD was normalized 
to b-Actin protein levels. The mean value ± SEM of 8 independent experiments is indicated in red.
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Chronic inhibition of CI or CIII does not induce cell death - ROT and AA treatment did not 
apparently affect the growth of HEK293 cells at concentrations up to 1 nM (Fig. 6.1C). At 100 
nM, cell growth was reduced in ROT- but not in AA-treated cells. At 1 µM, ROT treatment 
induced cell death (as evidenced by cell blebbing), whereas AA did not visibly affect cell 
growth and cell death (Fig. 6.1C). This suggests that the high levels of HEt oxidation at 1 
mM (and possibly also at 500 nM) of ROT treatment might be derived from cell death due 
to necrotic and/or apoptotic pathways (Fig 6.1B). We demonstrated previously that 24 h 
treatment with 100 nM ROT or AA does not alter the tubulin network in HEK293 cells while 
maximally inhibiting respiration at acute application [250]. Therefore, we used 100 nM 
ROT and AA as the standard concentration in the remainder of this study. 
Superoxide dismutase expression is not altered by chronic inhibition of CI or CIII - When 
O2
•- levels become too high, cells often upregulate SODs [251–254], which then convert 
O2
•- to H2O2 at extremely high rates [255]. The SOD family includes copper-zinc-SOD 
(CuZnSOD or SOD1) in the cytosol and mitochondrial IMS, and manganese-SOD (MnSOD 
or SOD2) in the mitochondrial matrix. Western blot analysis revealed that neither ROT nor 
AA treatment induced a consistent increase or decrease in MnSOD and CuZnSOD protein 
levels (expressed relative to cytosolic b-Actin and mitochondrial Porin loading controls, 
respectively; Fig. 6.1D). These results suggest that ROT and AA treatment do not increase 
ROS to a level that is sufficiently high for induction of SOD expression.
Measuring hydrogen peroxide using HyPer and SypHer - As mentioned above, H2O2 can 
diffuse across membranes and act as a signalling molecule [31,90,256]. To specifically 
measure live-cell cytosolic and mitochondrial H2O2 levels ([H2O2]) the H2O2 biosensor 
HyPer [38] was inducibly expressed in the cytosol (cyto-HyPer) or mitochondrial matrix 
(mito-HyPer) of HEK293 cells by stable transfection (Fig. 6.2B). HyPer consists of a 
circularly permuted (cp)YFP enclosed by the H2O2-sensitive regulatory domain of the E. 
coli transcription regulator OxyR (Fig. 6.2A). Given the pH-sensitivity of HyPer, we also 
generated HEK293 cell lines expressing H2O2-insensitive HyPer variants (cyto-SypHer and 
mito-SypHer) by mutating a critical HyPer cysteine residue (C199S). The SypHer protein has 
been used as a pH sensor [41,250]. 
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Figure 6.2 Assessment of hydrogen peroxide and pH sensitivity of cytosolic and mitochondrial 
HyPer/SypHer variants. (A) The HyPer protein (blue) consists of a cpYFP enclosed by the regulatory 
domain of OxyR (OxyR-RD). The mitochondrial variant is targeted using two N-terminal cox8 targeting 
sequences (2MTS). The reduced protein can be maximally excited at 420 nm, whereas 500 nm 
excitation induces highest emission of the oxidized form. Mutation of a critical residue (C199S) results 
in the H2O2 unresponsive SypHer (red) (B) Typical wide-field images of cyto-HyPer and mito-HyPer 
cells. Scalebar: 50 µm. (C) Effect of exogenous H2O2 application on the ratio signal (470 nm/420 nm) 
of cyto-HyPer and mito-HyPer (upper panel) and their individual 420 nm and 470 nm signals (lower 
panel). (D) Same as panel C but now for the effect of exogenous H2O2, the reducing agent DTT and 
NH4Cl on the signals of cyto-HyPer (left part) and cyto-SypHer (right part). N=6 cells (E) Effect of 
various exogenous H2O2 concentrations on the maximal cyto-HyPer ratio. The latter was calculated by 
dividing the maximal ratio value (Rmax) by the pre-H2O2 ratio (R0) from two independent experiments. 
Statistical significance was assessed using a 1-way ANOVA test using a Dunnett post-test against 25 
mM H2O2.
Treatment of HEK293 cells with 200 µM H2O2 induced a 2-fold increase in cyto-HyPer 
and mito-HyPer signal demonstrating that this ROS passes cellular membranes (Fig. 6.2C). 
Since the subsequent application of a reducing agent (dithiothreitol; DTT, 10 mM) returned 
the cyto-HyPer signal to levels slightly below basal (Fig. 6.2D; left panel), HyPer might 
be considered as a sensor for the balance between H2O2-mediated disulfide formation 
and glutathione-mediated disulfide reduction [135]. As expected, the SypHer signal did 
not respond to a challenge with 200 µM H2O2 (Fig. 6.2D; right panel) but increased with 
increasing of the pH following extracellular NH4Cl addition. Importantly, HyPer and SypHer 
ratio changes were caused by changes in the emission from 420 and 470 nm excitation in 
opposite directions, indicative of a cpYFP conformational change (Fig. 6.2C and D lower 
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panels). Intracellular [H2O2] generally is between the nM to low µM range [257] and the 
minimal [H2O2] to evoke a detectable change in the HyPer signal was ~5 µM [38]. In 
HEK293 cells, the HyPer signal appeared maximal at H2O2 concentrations >50 µM, as 
determined by adding increasing amounts of extracellular H2O2 (Fig. 6.2E). After reaching 
this maximum, the HyPer signal decreased within 10-15 minutes to basal level (data not 
shown). In contrast, at [H2O2] <50 µM, the HyPer ratio remained at a stable elevated level 
(data not shown), arguing against the activation of a H2O2 removal mechanism in HEK293 
cells at low [H2O2]. 
Chronic inhibition of CI or CIII increases cytosolic but not mitochondrial H2O2 levels - In 
untreated cells, the cytosolic HyPer and SypHer signals were lower than the corresponding 
signals in the mitochondrial matrix (Fig. 6.3A; SypHer data taken from [250]. This is 
compatible with the pH in the mitochondrial matrix being higher than in the cytosol 
[41,258]. Given its pH-sensitivity, the higher mitochondrial HyPer signal cannot be taken as 
direct evidence of a higher [H2O2] in the mitochondrial matrix ([H2O2]m). When correcting 
the HyPer signals for pH-induced changes (i.e. by dividing the mean HyPer ratio by the 
mean SypHer ratio), values of 0.69 (cyto-Hyper) and 0.82 were obtained (mito-Hyper). 
This suggests that the steady-state [H2O2]m exceeds the H2O2 concentration in the cytosol 
([H2O2]c). 
Correcting the ROT and AA treatment-induced HyPer signal (Fig. 6.3B) for the corresponding 
SypHer signal (Fig. 6.3C; [250]) revealed that ROT and AA significantly increased the 
cytosolic H2O2 level (Fig. 6.3D; left panel). Compatible with the HEt oxidation experiments, 
AA induced a larger increase in cytosolic HyPer signal than ROT. In contrast, no increase 
in mitochondrial HyPer signal was observed (Fig. 6.3D; right panel). These results suggest 
that both chronic ROT and AA inhibition do not increase [H2O2]m but elevate [H2O2]c to a 
variable extent.
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Figure 6.3 Hydrogen peroxide levels in CI- and CIII-inhibited cells. 
(A) Cytosolic and mitochondrial ratio signals for HyPer and SypHer in control cells. Mean of 3 (SypHer) 
or 4 (HyPer) independent experiments. The HyPer (B) and SypHer (C) ratios after 24 h of ROT or AA 
treatment were normalized for the mean CT ratio of each experimental day. (D) Cyto-HyPer and 
mito-HyPer ratio signals corrected for the effects on pH reported by SypHer (see Results for details). 
Numerals represent the number of cells from at least 3 independent experiments. 
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Chronic inhibition of CI or CIII does not induce cellular or mitochondrial lipid peroxidation 
- Mitochondrial lipids are particularly sensitive to peroxidation. Lipid peroxidation can 
cause functional differences in membrane fluidity thereby functionally affecting membrane 
proteins. For instance cardiolipin, a mitochondria-specific lipid component of the MIM 
that has an important signalling role, is particularly prone to oxidative attack because of its 
high content of unsaturated fatty acids [175]. Given the ROS increase detected by the HEt 
and HyPer sensors, we next determined whether ROT and AA can also increase total and 
mitochondria-specific lipid peroxidation in living HEK293 cells. To this end, we applied 
the classical fluorescent lipid peroxidation probe C11-BODIPY581/591 [113] and its MIM-
targeted variant MitoPerOx [40] (Fig 6.4A). 
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Figure 6.4 Lipid peroxidation in CI- and CIII-inhibited cells. 
(A) Typical microscopy images of cells stained with C11- BODIPY581/591 or MitoPerOx. Scalebar: 50 
µm. (B) MitoPerOx ratio of cells challenged with 50 mM H2O2 for 50 min or 10 nM MitoQ for 24 h. (C) 
CT-normalized total (C11- BODIPY581/591) and mitochondria-specific (MitoPerOx) lipid peroxidation 
levels in cells treated with 100 nM ROT or AA for 24 h. Data was expressed as percentage of vehicle-
treated cells (CT) measured on the same day. Numerals represent the number of cells from at least 3 
independent experiments. 
We previously demonstrated the responsiveness of C11-BODIPY581/591 towards exogenous 
H2O2 application (20 µM, 2 min; [174]) and chronic ROT treatment (100 nM, 72 h; [69]) 
in healthy human skin fibroblasts. In contrast, C11-BODIPY581/591 did not respond to the 
MIM-targeted antioxidant MitoQ (10 nM, 24 h; [69]). In HEK293 cells, treatment with H2O2 
(50 µM, 50 min) or MitoQ (10 nM, 24 h) slightly but significantly increased and decreased 
the MitoPerOx fluorescence ratio, respectively (Fig. 6.4B). ROT and AA treatment did not 
alter the C11-BODIPY581/591 signal (Fig. 6.4C; left panel). The MitoPerOx ratio was slightly 
increased in AA but not in ROT-treated cells (Fig. 6.4C; right panel). These results suggest 
that both inhibitor treatments do not induce a detectable peroxidation of cellular and MIM 
lipids.
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Chronic inhibition of CI or CIII does not induce protein carbonylation - Lipid peroxidation 
products can potentially induce metal-catalysed oxidation of specific amino acids, resulting 
in formation of stable carbonyl (CO) groups (aldehydes and ketones) on protein side chains 
[98,259,260]. In a final set of experiments we determined whether the increased ROS 
levels were associated with protein carbonylation in the absence of a detectable increase 
in lipid peroxidation. The most frequently used method to detect protein carbonylation 
is derivatisation of these groups using 2,4-dinitrophenylhydrazine (DNPH). The resulting 
2,4-dinitrophenylhydrazone (DNPhydrazone) can be subsequently detected by ELISA, 
spectrophotometric assays or, most sensitively, with SDS-PAGE followed by Western blot 
immunoassay (Oxyblot). Using the latter method, we observed that neither ROT nor AA 
treatment altered the total amount of derivatized proteins on the blot (Fig. 6.5). These data 
suggest that ROT and AA treatment do not detectably increase protein carbonylation.
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Figure 6.5. Oxyblot analysis of protein carbonylation in CI- and CIII-inhibited cells. 
Oxyblot-signals (DNP-protein) of whole-cell lysates of cells treated with 100 nM ROT or AA for 24 h 
at normal or decreased pH (by adding 25 µmol HCl/ml). Distinct DNP-protein bands are marked by 
arrowheads. 
Discussion
In most mammalian cells mitochondria are an important source of ROS, which are most 
likely produced primarily by CI and CIII of the ETC [7,11,161]. However, the relative 
contribution of these complexes to the mitochondrial ROS produced and the derived ROS 
distributed throughout the cell as well as the physiological or pathological role of these 
ROS has yet to be completely elucidated. Therefore we studied the subcellular levels of 
ROS generated by individual chronic inhibition of CI and CIII in HEK293 cells. We show 
that CI and CIII inhibition specifically increase cytosolic but not mitochondrial H2O2 levels, 
and that this did not lead to oxidative damage. 
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Low-level CI and CIII inhibition increase HEt-oxidizing ROS levels but do not upregulate 
SOD expression - CI inhibition induced by chronic ROT treatment stimulated cellular HEt 
oxidation, suggesting an increase in CI-mediated ROS production. Similarly, the levels of 
HEt-oxidizing ROS increased with decreasing residual CI activity in primary skin fibroblasts 
from patients with inherited CI deficiency [241]. Although several intact-cell studies have 
reported similar results, CI inhibition by ROT can also lower ROS levels by preventing 
RET [11,65,68–70,261]. While the observed decreased ROS levels induced by very low 
ROT concentrations (0.1 nM) suggest the involvement of RET, higher ROT concentrations 
increased HEt oxidation, arguing against mitochondrial ROS production via RET in HEK293 
cells. In contrast to most other cell models (e.g. [19,68,262–267]), very low concentrations 
(0.1 nM) of AA significantly increased HEt oxidation levels in HEK293 cells. Combined 
with our previous finding that acute additions of up to 2 nM AA hardly decreased cellular 
oxygen consumption [250], these data indicate that ROS production occurred at low levels 
of CIII inhibition. Moreover, higher concentrations of AA only marginally increased the 
HEt oxidation signal. This suggests that HEK293 cells may be very sensitive to AA-induced 
CIII inhibition compared to other cell models and/or have more reduced coenzyme Q10, 
allowing O2
•- production at the Qo site. Although both CI and CIII inhibition increased 
ROS levels, this does not necessarily imply that the observed increased ROS levels were 
produced by these enzyme complexes. We demonstrated that both inhibitors cause an 
increase in the NAD(P)H/NAD(P)+ ratio (Chapter 5), which also stimulates ROS production 
by α-ketoglutarate dehydrogenase [80]. Therefore, it is currently uncertain which enzyme(s) 
are responsible for the increased ROS levels caused by ROT and AA. Although it has been 
shown before that a constant increase in O2
•- production can induce expression of cytosolic 
and/or mitochondrial SODs [251–254] SOD expression did not detectably change after 
inhibition by ROT or AA. In agreement with this, we did not observe increased MnSOD 
protein levels in our CI patient cohort (unpublished data). This suggests that, in both cell 
models the increase in ROS levels is not high enough or toxic to induce upregulation of 
SOD expression.
CI and CIII inhibition specifically increase cytosolic H2O2 levels without inducing oxidative 
damage - Within cells, H2O2 is more stable than O2
•-, displays a larger range of action 
and, therefore, acts as a more “global” signalling/damaging ROS [19]. We employed an 
advanced combination of HyPer and SypHer to demonstrate that ROT and AA increased 
cytosolic H2O2 levels by ~10% and 50%, respectively. In contrast, mitochondrial H2O2 
levels were not increased or even slightly decreased by ROT. These data are consistent with 
the roGFP-reported thiol redox status in fibroblasts of patients with severe CI deficiency, 
which is specifically increased in the cytosol [20,268]. Quantification of AA-induced HEt 
oxidation was complicated by a decrease in Dy, driving the translocation of positively 
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charged oxidation products to the nucleus. Regardless, the overall HEt oxidation signal 
was higher in AA-treated cells than in ROT-treated cells, which in part could explain the 
observed differences in cytosolic H2O2 levels. In addition, a majority of O2
•- could have been 
produced by CIII into the IMS and converted to H2O2, which can subsequently diffuse to 
the cytosol. Assuming that the ROT-induced increased ROS levels were produced inside the 
mitochondrial matrix, and O2
•- does not easily traverse membranes, our findings suggest a 
strong regulation of intramitochondrial H2O2 levels. One likely possibility is the involvement 
of mitochondria-specific antioxidant systems such as peroxiredoxin 3 [92,269]. In addition, 
a MIM-embedded member of the aquaporin family of water channels, AQP8 [270], was 
found to be permeable to H2O2 [30,271]. Therefore, AQP8 is an interesting candidate to 
specifically transport mitochondrial matrix-produced H2O2 to the cytosol. This regulation 
has some clear functional implications, since (i) mitochondrial protein thiols are more likely 
modified by H2O2 than cytosolic thiols [33,34] and (ii) mitochondrial membrane lipids are 
very sensitive to peroxidative attack [175]. In this sense, H2O2 might be more damaging 
to macromolecules than O2
•-, since MnSOD knockout mice have normal levels of lipid 
peroxidation [272] and CuZnSOD overexpression has been linked to increased levels of 
lipid peroxidation [273]. Despite the increased cytosolic H2O2 levels in HEK293 cells, we 
did not find an increase in either total or mitochondria-specific lipid peroxidation. This 
points to a non-toxic increase since we have shown previously that 500 µM H2O2 can 
increase the MitoPerOx ratio by 25-50% both in HEK293 cells and human skin fibroblasts 
[40]. Taking into consideration that both in ROT-induced [20] and genetic CI dysfunction 
[245,268] the extent of lipid peroxidation has been ambiguous, it seems that the induction 
of lipid peroxidation requires more factors than simply increased H2O2 levels. Degradation 
of peroxidised lipids can result in the formation of hydrocarbons, alcohols, ethers, epoxides 
and aldehydes such as malonaldehyde and 4-hydroxynonenal [98]. Especially the latter two 
may introduce carbonyl (CO) groups on protein side chains of Cys, His, and Lys residues 
[260]. However, in this current study we did not observe a general increase in the Oxyblot 
pattern. This confirms our finding that lipid peroxidation is absent, and therefore does not 
lead to protein carbonylation. 
Conclusion
Here we demonstrated that separate chronic inhibition of CI and CIII specifically increases 
the H2O2 level in the cytosol and not in the mitochondrial matrix. We furthermore show 
that the increase in cellular ROS level under conditions of complete inhibition of oxygen 
consumption occurs without detectable signs of cell death, SOD upregulation, lipid 
peroxidation and protein carbonylation suggesting that the generated ROS did not culminate 
into cellular damage and instead may play a role in redox signalling. This type of regulation 
could particularly be exerted at the level of cysteine oxidation by H2O2, as exemplified 
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by the sensitivity of proteins involved in the modulation of intracellular calcium levels to 
oxidative modifications [274,275]. In line with this, the vitamin E derivative Trolox was 
shown to improve calcium removal that was repressed by external addition of H2O2 [160] 
and dose-dependently restored Ca2+ homeostasis in a CI-deficient patient fibroblast cell 
line [215]. Therefore, oxidation of proteins involved in calcium homeostasis might be an 
underlying cause for the deregulation of calcium levels in most CI-deficient patients [276]. 
Understanding the influence of these signalling redox modifications will be a vital next step 
to combat mitochondrial disease.
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Abstract
The regulation of energy transduction processes involves a fine control by the type and 
concentration of energy substrates. In particular, the mechanism that causes inhibition of 
mitochondrial oxygen (O2) consumption by elevated concentrations of glucose, the so-called 
Crabtree effect, remains largely unexplained. Previous evidence suggests involvement of 
the glycolysis intermediate fructose-1,6-bisphosphate (F1,6bP), which accumulates in the 
cytosol and inhibits O2 consumption by decreasing mitochondrial complex III and complex 
IV activity. Using HEK293 cells we here demonstrate that normal extracellular glucose 
levels (5 mM) inhibit O2 consumption in intact but not in permeabilised cells. When the 
latter were incubated with F1,6bP, complex I- and complex II-driven O2 consumption was 
inhibited. A non-hydrolysable F1,6bP analogue (2,5-anhydro-D-mannitol) did not induce 
the Crabtree effect in permeabilised cells, suggesting involvement of F1,6bP metabolites. 
The effect of F1,6bP was mimicked by the glycolysis intermediate methylglyoxal (MGO), 
proposed to be involved in protein glycation, and blocked by the glycation blocking agent 
aminoguanidine (AG). Our results suggest that the Crabtree effect is mediated by F1,6bP-
derived glycation products that enter mitochondria to inhibit oxidative phosphorylation 
thereby constituting a new potential control mechanism. 
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Introduction
In most mammalian cells, mitochondria play an important role in ATP production via 
oxidative phosphorylation (OXPHOS). The latter is tightly connected to cytoplasmic 
glycolysis, which produces a mere 14-17 times lower amount of ATP than OXPHOS but 
also provides high-energy intermediates such as pyruvate that ultimately fuel mitochondrial 
ATP generation. Glucose is thus an important source of energy for both glycolysis and 
coupled OXPHOS. Paradoxically, high levels of glucose were reported to induce an acute 
but reversible inhibition of oxygen (O2) consumption, a phenomenon referred to as the 
Crabtree effect. 
The latter was first observed in transplantable animal tumours [277] and has since then 
mostly been associated with cancer cell metabolism and was typically observed on cell 
culture models [278–282]. Therefore, a better understanding of the Crabtree effect might 
prove valuable in the development of bioenergetics therapy against tumours. However, the 
Crabtree effect is not restricted to cancer cells and was also demonstrated in yeast cells 
[283], bacterial cultures [284] and in normally proliferating primary cells including beating 
rat heart cells [285], isolated rat lung cells [286], hamster eight-cell embryos [287], vascular 
smooth muscle [288], rat thymocytes [289] and various endothelial cell types [290–292]. 
Apparently, most living organisms are intrinsically able to rapidly reduce their oxidative 
metabolism according to environmental changes, possibly with the aim of survival under 
toxic conditions such as high glucose levels that associate with the onset of metabolic 
syndrome in humans [28,293]. 
Despite its discovery more than 80 years ago, the mechanism(s) that underlie the Crabtree 
effect are still largely unknown. Because both glycolysis and OXPHOS are controlled by 
the phosphate potential ([ATP]/[ADP][Pi]; [294]) and glucose addition to Crabtree-sensitive 
cells has been associated with changes in ADP, ATP, AMP and Pi levels [281,295,296], it 
was proposed that glycolysis and OXPHOS compete for ADP and/or Pi [295]. However, 
changes in ADP, ATP, AMP and/or Pi levels were inconsistent across different labs [295]. 
In addition, more recent evidence suggests that the glycolysis intermediate fructose 
1,6-bisphosphate (F1,6bP) inhibits mitochondrial respiration both in the presence and 
absence of ADP [297]. Glucose administration increased cytosolic F1,6bP levels 50-fold in 
hepatoma cells, reaching concentrations between 7-25 mM [281,298]. In a physiological 
concentration range, F1,6bP inhibited respiration of isolated Saccharomyces cerevisiae 
mitochondria, nystatin-permeabilised yeast spheroplasts and rat liver mitochondria but not 
of a Crabtree-negative yeast strain [297]. In the latter study inhibition of mitochondrial 
respiration was the result of complex III and complex IV inhibition, suggesting that F1,6bP 
enters the mitochondrial matrix via a hitherto unknown mechanism.
In this study, we first demonstrate that the Crabtree effect is active in a human cell line 
(HEK293) and associated with increased reactive oxygen species (ROS) levels. Next, we 
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used this cell line to further dissect the role of F1,6bP and to gain insight into the cellular 
consequences of the Crabtree effect. Evidence is provided that F1,6bP indirectly inhibits 
mitochondrial respiration by the formation of glycation precursors that might ultimately 
inhibit mitochondrial enzyme activity. Our results support a model in which the Crabtree 
effect is mediated by mitochondrial glycation.
Materials & Methods
Chemicals – 2-Deoxy-D-glucose (2DG), D-fructose 1,6-bisphosphate trisodium 
salt octahydrate (F1,6bP), 40% methylglyoxal (MGO) solution and aminoguanidine 
hydrochloride (AG) were purchased from Sigma-Aldrich (Zwijndrecht, The Netherlands). 
2,5-Anhydro-D-mannitol-1,6-diphosphate dibarium salt (2,5-M) was purchased from Santa 
Cruz Biotechnology, inc. (Heidelberg, Germany).
Cell culture - Flp-In
. 
T-REx
.
293 cells were cultured in DMEM 10938 (Life Technologies, 
Bleiswijk, The Netherlands) containing 25 mM D-glucose and supplemented with 2 mM 
L-glutamine, 10% (v/v) FCS and 1% penicillin/streptomycin in a humified atmosphere of 
95% air and 5% CO2 at 37°C. In cell culture experiments in which the glucose concentration 
needed to be varied or completely absent, glucose-free DMEM 11966 (Life Technologies) 
was used and supplemented with the required substrate concentrations, 10% (v/v) FCS 
and 1% penicillin/streptomycin. For fluorescence microscopy, 100,000 cells were seeded 
on 24-mm circular coverslips (Thermo Scientific, Etten-Leur, The Netherlands) placed in 
35-mm CellStar tissue culture dishes (Sigma-Aldrich) two days before imaging. For high-
resolution respirometry analysis, the cells were grown to 80% confluence.
High-resolution respirometry - Culture medium was collected and cells were trypsinised, 
washed and resuspended to ~1 million cells per ml in the collected culture medium. For 
experiments in HEPES-Tris buffer (HT buffer; 132 mM NaCl, 10 mM HEPES, 4.2 mM KCl, 
1 mM MgCl2, 1 mM CaCl2 and the required amount and type of substrate, adjusted to pH 
7.4 with Tris) or permeabilised cells, cells were resuspended in HT buffer pre-warmed to 
37ºC containing the required substrates or mitochondrial respiration (MiR05) medium (3 
mM MgCl2, 90 mM K
+, 0.5 mM EGTA, 60 mM K-lactobionate, 20 mM taurine, 10 mM 
KH2PO4, 20 mM HEPES, 110 mM sucrose and 1 g/l BSA). O2 consumption was measured 
using 2 ml cell suspensions at 37°C using polarographic O2 sensors in a two-chamber 
Oxygraph (OROBOROS Instruments, Innsbruck, Austria). Part of the cell suspension was 
used to determine cell count using a Scepter Automated Cell Counter (Merck Millipore, 
Billerica, US).
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Fluorescence imaging of hydroethidine oxidation - After 20 minutes pre-incubation 
in HT buffer, Flp-In T-REx293 cells were incubated with 10 µM hydroethidine (HEt; 
Life Technologies) for 10 minutes at 37°C in the dark. HEt oxidation was terminated by 
thoroughly washing the cells with PBS to remove excess HEt after which the cells were 
covered in HT buffer. To quantify fluorescent HEt oxidation products, coverslips were 
mounted in an incubation chamber that was placed on the temperature-controlled (37°C) 
stage of an inverted microscope (Axiovert 200M, Carl Zeiss, Jena, Germany) equipped with 
a x40 1.3 NA Fluar oil-immersion objective. HEt was excited for 100 ms at 490 nm using 
a monochromator (Polychrome IV, TILL Photonics, Gräfelfing, Germany), directed to the 
cells using a 525DRLP dichroic mirror (Omega Optical Inc., Brattleboro, VT, USA). Emitted 
fluorescent light was captured through a 565ALP emission filter (Omega) onto the CCD-
camera. Routinely, ten fields of view were analysed per coverslip using MetaMorph 6.1 
(Universal Imaging Corporation).
Fluorescence imaging of cytosolic and mitochondrial pH - Mitochondrial and cytosolic pH 
were measured in Flp-In T-Rex 293 cells stably overexpressing the pH sensor SypHer [250]. 
SypHer was excited at 420 nm and 470 nm during 200 ms, directed by a 505DRLPXR 
(Omega) dichroic mirror. Emission signals were captured using a 535AF45 (Omega) 
emission filter using the microscopy system described above. Ten-fifteen fields of view were 
routinely analysed per coverslip.
Isolation of mitochondria - ∼150-200⋅106 cells were washed twice with PBS at 37°C, and 
harvested in cold isolation buffer (225 mM manitol, 10 mM HEPES, 75 mM sucrose, 0.1 
mM EGTA, 0.1 g/l BSA, 1x protease inhibitor cocktail and adjusted to pH 7.4 with KOH) 
using a cell scraper and stored on ice. After centrifugation at 2000g for 10 min at 4°C 
using a Hettich Rotina 420R centrifuge, the pellet was resuspended in cold isolation buffer 
and homogenised with a glass Dounce homogeniser. Cell debris was removed by a 1000g 
centrifugation for 5 min at 4°C using the Hettich centrifuge. Mitochondria were pelleted 
from the resulting supernatant by centrifugation at 15000g for 15 min at 4°C using an 
Eppendorf Centrifuge 5417R, washed three times in washing buffer (395 mM sucrose, 10 
mM HEPES, 0.1 mM EGTA and adjusted to pH 7.4 with KOH), resuspended in MiR05 
medium (see above) and stored on ice until use. Protein concentration was determined 
by measuring absorption at 280 nm using a Nanodrop 2000c spectrophotometer (Thermo 
Scientific).
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Amplex Red assay - H2O2 levels were monitored by measuring Amplex Red (Life 
Technologies) oxidation to resorufin using a Fluostar Galaxy fluorescence spectrophotometer 
(BMG Labtechnologies) at 37°C with filter wavelengths of 584 nm excitation and 612 nm 
emission. Samples were prepared in a black/clear imaging microplate (BD biosciences, 
Breda, The Netherlands) containing 25 ml MiR05 buffer with the appropriate substrates and 
F1,6bP or glucose and 25 ml mitochondrial suspension (2 mg/ml). The reaction was started 
by the addition of 50 ml MiR05 containing 100 mM Amplex Red and 0.2 U/ml horseradish 
peroxidase. Oxidation products were measured immediately and then every 28 seconds. 
After 20 minutes, 100 nM rotenone or 100 nM antimycin A was added to the reaction 
mixture and Amplex Red fluorescence was monitored for another 30 minutes.
Cell viability assay - 12,000 Cells were plated on poly-D-lysine-coated black/clear imaging 
microplate (BD biosciences) 2 days prior to the assay so that cells were ∼70% confluent. 
Cells were washed once with PBS and then incubated in HT buffer containing the desired 
concentration and type of substrate(s) for 1 h, followed by 25 min incubation with 5 mM 
calcein AM (Invitrogen) in a humified atmosphere of 95% air and 5% CO2 at 37°C. After 
a single wash in HT buffer, calcein fluorescence was measured on a Fluostar Galaxy 
fluorescence spectrophotometer (BMG Labtechnologies) at 37°C using filter wavelengths of 
485 nm (excitation) and 520 nm (emission).
Statistics - Unless stated otherwise, data is presented as mean ± SE (standard error). Statistical 
significance was assessed using a Kruskal-Wallis 2-way ANOVA following Dunn’s multiple 
comparison test, or a paired t-test using Graphpad Prism 5 software (GraphPad Software 
Inc., La Jolla, CA, USA). Asterisks indicate statistical significance: *p<0.05, **p<0.01 and 
***p<0.001.
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Results
HEK293 cells display the Crabtree effect - To test whether high glucose levels could 
decrease mitochondrial respiration, HEK293 cells were cultured chronically (24 h) in DMEM 
11966 (devoid of glucose) supplemented with 5 or 25 mM glucose, and O2 consumption 
of intact cells was measured (Fig. 7.1A and B). There was no statistical difference in the 
endogenous (routine), oligomycin-induced (leak), maximal (ETS, determined by titrating the 
mitochondrial uncoupler carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP)) or 
rotenone (ROT) and antimycin A (AA)-sensitive respiration (ROX). 
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Figure 7.1 Glucose and 2DG inhibit respiration in HEK293 cells.
(A) Protocol for measurement of O2 consumption in intact cells. (B) O2 consumption in intact HEK293 
cells in culture medium containing 5 or 25 M glucose. Basal O2 consumption (“Routine”), OLI-
inhibited O2 consumption (“Leak”), maximal O2 consumption (ETS) and residual O2 consumption 
(ROX) are indicated. Each bar reflects the mean of 4 independent experiments. (C) Example trace 
of respiratory inhibition by glucose (Glc) and 2-deoxyglucose (2DG; 1 and 5 mM). (D) Inhibition of 
O2 consumption by 1, 5 or 10 mM Glc or 2DG as a percentage of O2 consumption in glucose- and 
2DG-free DMEM (basal); the mean of these values is represented as the average Glc/2DG (N>3). 
(E) O2 consumption of intact cells, which were incubated in HT buffer with the indicated glucose 
concentrations for ≥1 h, immediately after addition of 2DG (T2DG, 100%) with or without 1 mM 
glutamine. Error bars indicate SEM. 
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In contrast, acute transmission of the cells from high glucose (25 mM) to glucose-free DMEM 
resulted in a respiration rate (Fig. 7.1C) that was twice as high as in figure 7.1B. Subsequent 
addition of 1 mM and then 5 mM of glucose (Fig. 7.1C, black line) reduced respiration to 
the oxygen consumption levels measured in figure 7.1B, clearly demonstrating the Crabtree 
effect. 
To evaluate the mechanism of this Crabtree effect we compared the effect of glucose to 
that of a non-metabolizable analogue, 2-deoxyglucose (2DG). In the presence of 2DG (in 
glucose-free DMEM), no intracellular glucose is used to fuel respiration due to inhibition 
of glycolytic enzyme hexokinase. Consequently, pyruvate will not be formed to be used as 
an OXPHOS substrate. Although 2DG acutely inhibited respiration (Fig. 7.1C, blue line), 
it was less effective than glucose, as exemplified during conditions of maximal respiration 
when the uncoupler FCCP was added (Fig. 7.1C and D). This implies that 2DG inhibits 
respiration in a different manner than glucose, and does not induce the Crabtree effect. 
Therefore it is conceivable that glucose breakdown to downstream metabolites could 
be required to mediate the Crabtree effect. To further understand the difference between 
glucose and 2DG, we performed a competition experiment where the two compounds 
were added sequentially to HEK293 cells and respiration was monitored. 2DG decreased 
O2 consumption after one hour of respiration without exogenous substrates or supplied 
with glucose concentrations up to 2.5 mM (Fig. 7.1E). In contrast, respiration remained 
stable or increased slightly when higher (>2.5 mM) concentrations of glucose were added. 
These findings suggest that the Crabtree effect requires glucose metabolism.
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Figure 7.2 Dependency of the Crabtree effect on external glucose concentration.
(A) Basal (Routine) and (B) maximal (ETS) respiration and (C) coupling ratio (routine/leak) of cells 
incubated with the indicated dose of glucose alone or in combination with pyruvate for 1 h. Mean of 
3-6 independent experiments. Asterisks indicate a significant difference from the same concentration 
of glucose or an indicated concentration of glucose.
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The Crabtree effect is induced between 1-2.5 mM glucose - To assess the glucose 
dose-dependence of the Crabtree effect, cells were incubated in HEPES-Tris (HT) buffer 
supplemented with various concentrations of glucose, in the presence or absence of the 
respiratory substrate pyruvate (1 mM). Cells were allowed to respire for one hour, after which 
ROX-corrected routine, leak and ETS respiration were determined. Within this hour, the rate 
of respiration generally did not increase due to consumption of glucose over time (data not 
shown). The Crabtree effect was induced between 1 and 2.5 mM glucose and was observed 
both in the routine (Fig. 7.2A) and ETS (Fig. 7.2B) values. The effect was most obvious at 5 
mM glucose, and pyruvate could not significantly counteract the decrease in respiration. At 
5 mM glucose, 1 mM pyruvate normalised the coupling ratio (routine/leak) suggesting more 
ATP-linked respiration (Fig 7.2C). This might be explained by a pyruvate-induced increase 
in citrate levels, which suppress phosphofructokinase (PFK1) activity resulting in decreased 
PFK1-generated levels of F1,6bP [299]. Importantly, increasing glucose concentrations 
did not significantly decrease calcein AM uptake, indicating that the observed decrease in 
respiration was not caused by a decrease in cell viability (Fig 7.3). 
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Fructose-1,6-bisphosphate inhibits respiration in permeabilised but not intact cells - It 
was previously shown in S. cerevisiae that the downstream glycolysis product D-fructose-
1,6-bisphosphate (F1,6bP) is a possible inducer of the Crabtree effect [297]. To evaluate 
this possibility in our mammalian cell system, 1 or 5 mM F1,6bP or glucose were acutely 
added to saponin-permeabilised cells respiring on CI substrates (10 mM glutamate plus 
2 mM malate) or CII substrate (10 mM succinate; Fig. 7.4A). Whereas F1,6bP acutely 
decreased respiration, addition of 5 mM glucose was ineffective. This suggests that glucose 
can only inhibit respiration when it is metabolised to F1,6bP. Next, CI- CII-, CI+CII- and 
CIV-dependent O2 consumption were determined. Compatible with a lower H
+/e- ratio 
[234,300], CII-dependent O2 consumption was higher than respiration driven by CI 
substrates (Fig. 7.4B). Evaluation of the Crabtree effect after addition of 5 mM F1,6bP or 
5 mM glucose showed that CI- (Fig. 7.4C), CII- (Fig. 7.4D) and CI+CII-driven respiration 
(Figs. 7.4C and D) were reduced by F1,6bP. This is consistent with CIII or CIV being a 
Figure 7.3 The effect of glucose on cell viability. Cell viability 
was assayed by measuring calcein AM uptake after 1-1.5 h 
incubation in HT buffer containing glucose (glc), pyruvate (Pyr) 
or hydrogen peroxide (H2O2).
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target of F1,6bP as shown previously in yeast cells [297]. In our study, respiration on CIV-
specific substrate was not significantly decreased by F1,6bP (Fig 7.4C,D) which suggests 
that F1,6bP acts on CIII. Repetition of our analyses in permeabilised cells placed under 
nonphosphorylating conditions (i.e. without ADP, data not shown) showed that F1,6BP 
was still potent to inhibit respiration, supporting a model in which it acts on the respiratory 
chain and not on the phosphorylation system of the OXPHOS machinery. 
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Figure 7.4 Fructose-1,6-bisphosphate inhibits respiration in permeabilised cells.
(A) Typical O2 consumption experiment on permeabilised cells. The dotted line interlude indicates a 
reoxygenation step. (B) O2 consumption of permeabilised cells on CI (glutamate+malate, GM) or CII 
(succinate, S) substrates in the presence of ADP (d). O2 consumption after addition of 5 mM F1,6bP or 
glucose of permeabilised cells initially fed with CI (C) or CII (D) substrates. Subsequently, either S (C) 
or GM (D) was added to measure CI+CII (GMSd), and then CI was inhibited with ROT to specifically 
measure CII respiration (GMSdR). Finally after CIII inhibition using AA, CIV activity was measured with 
ascorbate and TMPD. Mean of >3 independent experiments. 
The Crabtree effect is associated with increased ROS levels - In the presence of glucose 
respiration of HEK293 cells decreases, which can leave electron carriers upstream of the 
site of inhibition more reduced. As a consequence, the probability for superoxide formation 
increases [7,11] and the direct inhibition of CIII by F1,6bP could result in elevated ROS 
levels. Oxidation of the ROS probe hydroethidine (HEt; N=2) is inversely associated to 
the O2 consumption rate, following the hyperbolic shape of the so-called flux-force 
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relationships demonstrated in previous bioenergetics studies [301–303] (Fig. 7.5A). This 
relationship, linking respiratory rate, phosphorylation and proton motive force, was verified 
by measuring the DpH in these conditions (Fig 7.5B). Analysis of HEt oxidation-derived 
mitochondrial fluorescence revealed an increase at glucose concentrations exceeding 1 mM 
(Fig. 7.6A), which inversely correlates to the O2 consumption data (Fig. 7.6B; exponential 
decay on glucose-only data, R>0.99). We have previously shown that inhibition of CIII 
can lead to increased ROS production at CI through reverse electron transfer (RET; Chapter 
5). If this mode of ROS production is induced by glucose, then ROT should decrease the 
HEt oxidation signal. However, acute (10 min) ROT co-incubation further increased HEt 
oxidation (Fig. 7.6C), suggesting that ROS production did not occur via RET. 
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Figure 7.5 Correlation of O2 consumption with HEt oxidation and DpH. 
Routine O2 consumption of intact cells after 30 min incubation with 0 mM (0 glc) or 10 mM glucose 
(10 glc), 1 mM glutamine (gln), 1 mM pyruvate (pyr) or 1 mM glutamine+1 mM pyruvate (gln+pyr) 
were correlated with ROS levels (A) and DpH (B). Mean of 2 independent experiments. 
Are mitochondria a direct target of F1,6bP? - To evaluate our hypothesis that the Crabtree 
effect generates ROS at the level of mitochondria, we measured the hydrogen peroxide 
production of isolated mitochondria. The latter were suspended in respiratory medium 
containing either glutamate and malate (CI substrates) or succinate (CII substrate) plus 
ADP, and increasing concentrations of F1,6bP or glucose were added. Hydrogen peroxide 
(H2O2) production was continually monitored over a period of 20 minutes using Amplex 
Red fluorescence and the linear rate of fluorescence increase was calculated as a measure 
of H2O2 production. H2O2 production by mitochondria respiring on CI or CII substrates was 
similar (p=0.0736; Fig. 7.7A). The addition of F1,6bP dose-dependently increased H2O2 
production on both CI and CII substrates (Fig. 7.7B), while glucose did not. Subsequent 
addition of ROT or AA were used as positive controls, which increased H2O2 production 
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rates of mitochondria respiring on CI-selective substrates independent of the glucose or 
F1,6bP concentration but increased ROS production of mitochondria respiring on succinate 
at a variable rate only in the presence of glucose or F1,6bP (Fig 7.7C). 
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Figure 7.6 HEt oxidation in intact cells
(A) Mitochondrial fluorescence intensity of HEt oxidation products in intact cells treated with 
increasing glucose concentrations in HT buffer for a total of 30 minutes. Asterisks indicate a significant 
difference from 25 mM glucose. In (B), these values were correlated to O2 consumption and fitted 
to an monoexponential fit: (y(t) = y0 + A⋅e(-t/τ). Each data point reflects the mean of 3 independent 
measurements. (C) Effect of the addition of 100 nM of ROT for 10 minutes on the mean mitochondrial 
HEt oxidation signal (n.s.). Mean of 3 independent experiments. 
Mode of action of F1,6bP - Because phosphorylated sugars cannot permeate biological 
membranes, we hypothesised that a metabolite of F1,6bP could enter mitochondria to reach 
the respiratory chain and induce ETC inhibition. During glycolysis, F1,6bP is metabolised 
to glyceraldehyde-3-phosphate (GA3P) and dihydroxyacetone-phosphate (DHAP). These 
triose phosphates can be non-enzymatically broken down to form methylglyoxal (MGO), 
which is an α,b-dicarbonyl very potent to induce protein glycation [304]. In contrast to 
F1,6bP, α,b-dicarbonyls can diffuse through lipid membranes [305,306]. Our hypothesis 
was also influenced by findings showing that in a rat model of diabetes, CIII was inhibited by 
MGO-induced protein glycation [307]. In the latter model, administration of the dicarbonyl 
scavenger aminoguanidine (AG) reversed the inhibition of CIII activity and respiration, 
and decreased oxidative damage to mitochondrial proteins. Therefore we reasoned that 
increased levels of F1,6bP might glycation damage and thereby alter mitochondrial 
respiration (Fig. 7.8A). To test this idea, permeabilised cells respiring on CI substrates were 
treated with 5 mM of the nonhydrolysable F1,6bP analogue 2,5-anhydro-D-mannitol (2,5-
M) [308]. While 5 mM F1,6bP induced a strong decrease in mitochondrial respiration, 
2,5-M had no effect (Fig. 7.8B). In contrast, 50 mM of MGO reduced the respiration of 
permeabilised cells. This lowering was prevented by pre-administration of 100 mM AG in 
intact cells (Fig. 7.8C). This method successfully prevented respiration inhibition by 5 mM 
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F1,6bP (Fig. 7.8D), suggesting that in these cells at least part of the Crabtree effect is caused 
by glycation of mitochondrial proteins.
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Figure 7.7 ROS production by isolated mitochondria.
(A) Linear rate of Amplex Red-derived fluorescence increase of isolated mitochondria respiring 
on glutamate+malate (CI) or succinate (CII) substrate. Mean of 16 replicates in 4 independent 
measurements. (B) The effect of increasing concentrations of F1,6bP and glucose on Amplex Red-
derived fluorescence. Asterisks indicate a significant difference from the same concentration of 
glucose. (C) The mean rate of resorufin fluorescence increase during 30 min after addition of 100 
nM ROT or AA to the samples shown in (B). Each data point reflects the mean of 8 replicates in 4 
independent experiments. 
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glycation end-products. (A) Hypothetical scheme. After glucose enters the cell, it is converted to 
F1,6bP which can be subsequently split into DHAP and GA3P. These glycolysis intermediates can be 
broken down to form MGO, which then freely enters the mitochondrial matrix and induces glycation 
of mitochondrial macromolecules. O2 consumption of permeabilised cells on CI (glutamate+malate, 
GM) substrates treated with (B) either 5 mM F1,6bP or 5 mM 2,5-M, (C) 50 mM MGO with or without 
~10 min 50 mM AG intact cell-pre-treatment or (D) 5 mM F1,6bP with or without 100 mM AG pre-
treatment of permeabilised cells.
Discussion
Various theories have been postulated about the factors that contribute to the Crabtree 
effect. Because it comprises an acute reversible inhibition of mitochondrial respiration by 
glucose, most of these theories involve imbalances of metabolite concentration [295,309]. 
In this sense, it was recently proposed that a glycolysis intermediate (F1,6bP) inhibits O2 
consumption by decreasing CIII and CIV activity [297]. Here we provide evidence that 
inhibition of mitochondrial O2 consumption by external glucose is mediated by F1,6bP and 
the subsequent formation of mitochondrial glycation products. 
In intact HEK293 cells, glucose acutely inhibited mitochondrial respiration within the 
physiological concentration range (<5 mM). Because the non-metabolizable glucose 
analogue 2DG increased respiration of cells incubated with Crabtree-inducing concentrations 
of glucose, it seems that 2DG (partially) prevents the Crabtree effect. Because 2DG and 
glucose use the same glucose transporter for cellular entry, 2DG could competitively 
inhibit glucose influx. Consequently, 2DG prevents the formation of downstream glycolytic 
intermediates by inhibition of hexokinase. Although 2DG inhibited routine respiration at 
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lower glucose concentrations, maximal (ETS) respiration was less affected than with glucose. 
Therefore it seems that inhibition of respiration by 2DG does not resemble the inhibition by 
glucose, suggesting that glucose metabolism is required to induce a typical Crabtree effect. 
The finding that glucose does not decrease CI- and CII-driven respiration in permeabilised 
cells supports this conclusion. 
In contrast to 2DG, the D-glyeraldehyde-3-phosphate dehydrogenase inhibitor iodoacetic 
acid (IAA), did not reverse the inhibitory effect of glucose on O2 consumption in various cell 
systems [295]. This suggests that a glycolysis intermediate located between the inhibitory 
sites of 2DG and IAA is involved in the Crabtree effect (Fig. 7.8A). Addition of one of these 
intermediates, F1,6bP (5 mM), to permeabilised cells induced an acute small inhibition of 
respiration and a subsequent larger inhibition (by max. 35% of pre-inhibition) within 20 
minutes. This suggests that F1,6bP requires further reaction steps and/or accumulation of 
reaction products to achieve its full effect. Therefore, we conclude that glucose metabolism 
to F1,6bP results in inhibition of mitochondrial respiration. 
It is remarkable that F1,6bP, an intermediate of glycolysis which is produced in every cell, 
can induce inhibition of O2 consumption in Crabtree-sensitive cells but not in others. One 
possibility is that it accumulates to high concentrations in Crabtree-sensitive cells only, 
suggesting increased phosphofructokinase activity or decreased activity of a downstream 
glycolysis enzyme. Alternatively, F1,6bP might only have an inhibitory effect when it can 
interact with or enter the mitochondria. Due to the absence of dedicated mitochondrial 
hexose transporters, it seems rather unlikely that a large sugar could enter the mitochondria. 
However, a mitochondrial matrix-localised D-glucose-6-phosphate dehydrogenase was 
identified recently which suggests that mitochondria might participate in hexose phosphate 
metabolism through unknown pathways [267]. Conversion of F1,6bP into the triose 
phosphates GA3P and DHAP can potentially result in the spontaneous formation of the α,b-
dicarbonyl MGO [304]. Upon diffusing into mitochondria [305,306], α,b-dicarbonyls can 
induce glycation of mitochondrial proteins, and thereby alter their function. The potency of 
these modifications to decrease O2 consumption, ATP levels, CIII activity and increase ROS 
levels has been previously demonstrated (reviewed by [304]). Importantly, we here show that 
the prototypical dicarbonyl scavenger AG prevents the acute decrease in respiration caused 
by F1,6bP. This strongly suggests that mitochondrial proteins involved in O2 consumption 
are targets of glycation. For example, it has been shown that glutamate dehydrogenase 
activity was decreaed by methylglyoxal-induced glycation [310]. Alternatively, ETC activity 
could be affected indirectly by glycation of mitochondrial DNA and lipids [304]. 
Increased superoxide levels have been associated with hyperglycaemia in diabetes [293] 
and were suggested to mediate the Crabtree effect [311]. Increased ROS production could 
ultimately lead to inhibition of GA3P dehydrogenase, which then also increases the levels 
of GA3P and DHAP (Fig. 7.8A). Moreover, increased ROS levels can possibly promote lipid 
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peroxidation and thereby influence ETC activity by itself but also form a source of another 
α,b-dicarbonyl species called glyoxal [304]. In this study, both glucose supplementation to 
intact cells and F1,6bP addition to isolated mitochondria dose-dependently increased ROS 
levels. Whereas the HEt oxidation measurements in intact cells give an indication of cellular 
ROS (or perhaps more specifically, superoxide levels [171]) not specifically generated 
in the mitochondria, Amplex Red reacts with hydrogen peroxide, generated directly or 
via dismutation of superoxide, that diffuses out of isolated mitochondria. Despite these 
differences, both probes direct to a common conclusion; increasing intracellular glucose 
levels are metabolized to F1,6bP that directly interacts with mitochondria to stimulate ROS 
production. These ROS are probably produced by CIII because inhibition of CI by ROT 
increased the HEt fluorescence in intact cells, arguing against RET to CI. 
Conclusion & Future Directions
Based on our results, we hypothesise that increased levels of F1,6bP form precursors 
of α,b-dicarbonyls, that decrease mitochondrial respiration by specific glycation of 
mitochondrial proteins, DNA or lipids. Since the inhibitory effect of F1,6bP is only observed 
in permeabilised cells and isolated mitochondria, this theory would require fructose-
bisphosphate aldolase (or just aldolase) to be physically attached to the mitochondrial outer 
membrane to be able to perform the reaction that converts F1,6bP to GA3P and DHAP. 
Indeed, aldolase has been reported to be conditionally bound to intracellular membranes 
in rat liver [312]. Potentially, subcellular localization of aldolase could be under the same 
type of regulation as the glycolysis enzyme hexokinase, which can be found either in the 
cytosol or bound to the outer membrane protein voltage dependent anion channel (VDAC) 
[313,314]. Future investigations will have to provide evidence for this theory. In addition, 
the existence, reversibility and identity of glycated mitochondrial proteins is currently 
unknown, although candidate proteins have been previously identified [306]. Moreover, 
because in addition to dicarbonyl scavenging AG also inhibits nitric oxide synthase and 
semicarbazide-sensitive amine oxidase [315], further confirmation is needed for the effects 
of glycation on mitochondrial respiration. 
Although all the theories described above are interconnected, it is interesting to speculate 
that there is not a single mechanism describing the Crabtree effect but instead that this 
phenomenon can be observed as a consequence of several independent pathways, 
contingent on the preferred metabolism of the organ or cell under study. For example, in 
addition to the many hypotheses related to metabolite imbalances, a signalling pathway 
previously associated with glucose sensing and diabetes was recently identified to be a 
central player in the Crabtree effect [316]. In fact, metabolic flexibility is one of the most 
prominent hallmarks of most cancerous cells, utilised to overcome any “roadblock” they 
encounter. Blocking every escape route might kill even the most resistant tumour cells in 
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the end and by delineating every single aspect of the Crabtree effect might just give us the 
right tools to do so.
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Introduction
Mitochondria are central to the production and regulation of energy in the eukaryotic cell. 
This process of energy transfer and conversion also generates reactive oxygen species (ROS), 
which are often associated with diseases including genetic metabolic disorders, cancer, 
diabetes and metabolic syndrome, Alzheimer’s and Parkinson’s disease [12,13,317–319]. 
Because mitochondrial ROS production is linked to metabolism [7], it is strictly regulated. 
ROS are increasingly recognized as important intracellular signalling molecules (e.g. [52]). 
As a consequence, any alteration or imbalance in the amount, localization or types of ROS 
species could result in cellular dysfunction and ultimately, pathogenesis. This is exemplified 
in the most frequently encountered mitochondrial disorder, i.e. complex I (CI) deficiency, 
where ROS levels were found to be increased in patient-derived skin fibroblasts [20]. 
However, it remains to be investigated whether these increased ROS levels play a causative 
role in the pathology of the ensuing multisystem disease and premature death of these 
patients [15,16,18].
The aim of this thesis was to study the involvement of ROS in oxidative damage and 
signalling, both under physiological conditions and in mitochondrial dysfunction. In this 
chapter I will discuss and integrate our most important findings. 
ROS signalling potential: origin and modulating factors
As was mentioned in the General introduction and in Chapter 2, the type of ROS and 
its subcellular location determines the signalling capacity. Likewise, the mode of ROS 
production is influenced by the metabolic state of both the mitochondria and the rest of 
the cell. Hence it is of crucial importance to study mitochondrial ROS inside their natural 
milieu, the cell. 
The influence of CI and CIII inhibition on mitochondrial function - In order to explore 
the damaging and signalling roles of mitochondrial ROS in pathology, ROS levels should 
be induced to increase locally, i.e. in the mitochondria. In isolated mitochondria, CI 
and complex III (CIII) appear to be the most important sources of ROS [11]. To mimic 
mitochondria-selective ROS production in intact cells, CI and CIII were chemically inhibited 
in HEK293 cells using rotenone (ROT) and antimycin A (AA), respectively (Chapters 
5 and 6). Normally CI and CIII, together with complex IV (CIV), couple the transport of 
electrons to the translocation of protons into the mitochondrial intermembrane space 
(IMS), thereby creating a proton gradient and consequently, a membrane potential (Dy). 
The resulting proton motive force (PMF) is then consumed by the ATP synthase (complex 
V; CV) to produce ATP. Together, CI-CIV and CV constitute the oxidative phosphorylation 
(OXPHOS) system (Figure 8.1, CT). The chemical inhibition of CI and CIII decreased oxygen 
consumption to such an extent that the Dy was expected to have collapsed. Since it appears 
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that both ROS production and its detection are dependent on an intact Dy [320,321], we 
investigated the regulation of Dy after CI and CIII inhibition in Chapter 5. CIII inhibition 
resulted in Dy depolarization, whereas CI inhibition surprisingly increased Dy in a dose-
dependent fashion. Correspondingly, the cytosolic pH was decreased and the proton load 
of the mitochondrial matrix was increased in CIII-inhibited cells, indicative of a decreased 
DpH. In contrast, CI inhibition did not decrease the mitochondrial pH, confirming a lack 
of Dy depolarisation. Moreover, the Dy of CI-inhibited cells was extremely sensitive to 
chemical OXPHOS uncoupling. Together, these data indicated an increased proton gradient 
in CI-inhibited cells, suggesting that other mitochondrial proton pumps might increase Dy. 
We demonstrated that the Dy was not increased due to the well-established mechanism 
of CV reverse mode, which consumes ATP to expel protons to the IMS [204], but instead 
seemed to be driven by combined activity of CIII and CIV fuelled by electron input at 
complex II (CII; Figure 8.1, ROT). In this chapter we also discovered that inhibition of CIII 
triggered both CV and CI to run in reverse mode, resulting in net consumption of Dy and 
the production of high levels of NADH and hydroethidine (HEt)-detectable ROS (Figure 8.1, 
AA). In conclusion, the stimulation of ROS production by ROT and AA unavoidably altered 
mitochondrial function. This likely influences the amount of ROS production, which is 
known to be modulated by parameters such as the NAD+/NADH ratio and Dy [7]. The types 
and modes of ROS production under these conditions will be discussed in more detail in 
a separate section.
The influence of cell culture conditions on mitochondrial function - The studies in Chapters 
5 and 6 were mainly focussed on mitochondrial dysfunction; in Chapter 7 we investigated 
ROS signalling under physiologically relevant conditions during cell culture. Preliminary 
work had shown that when HEK293 cells were kept in a minimal medium containing low 
glucose (<5 mM) concentrations, oxygen consumption was higher than in the normal high 
glucose (25 mM) cell culture medium. This phenomenon, which was fully reversible, is 
also known as the Crabtree effect [277]. Further investigations revealed that respiration was 
partially inhibited at concentrations that were lower than physiologically relevant (i.e., <4-8 
mM), suggesting that the Crabtree effect might also occur in vivo. Importantly, the glucose-
induced inhibition of respiration also resulted in elevated ROS levels. Even though chemical 
inhibition of all OXPHOS complexes was effective indicating persistent mitochondrial 
activity, the Crabtree effect could have influenced subsequent ROS measurements in CI- 
and CIII-inhibited cells. In particular, increased basal ROS levels due to high glucose in the 
medium could have resulted in an underestimation of the amount of ROS increase upon CI 
and CIII inhibition.
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Figure 8.1 The effects of CI and CIII inhibition on mitochondrial physiology in HEK293 cells. 
A schematic model of the oxidative phosphorylation system embedded in the mitochondrial inner 
membrane (MIM) of CT and ROT- or AA-treated cells. The dotted black arrows indicate electron 
transport and the grey arrows and lines depict proton movement. For details, see main text.
Spatial dynamics of ROS production detected by live cell imaging
The term “ROS” entails a family of molecules each with a distinct chemistry and reactivity. 
Once locally generated, they can either react with sensitive macromolecules or be converted 
to other types of ROS with different potential targets. Both the chemical characteristics as 
well as the location govern the signalling potential of the ROS produced. It is therefore very 
important to measure ROS levels of specific types in multiple subcellular locations in live 
cells. We focused our research methodology on the use of specific chemical probes and 
novel protein-based sensors in live-cell imaging. 
Superoxide (O2
•-) is usually the primary ROS to be generated in mitochondria. Detection 
of O2
•- by measuring HEt oxidation remains the gold standard. Although HEt specifically 
reacts with O2
•-, only the less specific reaction by-product ethidium can be detected using 
fluorescence microscopy and therefore this type of assay must be considered as a semi-
quantitative measurement [171]. The application and pitfalls of HEt and the mitochondria-
targeted HEt, referred to as Mito-HEt, are described in Chapter 3. Although both probes 
localize to the mitochondrial matrix, HEt also displays a nuclear staining. Considering the 
higher fluorescence intensity and its potential to be used as an end-point measurement, we 
opted for the detection of HEt oxidation in a mitochondria-dense and in a nuclear region, 
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with the added advantage of being able to observe possible Dy alterations as well (Chapter 
6). Human skin fibroblasts showed a higher nuclear than mitochondrial fluorescence 
[69]. In contrast, in HEK293 cells mitochondrial fluorescence is usually higher than the 
nuclear fluorescence, suggesting a higher resting Dy than in fibroblasts. This implies that 
mitochondrial physiology of HEK293 cells is fundamentally different from fibroblasts, and 
both normal ROS levels as well as increased levels caused by pathology are expected to 
be different.
Unsaturated lipids in biological membranes are highly sensitive to ROS modification. This 
so-called peroxidation of membrane lipids changes membrane fluidity and with that, protein 
activity. The mitochondrial inner membrane is particularly vulnerable to ROS modification, 
due to the close proximity of ROS-producing enzyme complexes and the presence of 
cardiolipin, a phospholipid high in unsaturated bonds [175]. Until recently mitochondria-
specific lipid peroxidation could only be measured by mitochondrial isolation or by mass 
spectrometry assessment of cardiolipin. The newly developed fluorescent lipid peroxidation 
probe MitoPerOx can be easily targeted into the matrix-facing surface of the mitochondrial 
inner membrane in live cells (Chapter 4). Hydrogen peroxide (H2O2) treatment induced a 
maximal MitoPerOx ratio increase of 25-30%, although this could be a slight underestimation 
due to imaging settings. MitoPerOx was recently used to successfully demonstrate the 
involvement of mitochondrial lipid peroxidation in mitochondrial damage caused by high 
levels of fatty acids in preadipocytes [322]. In contrast, in our study MitoPerOx ratio was 
unaffected by CI or CIII inhibition and therefore we conclude that these treatments induced 
neither general nor mitochondria-specific lipid peroxidation (Chapter 6).
In general, chemical ROS sensors are most convenient to use, due to the relative ease by 
which they can be loaded into cells and the amount of control that can be exerted on 
fluorescence intensity by varying the loading concentration. In spite of these advantages, 
none of the chemical H2O2 probes known at present are both specific for reaction with H2O2 
and have a ratiometric readout to correct for volumetric/focussing changes. In this thesis 
the protein-based H2O2-specific sensor HyPer was used [38], of which the dynamic range 
was dramatically improved during recent years [129,130]. Whereas specific reaction of 
HyPer with H2O2 results in the formation of an intramolecular disulfide bond that changes 
fluorescence emission, HyPer reduction might be dependent on the glutathione system 
[135]. Therefore, HyPer oxidation and reduction are regulated by two different redox pairs; 
2H20/H2O2 and 2GSH/GSSG. This means that HyPer might be considered as a sensor for 
the cellular thiol oxidation and reduction status rather than only intracellular [H2O2] [135]. 
Interestingly, whereas the increased HyPer ratio after addition of high concentrations (<1 
mM) of extracellular added H2O2 ([H2O2]) would return to basal levels within 20 minutes 
without further interference, this ratio increase remained stable at lower (up to 50 mM) 
[H2O2]. This suggests that only at these high [H2O2] the glutathione disulfide (GSSG; see 
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Figure 2.1) reduction system was sufficiently activated to reduce the HyPer disulfide bond. 
In this respect, it is not unlikely that the lack of CI and CIII inhibition-induced mitochondrial 
HyPer oxidation (Chapter 6) was caused by an overactive mitochondrial glutathione system, 
most notably peroxiredoxin-3 [323]. However, the co-dependence of HyPer redox state on 
the glutathione system is not a shortcoming of this sensor. The main regulatory targets of 
H2O2 are specific cysteine protein residues. In addition to its location with respect to the 
source of H2O2 and to the protein context, the oxidation state of a certain cysteine residue is 
governed by the glutathione system. Therefore, the HyPer fluorescence ratio will probably 
give a truthful representation of the H2O2 oxidation state of the cell. One more important 
factor to consider is the high pH sensitivity of cpYFP. We resolved this issue by normalizing 
the HyPer ratio changes with a HyPer mutant unresponsive to H2O2 called SypHer [41]. 
This advanced approach allowed highly specific measurements of relevant H2O2 levels and, 
because SypHer remains pH sensitive, a method to monitor local pH changes. 
In this thesis, inducible expression of these protein-based sensors (HyPer, SypHer and the 
ATP sensor ATeam) was achieved by stable transfection into HEK293 Flp-In™ T-REx cells™ 
through integration into a single site of the host genome by homologous recombination. 
Since all cells are transfected with the sensor, this system has two advantages; (i) it is 
suitable for high-throughput microscopy and (ii) we found that cells expressing cytosolic 
or mitochondrial targeted sensors plated together on a coverslip can be successfully used 
to measure cytosolic and mitochondrial responses simultaneously in a single wide-field 
imaging experiment (Figure 8.2).
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Figure 8.2 Simultaneous application of cytosolic and mitochondria-targeted sensors in a single 
experiment. (A) Grey value microscopy images of cytosolic (c) and mitochondria-targeted (m) ATeam, 
HyPer and SypHer mixed on a coverslip and their ratio image represented in pseudocolor. (B) Example 
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cells without substrates (HT), or using pyruvate as a substrate for ATP production. 
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Mitochondrial ROS production in HEK293 cells
Having established our methods, different types of ROS levels were measured after 24 
h of CI or CIII inhibition (Chapter 6). CI inhibition resulted in increased HEt oxidation 
at concentrations higher than 10 nM, indicative of O2
•- production by CI. The fact that 
extremely low (0.1 nM ROT) levels of CI inhibition decreased HEt oxidation suggests 
that CI was actively generating ROS under physiological conditions. More specifically, 
this ROT-sensitivity indicates towards ROS production through reverse electron transport 
(RET), which requires a sufficiently large PMF and succinate oxidation. In the cells studied 
in this thesis ROT dose-dependently increased Dy and with that possibly also the PMF 
(Chapter 5), which forms the ideal background for RET. However, at these higher levels 
of CI inhibition the HEt oxidation measurements suggest that CI produces ROS primarily 
in the forward mode (Fig. 8.1, ROT). In contrast to other studies (e.g. [68]) CIII inhibition 
resulted in severely increased HEt oxidation rates at low concentrations that did not acutely 
decrease respiration. Because ∼50% of this increase was sensitive to ROT (Chapter 5), 
a large part of this ROS was most likely produced by CI. This mode of ROS production 
might be termed “CI reverse mode” rather than RET, since CIII inhibited cells lack the 
essential high PMF (Fig. 8.1, AA) [66,261]. Taken our conclusion that inhibition of CIII 
induces ROS production at CI, and because in CIII patient fibroblasts HEt oxidation levels 
were not increased, ROS production by CIII is probably not very relevant in intact cells 
under most circumstances [59]. Moreover, because both CI and CIII inhibition resulted in 
higher NAD(P)H autofluorescence (Chapter 5), this might have stimulated ROS production 
by α-ketoglutarate dehydrogenase [80]. 
Finally, in chapter 7 we found that increasing extracellular glucose levels increased HEt-
detectable ROS levels probably as an effect of CIII inactivity but not through the CI reverse 
mode or RET. Where (mito)HyPer detects local H2O2 levels in intact cells, it does not 
indicate the source of this diffusible type of ROS. In contrast, Amplex Red measures H2O2 
levels that diffuse out of isolated mitochondria, and can therefore be more specifically 
interpreted as mitochondrial ROS production. Incubation of isolated mitochondria with the 
glycolysis metabolite fructose-1,6 bisphosphate (F1,6bP) increased Amplex Red oxidation, 
ROS production was most likely an effect of direct interaction of F1,6bP or its breakdown 
products with mitochondria. In contrast, incubation of mitochondria with glucose did not 
significantly increase Amplex Red oxidation. Moreover, ROT did not decrease the rate of 
Amplex Red oxidation, supporting our conclusion that the Crabtree effect does not cause 
ROS production via RET. 
Evidence for ROS signalling
As was mentioned in the General introduction, H2O2 is probably the most potent 
intracellular signalling ROS. Surprisingly, although both CI and CIII inhibition increased 
General discussion  |  141
8
HEt oxidation, H2O2 levels were mainly increased in the cytosol of CIII-inhibited cells 
and were even slightly decreased in the mitochondrial matrix of CI-inhibited cells. This 
strongly suggests a regulation of H2O2 degradation and localization. Moreover, we found 
no evidence of oxidative damage in the form of lipid peroxidation or protein carbonylation, 
implying that the increased levels of cytosolic H2O2 might function as signalling molecules. 
Because also in CI patient fibroblasts the cytosolic thiol redox status is more oxidized 
whereas the mitochondrial thiol redox status was unchanged [20,268], we might conclude 
that in general CI dysfunction leads to increased ROS levels that do not harm the cell 
through classical oxidative damage. Instead it seems that these changes in ROS/redox 
status bring about more subtle adaptations to for instance protein thiols that alter their 
function and thereby deregulate cell physiology. In that respect, it is interesting to note that 
mitochondrial protein thiols are much more vulnerable to redox modifications than those 
in the cytosol, facilitated by the high pH of the mitochondrial matrix compartment [33,34]. 
One of the least known thiol modifications is glycation, which is mostly associated with 
the formation of glycation damage on nucleotides, lipids and protein amino groups [304]. 
Although related to and in some circumstances precursor to the above-mentioned protein 
carbonylation [260], glycation can arise from a large variety of reactions including lipid 
peroxidation [304,324]. We found evidence that the Crabtree effect might be caused by 
F1,6bP breakdown products, resulting in the formation of the glycating dicarbonyl species 
methylglyoxal (Chapter 7). Interestingly, while methylglyoxal has been demonstrated to 
decrease CIII activity [307], to our knowledge it has never been shown that this type of 
modification could be derived from glucose metabolism at physiological concentrations. 
Since the Crabtree effect is reversible, these glucose-derived modifications could prove to 
be a new field of hitherto unexplored cellular signalling molecules involved in fine-tuning 
energy metabolism through glycolysis and the respiratory chain. Further research will have 
to solidify these observations and identify its potential molecular targets. 
Regulation of ROS production by CI via mPTP - Finally I would like to propose a last 
addition to a theoretical model (Figure 8.1) that could bring together our findings on 
mitochondrial ROS production and Dy. Under certain (pathological) circumstances usually 
involving oxidative stress and high [Ca2+]m, a pore will open in the MIM to allow entrance 
of molecules of up to 1.5 kDa in size [325,326]. Prolonged opening of this so-called 
mitochondrial permeability transition pore (mPTP) leads to a decrease in Dy and ultimately, 
necrotic cell death. In several cell types, direct or indirect CI inhibition prevented mPTP 
opening by a mechanism similar to inhibition by cyclosporin A (CsA) [327,328]. Even 
more, CI was suggested to be a component of the mPTP because electron flux through 
CI increased the open probability of the mPTP [329]. In Leishmania mitochondria CsA 
prevented the depolarization induced by CII and CIII inhibition but did not reduce the 
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ROT-induced hyperpolarization [219], suggesting that CII and CIII inhibition induced mPTP 
opening whereas CI inhibition prevented mPTP opening, causing a Dy increase. Extending 
this theory to our finding that CI inhibition prevented depolarization caused by CIII (and 
CIV) inhibition, suggests that ROT reversed mPTP opening. Although it seems plausible 
according to this theory that CI is physically part of the mPTP, it could also be that CI has 
a mere regulatory or modulating function in this process. If this is true, this will open new 
windows of opportunity to interfere with ROS production by CI to prevent cell death in 
CI-related disease.
Concluding remarks
This thesis provides evidence for the specific and localized increase in ROS levels as a result 
of respiratory chain malfunction, which, importantly, did not result in obvious oxidative 
damage. This suggests that either (i) the cell can cope with these increased ROS levels by 
upregulating protective antioxidant systems that do not change the overall ROS levels or 
that (ii) the damage caused is more subtle, possibly leading to deregulation of intracellular 
processes rather than general dysfunction and cell death. Understanding how exactly 
these mitochondrial ROS act as signalling molecules that regulate normal cell function, 
however, will still require extensive future research. An interesting approach would be to 
use proteomic approaches to identify cysteine oxidative modifications on mitochondrial 
proteins [330]; this will likely be one of the major mechanisms that influence signalling 
by ROS. For instance, cysteine oxidation has been shown to reduce activity of proteins 
involved in calcium handling [274], which is disturbed in most CI-deficient patients [276].
Instead of increasing ROS production by changing mitochondrial function, as was the focus 
in this thesis, an alternative strategy could be applied using specific antioxidant molecules 
to decrease endogenous ROS levels. For example, the vitamin E analog Trolox reduced 
the levels of CM-H2DCF oxidizing ROS, lowered cellular lipid peroxidation, and induced 
a less oxidized mitochondrial thiol redox state in healthy human skin fibroblasts [160]. 
These decreased ROS levels presumably led to increased OXPHOS activity and oxygen 
consumption, and improved calcium handling. In HEK293 cells, however, Trolox did not 
increase oxygen consumption (unpublished data). Nonetheless, both cell lines were more 
sensitive to FCCP-induced uncoupling and further analysis showed that Trolox induced 
a higher reserve respiratory capacity paralleled by a decrease in ATP production-linked 
respiration. This suggests that also antioxidants can induce diverse side effects that might 
not be beneficial per se or have the same influence in every cell type or organ. The main 
challenge in these kinds of approaches will be to disentangle oxidant/antioxidant-specific 
effects from the possible side effects on for instance enzyme activity and membrane 
fluidity. Another level of complexity is introduced by the different culture and experimental 
conditions that are used across different cell lines and labs. Although in most cell lines 
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CI inactivity decreases Dy, it actually increases Dy in others (Chapter 5). Potentially, this 
could be caused by a difference in preferred metabolic pathway. As shown in Figure 8.2, 
switching from high glucose to glutamine or pyruvate drastically decreases mitochondrial 
ATP levels although CV is clearly still active. Moreover, in Chapter 7 we have shown that 
these same substrate alterations decrease the proton gradient and at the same time increase 
oxygen consumption. These changes all affect OXPHOS function, and therefore most 
likely will change the amount and perhaps the sites of ROS production within the electron 
transport chain (ETC). Of course, the most straightforward way to tackle this problem would 
be to measure ROS levels of an organ of interest in its natural environment, i.e. in vivo. 
An interesting recent development in this field is the mitochondria-targeted probe MitoB, 
which is oxidized by H2O2 in vivo and can be analysed using mass spectrometry [186].
In conclusion, our advancing knowledge on the cause and origin of increased ROS in 
mitochondrial disease and the identification of their targets will prove to be essential for the 
development of treatment strategies in a large range of pathologies.
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Samenvatting
Elke reactie die plaats vindt in de cellen van ons lichaam heeft energie nodig. Deze 
energie wordt verkregen uit het energierijke molecuul ATP. ATP wordt voor het grootste 
deel geproduceerd door een netwerk van subcompartimenten binnenin iedere cel, de 
mitochondriën. Energierijke suikers zoals glucose worden na opname uit het bloed via 
een serie enzymatische reacties afgebroken tot pyruvaat, waarbij per saldo twee ATP 
moleculen ontstaan. Het gevormde pyruvaat kan vervolgens de mitochondriën in worden 
getransporteerd en via diverse reacties in de citroenzuurcyclus worden omgezet in 
energiedragende moleculen zoals NADH. Uiteindelijk worden de energierijke elektronen 
uit NADH door een keten van enzymcomplexen (complex I tot V, ofwel CI-CV) gebruikt om 
een protonengradiënt op te bouwen die de aandrijving vormt voor complex V (CV), oftewel 
ATP synthase, om nog eens 28-30 ATP moleculen te produceren. De getransporteerde 
elektronen worden normaal geneutraliseerd door hun reactie met zuurstof, waarbij water 
ontstaat. Dit is de reden waarom wij zuurstof nodig hebben; het wordt verbruikt in de 
mitochondriën. De elektronen in dit proces van energieoverdracht en -omzetting kunnen 
echter ook reactieve zuurstofradicalen (ROS, “reactive oxygen species”) vormen, welke 
vaak geassocieerd worden met ziektes zoals genetische metabole stoornissen, kanker, 
diabetes en metabool syndroom en de ziektes van Alzheimer en Parkinson. De productie 
van mitochondriële ROS is zeer strikt gereguleerd doordat het gekoppeld is aan de metabole 
staat van de cel of het organisme. ROS, en de producten die ontstaan na reactie van 
ROS met andere cellulaire (macro)moleculen, worden daarom meer en meer erkend als 
belangrijke intracellulaire signaleringsmoleculen. Derhalve kan elke vorm van verandering 
of onbalans in de hoeveelheid, intracellulaire locatie of chemische samenstelling van 
ROS resulteren in cellulaire dysfunctie en uiteindelijk in ziekte. Een duidelijk voorbeeld 
hiervan is de verhoogde ROS niveaus in cellen van patiënten met een afwijking in complex 
I (CI). CI-deficiëntie is de meest voorkomende mitochondriële ziekte waar patiënten vaak 
op jonge leeftijd aan overlijden. Het is tot op heden echter onduidelijk welke rol deze 
verhoogde ROS niveaus spelen in de waargenomen multisysteem ziekteverschijnselen in 
de CI-deficiënte patiënten.
Het doel van het onderzoek beschreven in dit proefschrift was om de rol van ROS in het 
veroorzaken van celschade en als signaleringsmolecuul beter te begrijpen, dit zowel onder 
normale omstandigheden als in cellen met een afwijking in de mitochondriële functie.
Om de rol van ROS te kunnen bestuderen hebben we diverse onderzoeksmethoden 
ontwikkeld die het mogelijk maken om ROS te bepalen in specifieke compartimenten in de 
cel. Hiertoe hebben we gebruik gemaakt van fluorescente chemische en eiwit-gebaseerde 
sensoren. In Hoofdstuk 2 wordt een overzicht gegeven van de momenteel beschikbare 
sensoren en in Hoofdstuk 3 zijn protocollen beschreven om (i) de mitochondriële morfologie 
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en protongradiënt te bepalen en (ii) voor het meten van ROS aan de hand van de mate van 
hydroethidium (HEt) oxidatie. We hebben een nieuwe chemische sensor ontwikkeld om 
mitochondrieel-specifieke lipideperoxidatie te kunnen meten in levende cellen, genaamd 
MitoPerOx (Hoofdstuk 4). 
De potentie van ROS als signaleringmolecuul wordt mede bepaalt door de locatie 
van productie. Omdat de productie van mitochondriële ROS wordt beïnvloed door de 
metabolische staat van de cel, hebben wij mitochondriële ROS bestudeerd in zijn 
natuurlijke omgeving, namelijk in levende cellen. Eerder onderzoek duidde erop dat CI en 
complex III (CIII) de belangrijkste bronnen van ROS zijn in geïsoleerde mitochondriën. Om 
ROS productie door CI en CIII te induceren in levende cellen hebben we CI en CIII activiteit 
onderdrukt met behulp van chemische remmers. Dit zou echter als gevolg hebben dat de 
protonengradiënt die wordt opgebouwd tijdens elektronentransport door CI, CIII en CIV niet 
in stand zou kunnen worden gehouden. Omdat een verandering van de protonengradiënt 
en het daaruit volgende potentiaalverschil (Dy) implicaties heeft voor zowel de productie 
als de detectie van ROS, hebben we de regulatie van Dy als gevolg van CI en CIII remming 
onderzocht in Hoofdstuk 5. We vonden dat hoewel CIII remming de protonengradiënt 
verlaagde, CI remming juist zorgde voor een verhoging van de protonengradiënt. Dit laatste 
suggereert dat de protonengradiënt niet of minder wordt verbruikt als CI geremd wordt, en/
of dat andere protonpompen het gradiënt in stand kunnen houden. Een bekend mechanisme 
dat een verhoogd potentiaalverschil kan veroorzaken is de omgekeerde activiteit van ATP 
synthase, waardoor deze ATP gaat verbruiken om de protonengradiënt hoog te kunnen 
houden. ATP synthase leek echter de Dy niet op te bouwen, maar ook nauwelijks te 
verbruiken. Dit zou een deel van de verhoogde Dy kunnen verklaren. Verder onderzoek 
wees uit dat CII activiteit nog intact was, en via die route CIII en CIV in staat stelt om de 
protonengradiënt hoog te houden terwijl de ATP synthase deze bijna niet meer consumeert. 
Tevens hebben wij ontdekt dat remming van CIII resulteerde in omgekeerde activiteit van de 
ATP synthase en van CI, met als gevolg dat per saldo Dy wordt geconsumeerd en dat zowel 
NADH als ROS niveaus verhoogd waren in CIII-geremde cellen. Dit onderzoek heeft ons 
meer inzicht gegeven over hoe Dy wordt geconsumeerd wanneer CI en CIII activiteit wordt 
onderdrukt, met name over het ontstaan van een verhoogd potentiaalverschil. Daarnaast 
kunnen we ook concluderen dat de stimulatie van ROS productie door remming van CI en 
CIII onvermijdelijk tot een verandering van mitochondriële functie leidt.
In Hoofdstuk 6 hebben we vervolgens de hoeveelheid en de verschillende types ROS die 
ontstonden door remming van CI en CIII in meer detail bestudeerd. Elk type ROS type heeft 
een andere chemische samenstelling die de potentie om met cellulaire (macro)moleculen 
te reageren bepaalt. Superoxide (O2
•-) is meestal het eerste ROS type dat geproduceerd 
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wordt na een onvolledige reactie van zuurstof met elektronen. We hebben O2
•- niveaus 
bepaald aan de hand van HEt oxidatie, een verhoogde HEt oxidatie geeft aan dat er meer 
O2
•- was. Een zeer milde remming van CI verlaagde de oxidatie van HEt, wat suggereert 
dat CI actief ROS produceerde onder fysiologische omstandigheden. Echter hoe meer CI 
geremd werd, hoe meer HEt oxidatie gemeten werd. Toch betekent dit niet per se dat deze 
ROS door CI werd geproduceerd, het is ook mogelijk dat deze werd gegenereerd door 
het mitochondriële enzym α-ketoglutaraat dehydrogenase, die ROS kan produceren bij 
een verhoogd NADH (gemeten in Hoofdstuk 5). Milde remming van CIII resulteerde in 
zeer verhoogde HEt oxidatie. Omdat ongeveer 50% van deze toename in HEt oxidatie 
gevoelig was voor remming van CI, werd een groot deel van deze ROS waarschijnlijk door 
CI geproduceerd en niet door CIII. Welk enzym binnen de mitochondriën O2
•- produceert is 
van groot belang voor de mogelijke schade die het kan veroorzaken; O2
•- is zodanig reactief 
dat het maar een zeer kleine reikwijdte heeft.
Een andere belangrijk ROS is waterstofperoxide (H2O2). Dit kan gevormd worden door 
zowel spontane als enzymatische omzetting van O2
•-. Omdat H2O2 minder reactief is kan 
het ook met verder gelegen moleculen reageren, met name eiwitten. Om H2O2 specifiek 
in de mitochondriën en in het grootste compartiment van de cel genaamd het cytosol 
te meten, hebben we gebruik gemaakt van de H2O2 sensor HyPer. Door de uitkomsten 
van deze sensor te vergelijken met een H2O2-ongevoelige controle (SypHer), kon een 
zeer goede schatting worden gemaakt van de lokale H2O2 niveaus. Hoewel CI en CIII 
remming HEt oxidatie verhoogde, was het H2O2 niveau alleen verhoogd in het cytosol 
van CIII-geremde cellen en zelfs lichtelijk verlaagd in de mitochondriën van CI-geremde 
cellen. De verhoogde cytosolische H2O2 niveaus resulteerden bovendien niet in schade 
aan macromoleculen zoals membranen of eiwitten. Dit suggereert dat de lokalisatie en 
neutralisatie van H2O2 strikt gereguleerd zijn, wat dus een sterke indicatie is voor ROS als 
een signaleringsmolecuul.
De studies in beschreven in Hoofdstuk 5 en 6 waren vooral gebaseerd op mitochondriële 
dysfunctie; in Hoofdstuk 7 hebben ROS bestudeerd onder meer fysiologisch relevante 
omstandigheden tijdens de celkweek. Voorbereidend werk had aangetoond dat gekweekte 
humane cellen meer zuurstof gebruiken in celkweekmedium met een lage concentratie 
glucose (<5 mM) dan in hoog-glucose (25 mM) medium. Dit verschijnsel, dat volledig 
omkeerbaar is, staat ook wel bekend als het Crabtree effect. We hebben aangetoond dat 
zuurstofconsumptie gedeeltelijk geremd werd bij concentraties die lager zijn dan normale 
bloedsuiker niveaus (oftewel <4-8 mM), wat suggereert dat het Crabtree effect ook kan 
optreden in ons lichaam. Een zeer belangrijke bevinding hierbij was, dat de remming 
van mitochondriële functie door glucose een verhoogde mitochondriële ROS productie 
als gevolg had. Het is mogelijk dat glucose dus fungeert als signaleringsmolecuul via de 
regulatie van lokale ROS productie. 
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In dit proefschrift heb ik inzicht verkregen in de specifieke en gelokaliseerde toename in 
ROS niveaus als gevolg van mitochondriële dysfunctie. Een zeer belangrijke bevinding 
hierbij was deze verhoogde ROS niveaus niet per definitie tot celschade leken te leiden. Dit 
zou kunnen betekenen dat (i) de cel met deze verhoogde ROS niveaus om kan gaan doordat 
het bijvoorbeeld antioxidant systemen aanzet of dat (ii) de schade vrij subtiel is en resulteert 
in deregulatie van processen in de cel maar niet in algemene dysfunctie en celdood. H2O2 
kan bijvoorbeeld zeer effectief reageren met bepaalde regio’s in met name mitochondriële 
eiwitten, waardoor de activiteit van deze eiwitten veranderd. De identificatie van de eiwitten 
die hierdoor gemodificeerd worden kan mogelijk meer inzicht geven in hoe mitochondriële 
ROS normale celfunctie reguleert/beïnvloedt. Een gedetailleerd begrip van de oorzaak en 
oorsprong van verhoogde ROS in mitochondriële ziekten en de processen die hierdoor 
beïnvloed worden zal instrumenteel zijn in de ontwikkeling van therapeutische strategieën.
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